Medications for human use with a single active ingredient starting with the letter A-C

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre A-C

Updated | Mise à jour : 2021-09-02
∙ Product Name | Nom du produit
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercisalisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN:
Monograph | Monographie
∙ ZIAGEN
∙ abacavir (abacavir sulfate) 20 mg / ml;
∙ 1999-06-15;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02240358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63900
∙ ZIAGEN
∙ abacavir (abacavir sulfate) 300 mg;
∙ 1999-06-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02240357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63899
∙ APO-ABACAVIR
∙ abacavir (abacavir sulfate) 300 mg;
∙ 2016-03-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02396769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88178
∙ MINT-ABACAVIR
∙ abacavir (abacavir sulfate) 300 mg;
∙ 2019-03-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02480956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97160
∙ ORENCIA
∙ abatacept 125 mg / ml;
∙ 2013-05-09;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02402475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88731
∙ ORENCIA
∙ abatacept 250 mg / vial;
∙ 2006-08-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02282097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76776
∙ VERZENIO
∙ abemaciclib 100 mg;
∙ 2019-07-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02487101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97724
∙ VERZENIO
∙ abemaciclib 150 mg;
∙ 2019-07-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02487128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97725
∙ VERZENIO
∙ abemaciclib 200 mg;
∙ 2019-07-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02487136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97726
∙ VERZENIO
∙ abemaciclib 50 mg;
∙ 2019-07-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02487098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97723
∙ ZYTIGA
∙ abiraterone acetate 250 mg;
∙ 2011-07-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02371065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85626
∙ REDDY-ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02477114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96788
∙ SANDOZ ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-01-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02486393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97660
∙ APO-ABIRATERONE FILM COATED TABLETS
∙ abiraterone acetate 250 mg;
∙ 2021-01-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02491397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98140
∙ PMS-ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-01-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02492601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98260
∙ NAT-ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-01-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02494132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98417
∙ JAMP ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-02-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02502305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99188
∙ MAR-ABIRATERONE
∙ abiraterone acetate 250 mg;
∙ 2021-02-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02503980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99344
∙ ZYTIGA
∙ abiraterone acetate 500 mg;
∙ 2016-09-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02457113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94420
∙ APO-ABIRATERONE FILM COATED TABLETS
∙ abiraterone acetate 500 mg;
∙ 2021-01-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02491400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98141
∙ PMS-ABIRATERONE
∙ abiraterone acetate 500 mg;
∙ 2021-01-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02501503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99112
∙ MAR-ABIRATERONE
∙ abiraterone acetate 500 mg;
∙ 2021-02-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02503999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99345
∙ DYSPORT AESTHETIC
∙ abobotulinumtoxina 300 unit / vial;
∙ 2013-02-19;
∙ Intramuscular | Intramusculaire;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02387735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87332
∙ DYSPORT THERAPEUTIC
∙ abobotulinumtoxina 300 unit / vial;
∙ 2017-02-27;
∙ Intramuscular | Intramusculaire;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02460203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94749
∙ DYSPORT THERAPEUTIC
∙ abobotulinumtoxina 500 unit / vial;
∙ 2017-02-27;
∙ Intramuscular | Intramusculaire;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02456117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94296
∙ CALQUENCE
∙ acalabrutinib 100 mg;
∙ 2019-10-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02491788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98179
∙ CAMPRAL
∙ acamprosate calcium 333 mg;
∙ 2007-07-30;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02293269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77863
∙ GLUCOBAY
∙ acarbose 100 mg;
∙ 1996-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02190893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19655
∙ ACARBOSE TABLETS
∙ acarbose 100 mg;
∙ 2020-05-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ STRIDES PHARMA CANADA INC;
∙ DIN: 02493799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98379
∙ MAR-ACARBOSE
∙ acarbose 100 mg;
∙ 2020-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02494086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98411
∙ GLUCOBAY
∙ acarbose 50 mg;
∙ 1996-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02190885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19648
∙ ACARBOSE TABLETS
∙ acarbose 50 mg;
∙ 2020-05-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ STRIDES PHARMA CANADA INC;
∙ DIN: 02493780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98378
∙ MAR-ACARBOSE
∙ acarbose 50 mg;
∙ 2020-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.02 – ALPHA-GLUCOSIDASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02494078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98410
∙ APO-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 100 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02147602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17826
∙ ACEBUTOLOL-100
∙ acebutolol (acebutolol hydrochloride) 100 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02164396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19939
∙ TEVA-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 100 mg;
∙ 1996-08-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02204517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42996
∙ APO-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 200 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02147610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17827
∙ ACEBUTOLOL-200
∙ acebutolol (acebutolol hydrochloride) 200 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02164418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19940
∙ TEVA-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 200 mg;
∙ 1996-08-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02204525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42997
∙ APO-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 400 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02147629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17828
∙ ACEBUTOLOL – 400
∙ acebutolol (acebutolol hydrochloride) 400 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02164426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19941
∙ TEVA-ACEBUTOLOL
∙ acebutolol (acebutolol hydrochloride) 400 mg;
∙ 1996-08-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02204533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42998
∙ ACETAMINOPHEN INJECTION
∙ acetaminophen 10 mg / ml;
∙ 2019-09-13;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02483343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97378
∙ ACET 120
∙ acetaminophen 120 mg;
∙ 1998-01-05;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02230434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49357
∙ ACETAMINOPHEN CHEWABLE TABLETS 160 MG
∙ acetaminophen 160 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 01996169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14449
∙ ACETAMINOPHEN CHEWABLE TABLETS 160 MG FOR CHILDREN
∙ acetaminophen 160 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02017431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14450
∙ ACET 160
∙ acetaminophen 160 mg;
∙ 1998-01-05;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02230435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49359
∙ ACETAMINOPHEN 160 MG CHEWABLE TABLETS
∙ acetaminophen 160 mg;
∙ 1998-08-27;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 02237562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60900
∙ CHILDREN’S TYLENOL CHEWABLES
∙ acetaminophen 160 mg;
∙ 2000-08-22;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02241361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64993
∙ CHILDREN’S TYLENOL FEVER & SORE THROAT PAIN
∙ acetaminophen 160 mg;
∙ 2015-07-06;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02435144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91942
∙ JUNIOR STRENGTH CHILDREN’S ACETAMINOPHEN TABLETS
∙ acetaminophen 160 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02447819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93341
∙ PDP-ACETAMINOPHEN SOLUTION 160MG/5ML
∙ acetaminophen 160 mg / 5 ml;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00792691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10450
∙ ACETAMINOPHEN ORAL SOL FOR CHILDREN USP
∙ acetaminophen 160 mg / 5 ml;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 01958836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12412
∙ ACETAMINOPHENE – LIQ 160 MG/5 ML
∙ acetaminophen 160 mg / 5 ml;
∙ 1997-01-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02226871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33482
∙ TEMPRA DOUBLE STRENGTH CHILDREN’S SYRUP
∙ acetaminophen 160 mg / 5 ml;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 00875996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42066
∙ PEDIATRIX
∙ acetaminophen 160 mg / 5 ml;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02027798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42135
∙ CHILDREN’S TYLENOL
∙ acetaminophen 160 mg / 5 ml;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02046040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42388
∙ CHILDREN’S ACETAMINOPHEN SUSPENSION
∙ acetaminophen 160 mg / 5 ml;
∙ 1998-10-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02236728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60014
∙ CHILDREN’S TYLENOL FEVER & SORE THROAT PAIN
∙ acetaminophen 160 mg / 5 ml;
∙ 2018-05-28;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02389924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87539
∙ CHILDREN’S ACETAMINOPHEN DYE-FREE
∙ acetaminophen 160 mg / 5 ml;
∙ 2018-08-02;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02468417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95684
∙ CHILDREN’S ACETAMINOPHEN SUSPENSION
∙ acetaminophen 160 mg / 5 ml;
∙ 2021-05-23;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02486830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97700
∙ APO-ACETAMINOPHEN
∙ acetaminophen 325 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 00544981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4733
∙ NOVO-GESIC
∙ acetaminophen 325 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00389218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5035
∙ TYLENOL REGULAR STRENGTH
∙ acetaminophen 325 mg;
∙ 1961-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 00559393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5254
∙ ACETAMINOPHEN TABLETS 325 MG
∙ acetaminophen 325 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 00605751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5570
∙ TYLENOL REGULAR STRENGTH CAPLETS
∙ acetaminophen 325 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 00723894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8597
∙ ACETAMINOPHEN TAB 325MG USP
∙ acetaminophen 325 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 00789801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9628
∙ ACÉTAMINOPHÈNE COMPRIMÉ TABLET 325
∙ acetaminophen 325 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02022214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14130
∙ ACETAMINOPHEN CAPLET 325MG USP
∙ acetaminophen 325 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 01977415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19418
∙ JAMP ACETAMINOPHEN 325
∙ acetaminophen 325 mg;
∙ 2003-07-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 01938088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22086
∙ APO-ACETAMINOPHEN CAPLETS
∙ acetaminophen 325 mg;
∙ 1998-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02229873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48231
∙ ACET 325
∙ acetaminophen 325 mg;
∙ 1998-01-05;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02230436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49360
∙ ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH
∙ acetaminophen 325 mg;
∙ 2004-12-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02252805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73774
∙ REGULAR STRENGTH ACETAMINOPHEN
∙ acetaminophen 325 mg;
∙ 2014-02-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02332647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81831
∙ ACÉTAMINOPHÈNE CAPLET 325
∙ acetaminophen 325 mg;
∙ 2014-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02362198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84722
∙ ACETAMINOPHEN CAPLETS 325 MG
∙ acetaminophen 325 mg;
∙ 2011-06-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02362341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84736
∙ ACETAMINOPHEN TABLETS USP 325 MG
∙ acetaminophen 325 mg;
∙ 2011-05-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02362422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84743
∙ TYLENOL LIQUID GELS
∙ acetaminophen 325 mg;
∙ 2016-06-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02407612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89234
∙ APO-ACETAMINOPHEN EXTRA STRENGTH
∙ acetaminophen 500 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 00545007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4734
∙ NOVO-GESIC FORTE
∙ acetaminophen 500 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00482323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5184
∙ TYLENOL EXTRA STRENGTH
∙ acetaminophen 500 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 00559407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5255
∙ EXTRA STRENGTH ACETAMINOPHEN TABLETS 500 MG
∙ acetaminophen 500 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 00605778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5571
∙ TYLENOL EXTRA STRENGTH CAPLETS
∙ acetaminophen 500 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 00723908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8387
∙ ACETAMINOPHEN TAB 500MG USP
∙ acetaminophen 500 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 00789798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9627
∙ TYLENOL RAPID RELEASE
∙ acetaminophen 500 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 00863270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13865
∙ ACÉTAMINOPHÈNE COMPRIMÉ TABLET 500
∙ acetaminophen 500 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02022222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14131
∙ PAINAID FREE ACETAMINOPHEN TABLETS – 500MG
∙ acetaminophen 500 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ ZEE MEDICAL;
∙ DIN: 02144514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19084
∙ ACETAMINOPHEN CAPLET 500MG
∙ acetaminophen 500 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 01977474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19419
∙ JAMP ACETAMINOPHEN 500
∙ acetaminophen 500 mg;
∙ 2003-07-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 01939122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22143
∙ APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH
∙ acetaminophen 500 mg;
∙ 1998-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02229977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48431
∙ TAMINOL CAPLETS
∙ acetaminophen 500 mg;
∙ 2006-12-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VIVA PHARMACEUTICAL INC.;
∙ DIN: 02244331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68299
∙ ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH
∙ acetaminophen 500 mg;
∙ 2004-09-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02252813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73775
∙ ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW
∙ acetaminophen 500 mg;
∙ 2005-01-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02255251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74040
∙ EXTRA STRENGTH ACETAMINOPHEN
∙ acetaminophen 500 mg;
∙ 2006-10-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02285797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77128
∙ RAPID ACTION
∙ acetaminophen 500 mg;
∙ 2009-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02319942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80540
∙ EXTRA STRENGTH ACETAMINOPHEN CAPLETS
∙ acetaminophen 500 mg;
∙ 2014-02-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02326698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81204
∙ JAMP ACETAMINOPHEN BLAZON 500
∙ acetaminophen 500 mg;
∙ 2011-11-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02355299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84054
∙ ACÉTAMINOPHÈNE BLASON SHIELD 500
∙ acetaminophen 500 mg;
∙ 2014-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02362201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84723
∙ ACÉTAMINOPHÈNE CAPLET 500
∙ acetaminophen 500 mg;
∙ 2014-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02362228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84724
∙ ACETAMINOPHEN TABLETS USP 500 MG
∙ acetaminophen 500 mg;
∙ 2011-09-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02362244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84726
∙ ACETAMINOPHEN CAPLETS 500 MG
∙ acetaminophen 500 mg;
∙ 2011-05-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02362368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84737
∙ ACETAMINOPHEN EXTRA STRENGTH LIQUID GELS
∙ acetaminophen 500 mg;
∙ 2019-03-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 02469928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95882
∙ ACET 650
∙ acetaminophen 650 mg;
∙ 1998-01-05;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02230437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49361
∙ TYLENOL ARTHRITIS PAIN 8H
∙ acetaminophen 650 mg;
∙ 1999-11-10;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02238885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62325
∙ TYLENOL MUSCLE & BODY
∙ acetaminophen 650 mg;
∙ 2002-11-01;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02246060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70191
∙ ACETAMINOPHEN ARTHRITIS PAIN
∙ acetaminophen 650 mg;
∙ 2006-08-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PERRIGO INTERNATIONAL;
∙ DIN: 02272482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75800
∙ MUSCLE ACHES AND BODY PAIN RELIEF
∙ acetaminophen 650 mg;
∙ 2016-08-15;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02455560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94236
∙ ARTHRITIS PAIN RELIEF
∙ acetaminophen 650.0 mg;
∙ 2012-04-16;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02371146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85632
∙ ACETAMINOPHEN CHEWABLE TABLETS 80 MG
∙ acetaminophen 80 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 01905856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11794
∙ ACETAMINOPHEN CHEWABLE TABLETS 80 MG FOR CHILDREN
∙ acetaminophen 80 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02017458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14206
∙ TEMPRA INFANT DROPS
∙ acetaminophen 80 mg / ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 00875988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41869
∙ PEDIATRIX DROPS
∙ acetaminophen 80 mg / ml;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 02027801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42136
∙ INFANTS’ TYLENOL
∙ acetaminophen 80 mg / ml;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02046059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42341
∙ INFANTS’ TYLENOL FEVER & SORE THROAT PAIN
∙ acetaminophen 80 mg / ml;
∙ 2018-08-03;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02389908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87537
∙ TEMPRA CHILDREN’S SYRUP
∙ acetaminophen 80 mg / 5 ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
∙ Otc | En Vente Libre;
∙ PALADIN LABS INC.;
∙ DIN: 00884553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41867
∙ ACETAZOLAMIDE FOR INJECTION, USP
∙ acetazolamide (acetazolamide sodium) 500 mg / vial;
∙ 2010-12-03;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 52:40.00 – ANTIGLAUCOMA AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02358328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84336
∙ ACETAZOLAMIDE
∙ acetazolamide 250 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00545015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4899
∙ MIOCHOL E
∙ acetylcholine chloride 20 mg / vial;
∙ 1996-08-14;
∙ Ophthalmic | Ophtalmique;
∙ Powder For Solution | Poudre Pour Solution;
∙ 52:40.20 – MIOTICS;
∙ Prescription | Prescription;
∙ BAUSCH & LOMB INC;
∙ DIN: 02133326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31096
∙ ACETYLCYSTEINE SOLUTION USP
∙ acetylcysteine 200 mg / ml;
∙ 2018-01-26;
∙ Inhalation , Intravenous , Oral | Inhalation , Intraveineuse , Orale;
∙ Solution | Solution;
∙ 92:12.00 – ANTIDOTES;
∙ Ethical | Spécialité Médicale;
∙ TELIGENT OU;
∙ DIN: 02459906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94721
∙ ASA 325MG
∙ acetylsalicylic acid 325 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 00530336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4272
∙ ASPIRIN REGULAR STRENGTH
∙ acetylsalicylic acid 325 mg;
∙ 1970-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19474
∙ ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH
∙ acetylsalicylic acid 325 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19489
∙ ASPIRIN EXTRA STRENGTH
∙ acetylsalicylic acid 500 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19475
∙ ASA 500 MG TABLETS EXTRA STRENGTH
∙ acetylsalicylic acid 500 mg;
∙ 2013-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02270323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75571
∙ ASAPHEN
∙ acetylsalicylic acid 80 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02009013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18349
∙ RIVASA 80MG CROQUABLE – TAB
∙ acetylsalicylic acid 80 mg;
∙ 1999-12-01;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02202352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36346
∙ RIVASA FC
∙ acetylsalicylic acid 80 mg;
∙ 2004-01-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02202360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36347
∙ ASAPHEN E.C. 80 MG
∙ acetylsalicylic acid 80 mg;
∙ 1998-12-03;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02238545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61971
∙ JAMP-ASA CHEW
∙ acetylsalicylic acid 80 mg;
∙ 2006-10-26;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02269139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75453
∙ ASATAB 80 MG CHEWABLE TABLETS
∙ acetylsalicylic acid 80 mg;
∙ 2006-05-23;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02280167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76584
∙ JAMP-ASA EC
∙ acetylsalicylic acid 80 mg;
∙ 2006-09-28;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02283905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76948
∙ PRO-AAS EC – 80
∙ acetylsalicylic acid 80 mg;
∙ 2008-07-03;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PRO DOC LIMITEE;
∙ DIN: 02311496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79706
∙ PRO-AAS – 80 (CROQUABLE)
∙ acetylsalicylic acid 80 mg;
∙ 2008-07-03;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PRO DOC LIMITEE;
∙ DIN: 02311518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79707
∙ SNS-ASA EC
∙ acetylsalicylic acid 80 mg;
∙ 2014-07-16;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ SANIS HEALTH INC;
∙ DIN: 02427176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91170
∙ M-ASA 80 MG CROQUABLE
∙ acetylsalicylic acid 80 mg;
∙ 2015-02-11;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ MANTRA PHARMA INC;
∙ DIN: 02429950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91435
∙ RIVASA 80 MG EC
∙ acetylsalicylic acid 80 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02485222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97547
∙ ASA 80MG
∙ acetylsalicylic acid 80 mg;
∙ 2020-11-27;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ ALTAMED PHARMA;
∙ DIN: 02497115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98698
∙ BIO-ASA
∙ acetylsalicylic acid 80 mg;
∙ 2021-05-25;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BIOMED PHARMA;
∙ DIN: 02515687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100507
∙ ASPIRIN 81MG
∙ acetylsalicylic acid 81 mg;
∙ 1998-09-02;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02237726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61080
∙ ENTROPHEN
∙ acetylsalicylic acid 81 mg;
∙ 2000-06-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02242281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65982
∙ ENTROPHEN CHEWABLE
∙ acetylsalicylic acid 81 mg;
∙ 2001-11-01;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02243974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67917
∙ ASA 81 MG
∙ acetylsalicylic acid 81 mg;
∙ 2001-11-30;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02244993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68992
∙ PRAXIS ASA EC 81 MG DAILY LOW DOSE
∙ acetylsalicylic acid 81 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02283700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76929
∙ ASPIRIN 81MG QUICK CHEWS
∙ acetylsalicylic acid 81 mg;
∙ 2007-05-22;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02289970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77528
∙ ENTERIC COATED DAILY LOW DOSE ASA 81MG
∙ acetylsalicylic acid 81 mg;
∙ 2011-06-27;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02363127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84814
∙ ASA 81 MG
∙ acetylsalicylic acid 81 mg;
∙ 2012-01-12;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02372177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85732
∙ ASA DAILY LOW DOSE
∙ acetylsalicylic acid 81 mg;
∙ 2013-05-01;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02394790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87994
∙ RIVASA 81 MG EC
∙ acetylsalicylic acid 81 mg;
∙ 2014-03-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02420279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90486
∙ ASA EC
∙ acetylsalicylic acid 81 mg;
∙ 2014-07-25;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ SANIS HEALTH INC;
∙ DIN: 02426811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91137
∙ JAMP-ASA 81MG EC
∙ acetylsalicylic acid 81 mg;
∙ 2015-01-13;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02427206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91173
∙ ASA
∙ acetylsalicylic acid 81 mg;
∙ 2015-05-06;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02433044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91745
∙ ASA 81 MG
∙ acetylsalicylic acid 81 mg;
∙ 2016-04-20;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 28:08.04.24 – SALICYLATES;
∙ Otc | En Vente Libre;
∙ LABORATOIRES TRIANON INC.;
∙ DIN: 02449277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93510
∙ SORIATANE
∙ acitretin 10 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02070847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16168
∙ TARO-ACITRETIN
∙ acitretin 10 mg;
∙ 2018-02-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02466074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95437
∙ MINT-ACITRETIN
∙ acitretin 10 mg;
∙ 2018-01-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02468840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95745
∙ SORIATANE
∙ acitretin 25 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02070863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16167
∙ TARO-ACITRETIN
∙ acitretin 25 mg;
∙ 2018-03-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02466082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95438
∙ MINT-ACITRETIN
∙ acitretin 25 mg;
∙ 2018-01-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02468859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95746
∙ TUDORZA GENUAIR
∙ aclidinium bromide 400 mcg / act;
∙ 2013-09-13;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02409720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89440
∙ ACYCLOVIR SODIUM INJECTION
∙ acyclovir (acyclovir sodium) 25 mg / ml;
∙ 1998-03-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02236916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60208
∙ ACYCLOVIR SODIUM INJECTION
∙ acyclovir (acyclovir sodium) 50 mg / ml;
∙ 1998-05-08;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02236926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60218
∙ ACYCLOVIR SODIUM INJECTION
∙ acyclovir (acyclovir sodium) 50 mg / ml;
∙ 2018-09-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02456524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94341
∙ ACYCLOVIR SODIUM INJECTION
∙ acyclovir (acyclovir sodium) 50 mg / ml;
∙ 2020-10-21;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02494558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98455
∙ APO-ACYCLOVIR – TAB 200MG
∙ acyclovir 200 mg;
∙ 1997-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02207621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43018
∙ MYLAN-ACYCLOVIR
∙ acyclovir 200 mg;
∙ 2000-09-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02242784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66607
∙ TEVA-ACYCLOVIR
∙ acyclovir 200 mg;
∙ 2006-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02285959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77144
∙ ZOVIRAX
∙ acyclovir 200 mg / 5 ml;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 00886157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11416
∙ APO-ACYCLOVIR – TAB 400MG
∙ acyclovir 400 mg;
∙ 1997-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02207648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43019
∙ MYLAN-ACYCLOVIR
∙ acyclovir 400 mg;
∙ 2000-06-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02242463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66188
∙ TEVA-ACYCLOVIR
∙ acyclovir 400 mg;
∙ 2006-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02285967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77145
∙ ZOVIRAX
∙ acyclovir 5 % / w/w;
∙ 1982-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.06 – ANTIVIRALS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 00569771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4959
∙ ZOVIRAX
∙ acyclovir 5 % / w/w;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.06 – ANTIVIRALS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02039524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15525
∙ APO-ACYCLOVIR OINTMENT
∙ acyclovir 5 % / w/w;
∙ 2019-03-14;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.06 – ANTIVIRALS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02477130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96789
∙ APO-ACYCLOVIR
∙ acyclovir 800 mg;
∙ 1997-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02207656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43020
∙ MYLAN-ACYCLOVIR
∙ acyclovir 800 mg;
∙ 2000-06-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02242464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66189
∙ TEVA-ACYCLOVIR
∙ acyclovir 800 mg;
∙ 2006-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02285975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77146
∙ HUMIRA
∙ adalimumab 20 mg / 0.2 ml;
∙ 2020-08-18;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ABBVIE CORPORATION;
∙ DIN: 02474263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96431
∙ HYRIMOZ
∙ adalimumab 20 mg / 0.4 ml;
∙ 2021-02-15;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02505258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99460
∙ HUMIRA
∙ adalimumab 40 mg / 0.8 ml;
∙ 2004-09-24;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ABBVIE CORPORATION;
∙ DIN: 02258595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74379
∙ HADLIMA
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 56:92.00 – MISCELLANEOUS GI DRUGS , 92:20.00 – Immunomodulatory Agents , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SAMSUNG BIOEPIS CO., LTD;
∙ DIN: 02473097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96243
∙ HADLIMA PUSHTOUCH
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 56:92.00 – MISCELLANEOUS GI DRUGS , 92:20.00 – Immunomodulatory Agents , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SAMSUNG BIOEPIS CO., LTD;
∙ DIN: 02473100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96244
∙ HYRIMOZ
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-15;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02492156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98214
∙ HYRIMOZ
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-15;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02492164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98215
∙ HULIO
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-16;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BGP PHARMA ULC;
∙ DIN: 02502399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99197
∙ HULIO
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-16;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BGP PHARMA ULC;
∙ DIN: 02502402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99198
∙ IDACIO
∙ adalimumab 40 mg / 0.8 ml;
∙ 2021-02-16;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02502674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99222
∙ AMGEVITA
∙ adalimumab 50 mg / ml;
∙ 2021-02-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02459299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94649
∙ AMGEVITA
∙ adalimumab 50 mg / ml;
∙ 2021-02-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02459302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94650
∙ AMGEVITA
∙ adalimumab 50 mg / ml;
∙ 2021-02-19;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02459310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94651
∙ DIFFERIN
∙ adapalene 0.1 %;
∙ 1996-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02148749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20107
∙ DIFFERIN
∙ adapalene 0.1 %;
∙ 1998-01-08;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02231592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50959
∙ DIFFERIN XP
∙ adapalene 0.3 %;
∙ 2007-07-19;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02274000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75946
∙ HEPSERA
∙ adefovir dipivoxil 10 mg;
∙ 2006-04-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02247823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72117
∙ AA-ADEFOVIR
∙ adefovir dipivoxil 10 mg;
∙ 2014-08-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02420333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90493
∙ ADENOSINE INJECTION
∙ adenosine 3 mg / ml;
∙ 2007-03-27;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:04.04.24 – CLASS IV ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02267659
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75307
∙ ADENOSINE INJECTION
∙ adenosine 3 mg / ml;
∙ 2017-08-17;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:04.04.24 – CLASS IV ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02457474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94452
∙ ADENOSINE INJECTION
∙ adenosine 3 mg / ml;
∙ 2017-08-17;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:04.04.24 – CLASS IV ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02457482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94453
∙ GIOTRIF
∙ afatinib (afatinib dimaleate) 20 mg;
∙ 2014-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02415666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90026
∙ GIOTRIF
∙ afatinib (afatinib dimaleate) 30 mg;
∙ 2014-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02415674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90027
∙ GIOTRIF
∙ afatinib (afatinib dimaleate) 40 mg;
∙ 2014-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BOEHRINGER INGELHEIM (CANADA) LTD LTEE;
∙ DIN: 02415682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90028
∙ EYLEA
∙ aflibercept 40 mg / ml;
∙ 2013-12-23;
∙ Intravitreal | Intravitreuse;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BAYER INC;
∙ DIN: 02415992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90055
∙ EYLEA
∙ aflibercept 40 mg / ml;
∙ 2020-11-17;
∙ Intravitreal | Intravitreuse;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BAYER INC;
∙ DIN: 02505355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99471
∙ REPLAGAL
∙ agalsidase alfa 1 mg / ml;
∙ 2004-03-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02249057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73392
∙ FABRAZYME
∙ agalsidase beta 35 mg / vial;
∙ 2004-04-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02248966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73341
∙ FABRAZYME
∙ agalsidase beta 5 mg / vial;
∙ 2004-09-17;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02248965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73340
∙ MEDICAL AIR 100%
∙ air 100 %;
∙ 1911-12-31;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ AIR LIQUIDE CANADA INC.;
∙ DIN: 00572837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5684
∙ STERILE DILUENT FOR ALLERGENIC EXTRACT – ALBUMIN SALINE WITH PHENOL
∙ albumin (human) 0.03 %;
∙ 2007-03-02;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 40:50.00* – DILUENTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO INC;
∙ DIN: 02283735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76932
∙ STERILE DILUENT FOR ALLERGENIC EXTRACTS NORMAL SALINE WITH HSA
∙ albumin (human) 0.03 %;
∙ 2014-02-19;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 40:50.00* – DILUENTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02375141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86055
∙ ALBUMIN (HUMAN) 25% SOLUTION USP
∙ albumin (human) 25 %;
∙ 1997-02-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ GRIFOLS THERAPEUTICS LLC;
∙ DIN: 02223708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43385
∙ OCTALBIN 25%
∙ albumin (human) 25 %;
∙ 2015-01-06;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02267357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75278
∙ ALBUREX – 25
∙ albumin (human) 25 %;
∙ 2007-10-16;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02274663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76014
∙ ALBUMIN (HUMAN) 5% SOLUTION, USP
∙ albumin (human) 5 %;
∙ 1997-05-06;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ GRIFOLS THERAPEUTICS LLC;
∙ DIN: 02223694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43384
∙ ALBUREX – 5
∙ albumin (human) 5 %;
∙ 2008-01-15;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02274655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76013
∙ OCTALBIN 5%
∙ albumin (human) 5 %;
∙ 2015-01-06;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02302705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78800
∙ PLASBUMIN-5
∙ albumin (human) 50 mg / ml;
∙ 1997-01-17;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 16:00.00 – BLOOD DERIVATIVES;
∙ Schedule D | Annexe D;
∙ GRIFOLS THERAPEUTICS LLC;
∙ DIN: 02189100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42926
∙ PROLEUKIN
∙ aldesleukin 22000000 unit / vial;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ STERIMAX INC;
∙ DIN: 02130181
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18314
∙ ALECENSARO
∙ alectinib (alectinib hydrochloride) 150 mg;
∙ 2016-10-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02458136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94518
∙ LEMTRADA
∙ alemtuzumab 12 mg / 1.2 ml;
∙ 2014-01-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02418320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90290
∙ MABCAMPATH
∙ alemtuzumab 30 mg / ml;
∙ 2007-09-07;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02290960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77636
∙ ACH-ALENDRONATE
∙ alendronic acid (alendronate sodium) 10 mg;
∙ 2012-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02381486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86733
∙ AURO-ALENDRONATE
∙ alendronic acid (alendronate sodium) 10 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02388545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87407
∙ ACH-ALENDRONATE
∙ alendronic acid (alendronate sodium) 5 mg;
∙ 2012-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02381478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86732
∙ FOSAMAX
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2002-02-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02245329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69356
∙ APO-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2005-05-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02248730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73098
∙ TEVA-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2005-05-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02261715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74709
∙ RIVA-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2005-09-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02270889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75626
∙ PMS-ALENDRONATE-FC
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2006-08-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02284006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76957
∙ SANDOZ ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2007-01-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02288109
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77349
∙ ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2008-03-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02299712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78508
∙ ALENDRONATE-70
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2008-07-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02303078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78840
∙ ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02352966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83819
∙ ACH-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2012-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02381494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86734
∙ JAMP-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2012-06-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02385031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87070
∙ AURO-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02388553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87408
∙ AG-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70 mg;
∙ 2021-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02485184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97543
∙ MINT-ALENDRONATE
∙ alendronic acid (alendronate sodium) 70.0 mg;
∙ 2012-11-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02394871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88003
∙ PROLASTIN-C
∙ alfa 1-proteinase inhibitor (human) 1000 mg / vial;
∙ 1996-11-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 44:00.00 – ENZYMES;
∙ Schedule D | Annexe D;
∙ GRIFOLS THERAPEUTICS LLC;
∙ DIN: 02204606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43004
∙ ONE-ALPHA
∙ alfacalcidol 0.25 mcg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 00474517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7292
∙ ONE-ALPHA
∙ alfacalcidol 1 mcg;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 00474525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7293
∙ ONE-ALPHA
∙ alfacalcidol 2 mcg / ml;
∙ 2000-12-04;
∙ Oral | Orale;
∙ Drops | Gouttes;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02240329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63869
∙ ONE-ALPHA
∙ alfacalcidol 2 mcg / ml;
∙ 2001-02-20;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02242502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66245
∙ XATRAL
∙ alfuzosin hydrochloride 10 mg;
∙ 2002-02-21;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02245565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69657
∙ SANDOZ ALFUZOSIN
∙ alfuzosin hydrochloride 10 mg;
∙ 2008-08-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02304678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78993
∙ APO-ALFUZOSIN
∙ alfuzosin hydrochloride 10 mg;
∙ 2008-08-20;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02315866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80137
∙ AURO-ALFUZOSIN
∙ alfuzosin hydrochloride 10 mg;
∙ 2015-09-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02443201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92777
∙ ALFUZOSIN
∙ alfuzosin hydrochloride 10 mg;
∙ 2015-11-25;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02447576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93315
∙ MYOZYME
∙ alglucosidase alfa 50 mg / vial;
∙ 2006-12-06;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC;
∙ DIN: 02284863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77041
∙ PRALUENT
∙ alirocumab 150 mg / ml;
∙ 2016-04-29;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02453835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94037
∙ PRALUENT
∙ alirocumab 75 mg / ml;
∙ 2016-05-18;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02453819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94035
∙ RASILEZ
∙ aliskiren (aliskiren fumarate) 150 mg;
∙ 2007-11-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.40 – RENIN INHIBITORS;
∙ Prescription | Prescription;
∙ NODEN PHARMA DAC;
∙ DIN: 02302063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78739
∙ RASILEZ
∙ aliskiren (aliskiren fumarate) 300 mg;
∙ 2007-11-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.40 – RENIN INHIBITORS;
∙ Prescription | Prescription;
∙ NODEN PHARMA DAC;
∙ DIN: 02302071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78740
∙ TOCTINO
∙ alitretinoin 10 mg;
∙ 2011-01-11;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02337630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82321
∙ HANZEMA
∙ alitretinoin 10 mg;
∙ 2021-06-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES INC;
∙ DIN: 02477432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96841
∙ TOCTINO
∙ alitretinoin 30 mg;
∙ 2010-11-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02337649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82322
∙ HANZEMA
∙ alitretinoin 30 mg;
∙ 2021-06-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES INC;
∙ DIN: 02477440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96842
∙ ALLERGY CANADA ALLERGEN EXTRACT – ALUM PRECIPITATED
∙ allergen extract – alum precipitated 10000 unit / ml;
∙ 2001-04-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALLERGY CANADA LTD;
∙ DIN: 02242713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66518
∙ OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (AQUEOUS)
∙ allergenic extract non-pollen 40000 unit / ml;
∙ 2003-06-30;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Solution | Solution;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72048
∙ OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (GLYCERINATED)
∙ allergenic extract non-pollen 40000 unit / ml;
∙ 2003-07-02;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72049
∙ OMEGA ALLERGENIC EXTRACTS – NON-POLLENS (SUSPAL)
∙ allergenic extract non-pollen 40000 unit / ml;
∙ 2003-07-02;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72050
∙ OMEGA ALLERGENIC EXTRACTS – POLLENS (AQUEOUS)
∙ allergenic extracts pollens 40000 unit / ml;
∙ 2003-06-30;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72045
∙ OMEGA ALLERGENIC EXTRACTS – POLLENS (GLYCERINATED)
∙ allergenic extracts pollens 40000 unit / ml;
∙ 2003-07-02;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72046
∙ OMEGA ALLERGENIC EXTRACTS – POLLENS (SUSPAL)
∙ allergenic extracts pollens 40000 unit / ml;
∙ 2003-07-02;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02247755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72047
∙ ZYLOPRIM
∙ allopurinol 100 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00402818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4276
∙ ALLOPURINOL-100
∙ allopurinol 100 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00555681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4724
∙ MAR-ALLOPURINOL
∙ allopurinol 100 mg;
∙ 2013-04-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02396327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88136
∙ APO-ALLOPURINOL
∙ allopurinol 100 mg;
∙ 2013-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02402769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88760
∙ JAMP-ALLOPURINOL
∙ allopurinol 100 mg;
∙ 2014-03-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02421593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90624
∙ AG-ALLOPURINOL
∙ allopurinol 100 mg;
∙ 2019-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02481863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97234
∙ ZYLOPRIM
∙ allopurinol 200 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00479799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4303
∙ ALLOPURINOL-200
∙ allopurinol 200 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02130157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19183
∙ MAR-ALLOPURINOL
∙ allopurinol 200 mg;
∙ 2013-04-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02396335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88137
∙ APO-ALLOPURINOL
∙ allopurinol 200 mg;
∙ 2013-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02402777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88761
∙ JAMP-ALLOPURINOL
∙ allopurinol 200 mg;
∙ 2014-03-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02421607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90625
∙ AG-ALLOPURINOL
∙ allopurinol 200 mg;
∙ 2019-09-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02481871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97235
∙ ZYLOPRIM
∙ allopurinol 300 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00402796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4302
∙ ALLOPURINOL-300
∙ allopurinol 300 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00555703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4725
∙ MAR-ALLOPURINOL
∙ allopurinol 300 mg;
∙ 2013-04-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02396343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88138
∙ APO-ALLOPURINOL
∙ allopurinol 300 mg;
∙ 2013-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02402785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88762
∙ JAMP-ALLOPURINOL
∙ allopurinol 300 mg;
∙ 2014-03-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02421615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90626
∙ AG-ALLOPURINOL
∙ allopurinol 300 mg;
∙ 2019-09-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:16.00 – ANTIGOUT AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02481898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97236
∙ MYLAN-ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 12.5 mg;
∙ 2013-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02398443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88340
∙ SANDOZ ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 12.5 mg;
∙ 2013-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02405334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89013
∙ ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 12.5 mg;
∙ 2014-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02424029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90875
∙ TEVA-ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 12.5 mg;
∙ 2014-12-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02434849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91914
∙ ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 12.5 mg;
∙ 2018-03-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95519
∙ MYLAN-ALMOTRIPTAN
∙ almotriptan (almotriptan malate) 6.25 mg;
∙ 2013-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:32.28 – SELECTIVE SEROTONIN AGONISTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02398435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88339
∙ NESINA
∙ alogliptin (alogliptin benzoate) 12.5 mg;
∙ 2014-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90183
∙ NESINA
∙ alogliptin (alogliptin benzoate) 25 mg;
∙ 2014-05-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90184
∙ NESINA
∙ alogliptin (alogliptin benzoate) 6.25 mg;
∙ 2014-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02417189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90182
∙ PIQRAY
∙ alpelisib 150 mg;
∙ 2020-06-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02497069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98692
∙ PIQRAY
∙ alpelisib 200 mg;
∙ 2020-06-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02497077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98693
∙ ALPRAZOLAM-0.5
∙ alprazolam .5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 01908170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11485
∙ XANAX
∙ alprazolam 0.25 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ UPJOHN CANADA ULC;
∙ DIN: 00548359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4471
∙ APO-ALPRAZ
∙ alprazolam 0.25 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 00865397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10904
∙ ALPRAZOLAM-0.25
∙ alprazolam 0.25 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 01908189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11484
∙ TEVA-ALPRAZOLAM
∙ alprazolam 0.25 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 01913484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11803
∙ ALPRAZOLAM
∙ alprazolam 0.25 mg;
∙ 2010-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ SANIS HEALTH INC;
∙ DIN: 02349191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83451
∙ XANAX
∙ alprazolam 0.5 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ UPJOHN CANADA ULC;
∙ DIN: 00548367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4472
∙ APO-ALPRAZ
∙ alprazolam 0.5 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 00865400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10905
∙ TEVA-ALPRAZOLAM
∙ alprazolam 0.5 mg;
∙ 1993-09-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 01913492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11804
∙ ALPRAZOLAM
∙ alprazolam 0.50 mg;
∙ 2010-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ SANIS HEALTH INC;
∙ DIN: 02349205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83452
∙ XANAX
∙ alprazolam 1 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ UPJOHN CANADA ULC;
∙ DIN: 00723770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13685
∙ APO-ALPRAZ
∙ alprazolam 1 mg;
∙ 2001-04-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02243611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67530
∙ ALPRAZOLAM
∙ alprazolam 1 mg;
∙ 2004-04-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 02248706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73070
∙ XANAX TS
∙ alprazolam 2 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ UPJOHN CANADA ULC;
∙ DIN: 00813958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13686
∙ APO-ALPRAZ TS
∙ alprazolam 2 mg;
∙ 2001-04-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02243612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67531
∙ MUSE
∙ alprostadil 1000 mcg;
∙ 1998-09-24;
∙ Urethral | Urétrale;
∙ Suppository | Suppositoire;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02238595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62023
∙ CAVERJECT STERILE POWDER
∙ alprostadil 20 mcg / vial;
∙ 1996-07-30;
∙ Intracavernosal | Intracaverneuse;
∙ Kit , Liquid , Powder For Solution | Trousse , Liquide , Poudre Pour Solution;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02215756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20353
∙ CAVERJECT STERILE POWDER – PWS 23.2MCG/VIAL
∙ alprostadil 20 mcg / vial;
∙ 1997-09-24;
∙ Intracavernosal | Intracaverneuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02215187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43155
∙ MUSE
∙ alprostadil 250 mcg;
∙ 1998-09-24;
∙ Urethral | Urétrale;
∙ Suppository | Suppositoire;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02238593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62021
∙ MUSE
∙ alprostadil 500 mcg;
∙ 1998-09-24;
∙ Urethral | Urétrale;
∙ Suppository | Suppositoire;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02238594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62022
∙ PROSTIN VR STERILE SOLUTION
∙ alprostadil 500 mcg / ml;
∙ 1982-12-31;
∙ Intra-Arterial , Intravenous | Intra-Artérielle , Intraveineuse;
∙ Solution | Solution;
∙ 24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00559253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4802
∙ CATHFLO
∙ alteplase 2 mg / vial;
∙ 2002-09-26;
∙ Instillation | Instillation;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:12.20 – THROMBOLYTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02245859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69976
∙ PDP-AMANTADINE HYDROCHLORIDE CAPSULES
∙ amantadine hydrochloride 100 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.04 – ADAMANTANES , 28:36.04 – ADAMANTANES;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 01990403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13464
∙ PDP-AMANTADINE HYDROCHLORIDE SYRUP
∙ amantadine hydrochloride 50 mg / 5 ml;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 08:18.04 – ADAMANTANES , 28:36.04 – ADAMANTANES;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02022826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14393
∙ VOLIBRIS
∙ ambrisentan 10 mg;
∙ 2008-06-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02307073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79275
∙ APO-AMBRISENTAN
∙ ambrisentan 10 mg;
∙ 2018-11-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02475383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96576
∙ VOLIBRIS
∙ ambrisentan 5 mg;
∙ 2008-06-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02307065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79274
∙ APO-AMBRISENTAN
∙ ambrisentan 5 mg;
∙ 2018-11-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02475375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96575
∙ TARO-AMCINONIDE
∙ amcinonide 0.1 %;
∙ 2003-02-13;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02246714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70909
∙ FIRDAPSE
∙ amifampridine (amifampridine phosphate) 10 mg;
∙ 2020-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ KYE PHARMACEUTICALS INC.;
∙ DIN: 02502984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99250
∙ RUZURGI
∙ amifampridine 10 mg;
∙ 2020-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ MEDUNIK CANADA;
∙ DIN: 02503034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99254
∙ AMIKACIN SULFATE INJECTION USP
∙ amikacin (amikacin sulfate) 250 mg / ml;
∙ 2001-01-29;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66810
∙ AMIKACIN SULFATE INJECTION
∙ amikacin (amikacin sulfate) 250 mg / ml;
∙ 2019-07-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02486717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97689
∙ ERFA-AMIKACIN
∙ amikacin (amikacin sulfate) 250 mg / ml;
∙ 2019-11-29;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 02489147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97920
∙ AMIKACIN SULFATE INJECTION USP
∙ amikacin (amikacin sulfate) 500 mg / 2 ml;
∙ 2019-03-01;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02481073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97163
∙ VPI-AMIKACIN
∙ amikacin (amikacin sulfate) 500 mg / 2 ml;
∙ 2021-01-25;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.02 – AMINOGLYCOSIDES;
∙ Prescription | Prescription;
∙ VPI PHARMACEUTICALS INC;
∙ DIN: 02506599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99595
∙ MIDAMOR
∙ amiloride hydrochloride 5.0 mg;
∙ 2004-06-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.16 – POTASSIUM-SPARING DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02249510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73433
∙ GLEOLAN
∙ aminolevulinic acid hydrochloride 1.5 g / vial;
∙ 2021-02-22;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 36:68.00 – ROENTGENOGRAPHY;
∙ Prescription | Prescription;
∙ MEDEXUS INC;
∙ DIN: 02504928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99429
∙ LEVULAN KERASTICK
∙ aminolevulinic acid hydrochloride 20 %;
∙ 2004-06-03;
∙ Topical | Topique;
∙ Powder For Solution | Poudre Pour Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ DUSA PHARMACEUTICALS INC;
∙ DIN: 02243933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67875
∙ AMINOPHYLLINE INJECTION USP
∙ aminophylline 25 mg / ml;
∙ 1981-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00497193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4226
∙ AMINOPHYLLINE INJ 25MG/ML
∙ aminophylline 25 mg / ml;
∙ 1984-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 00582662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5705
∙ PMS-AMIODARONE
∙ amiodarone hydrochloride 100 mg;
∙ 2007-04-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02292173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77754
∙ TEVA-AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 1999-03-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02239835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63322
∙ PMS-AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 2000-07-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02242472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66199
∙ SANDOZ AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 2001-08-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67777
∙ APO-AMIODARONE TABLETS
∙ amiodarone hydrochloride 200 mg;
∙ 2003-09-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02246194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70344
∙ RIVA-AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 2003-03-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02247217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71459
∙ PRO-AMIODARONE – 200
∙ amiodarone hydrochloride 200 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02309661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79532
∙ AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02364336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84924
∙ AMIODARONE
∙ amiodarone hydrochloride 200 mg;
∙ 2012-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87109
∙ AMIODARONE HYDROCHLORIDE FOR INJECTION
∙ amiodarone hydrochloride 50 mg / ml;
∙ 2000-06-14;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66036
∙ AMIODARONE HYDROCHLORIDE INJECTION
∙ amiodarone hydrochloride 50 mg / ml;
∙ 2002-04-23;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 24:04.04.20 – CLASS III ANTIARRYTHMICS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02245248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69271
∙ ELAVIL
∙ amitriptyline hydrochloride 10 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00335053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2213
∙ AMITRIPTYLINE-10
∙ amitriptyline hydrochloride 10 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00370991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2426
∙ PMS-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 00654523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9417
∙ TEVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 2014-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02326043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81139
∙ APO-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 2013-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02403137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88796
∙ MAR-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 2015-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02429861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91430
∙ JAMP-AMITRIPTYLINE TABLETS
∙ amitriptyline hydrochloride 10 mg;
∙ 2015-01-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02435527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91987
∙ AG-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 2018-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96850
∙ PRIVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 10 mg;
∙ 2020-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98018
∙ PMS-AMITRIPTYLINE
∙ amitriptyline hydrochloride 100 mg;
∙ 2017-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02468409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95683
∙ ELAVIL
∙ amitriptyline hydrochloride 25 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00335061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2214
∙ AMITRIPTYLINE-25
∙ amitriptyline hydrochloride 25 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00371009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2427
∙ PMS-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 00654515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9346
∙ TEVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 2014-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02326051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81140
∙ APO-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 2013-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02403145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88797
∙ MAR-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 2015-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02429888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91431
∙ JAMP-AMITRIPTYLINE TABLETS
∙ amitriptyline hydrochloride 25 mg;
∙ 2015-01-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02435535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91988
∙ AG-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 2018-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96851
∙ PRIVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 25 mg;
∙ 2020-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98019
∙ ELAVIL
∙ amitriptyline hydrochloride 50 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00335088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2215
∙ AMITRIPTYLINE-50
∙ amitriptyline hydrochloride 50 mg;
∙ 1978-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00456349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3141
∙ PMS-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 00654507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9418
∙ TEVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 2014-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02326078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81141
∙ APO-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 2013-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02403153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88798
∙ MAR-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 2015-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02429896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91432
∙ JAMP-AMITRIPTYLINE TABLETS
∙ amitriptyline hydrochloride 50 mg;
∙ 2015-01-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02435543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91989
∙ AG-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 2018-12-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96852
∙ PRIVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 50 mg;
∙ 2020-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98020
∙ ELAVIL
∙ amitriptyline hydrochloride 75 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00754129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8199
∙ APO-AMITRIPTYLINE
∙ amitriptyline hydrochloride 75 mg;
∙ 2013-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02403161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88799
∙ MAR-AMITRIPTYLINE
∙ amitriptyline hydrochloride 75 mg;
∙ 2015-04-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02429918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91433
∙ JAMP-AMITRIPTYLINE TABLETS
∙ amitriptyline hydrochloride 75 mg;
∙ 2015-01-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02435551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91990
∙ PRIVA-AMITRIPTYLINE
∙ amitriptyline hydrochloride 75 mg;
∙ 2020-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02490145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98021
∙ PDP-AMLODIPINE
∙ amlodipine (amlodipine besylate) 1 mg / ml;
∙ 2019-08-28;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02484706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97499
∙ NORVASC
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 00878936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12939
∙ APO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02273381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75887
∙ SANDOZ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02284391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76998
∙ ACT AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02297493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78284
∙ TARO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02321866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80727
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02326817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81215
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02331292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81700
∙ RIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2009-10-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02331500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81719
∙ JAMP-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2011-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84233
∙ MINT-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2011-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02362678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84767
∙ AG-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2014-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85418
∙ MAR-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2012-10-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85686
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87142
∙ BIO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2013-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02392143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87743
∙ AURO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2013-02-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02397080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88207
∙ ACH-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2018-11-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02419572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90419
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2014-09-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02429225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91366
∙ PRIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2017-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02444461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92952
∙ M-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2018-04-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02468034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95639
∙ PHARMA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95769
∙ NRA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2018-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96696
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 10 mg;
∙ 2019-12-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ALTAMED PHARMA;
∙ DIN: 02490811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98086
∙ MYLAN-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10.0 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02272121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75766
∙ PMS-AMLODIPINE
∙ amlodipine (amlodipine besylate) 10.0 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02284073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76964
∙ PMS-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2009-07-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02295148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78046
∙ ACT AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2010-03-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02297477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78282
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2009-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02326795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81213
∙ SANDOZ AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2009-08-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02330474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81620
∙ RIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2009-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02331489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81717
∙ JAMP-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2011-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84231
∙ AG-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2018-06-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85416
∙ MAR-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2012-10-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85684
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87140
∙ BIO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2013-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02392127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87741
∙ ACH-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2018-11-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02419556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90417
∙ PRIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2017-11-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02444445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92950
∙ M-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02468018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95637
∙ PHARMA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95767
∙ NRA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2018-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96694
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2019-12-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ALTAMED PHARMA;
∙ DIN: 02490781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98084
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 2.5 mg;
∙ 2020-08-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02492199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98218
∙ NORVASC
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 00878928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12938
∙ APO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02273373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75886
∙ PMS-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02284065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76963
∙ SANDOZ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02284383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76997
∙ ACT AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02297485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78283
∙ TARO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02321858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80726
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02326809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81214
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02331284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81699
∙ RIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2009-10-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02331497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81718
∙ JAMP-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2011-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84232
∙ MINT-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2011-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02362651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84766
∙ AG-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2014-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85417
∙ MAR-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2012-10-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85685
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2012-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87141
∙ BIO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2013-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02392135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87742
∙ AURO-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2013-02-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02397072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88206
∙ ACH-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2018-11-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02419564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90418
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2014-09-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02429217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91365
∙ PRIVA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2017-10-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02444453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92951
∙ M-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2017-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02468026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95638
∙ PHARMA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2018-05-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02469030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95768
∙ NRA-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2018-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96695
∙ AMLODIPINE
∙ amlodipine (amlodipine besylate) 5 mg;
∙ 2019-12-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ ALTAMED PHARMA;
∙ DIN: 02490803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98085
∙ MYLAN-AMLODIPINE
∙ amlodipine (amlodipine besylate) 5.0 mg;
∙ 2009-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:28.08 – DIHYDROPYRIDINES;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02272113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75765
∙ APO-AMOXI
∙ amoxicillin (amoxicillin trihydrate) 125 mg / 5 ml;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00628131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5824
∙ NOVAMOXIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00406724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3264
∙ APO-AMOXI
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00628115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5822
∙ NOVAMOXIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02036355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14506
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 2010-08-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02352710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83797
∙ AURO-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02388073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87364
∙ JAMP-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg;
∙ 2015-12-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02433060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91747
∙ NOVAMOXIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00452130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3344
∙ APO-AMOXI
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00628158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5825
∙ PRO-AMOX-250
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00644331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6511
∙ NOVAMOXIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01934163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16954
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 2010-11-02;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02352753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83801
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 2010-09-27;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02352788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83803
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 250 mg / 5 ml;
∙ 2013-02-14;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02401541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88644
∙ NOVAMOXIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00406716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3263
∙ APO-AMOXI
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 1984-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00628123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5823
∙ PRO-AMOX-500
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00644315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6510
∙ PMS-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2002-10-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02230244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48976
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2010-07-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02352729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83798
∙ AURO-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02388081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87365
∙ AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2013-02-14;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02401509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88640
∙ JAMP-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2015-12-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02433079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91748
∙ AG-AMOXICILLIN
∙ amoxicillin (amoxicillin trihydrate) 500 mg;
∙ 2018-09-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02477726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96865
∙ ABELCET
∙ amphotericin b 5 mg / ml;
∙ 1997-09-25;
∙ Intravenous | Intraveineuse;
∙ Suspension | Suspension;
∙ 08:14.28 – POLYENES;
∙ Prescription | Prescription;
∙ LEADIANT BIOSCIENCES, INC;
∙ DIN: 02231590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50926
∙ FUNGIZONE
∙ amphotericin b 50 mg / vial;
∙ 1958-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.28 – POLYENES;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 00029149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=933
∙ AMBISOME
∙ amphotericin b 50 mg / vial;
∙ 2000-05-29;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.28 – POLYENES;
∙ Prescription | Prescription;
∙ ASTELLAS PHARMA CANADA INC;
∙ DIN: 02241630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65288
∙ AMPICILLIN SODIUM FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 1 g / vial;
∙ 1992-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01933345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12267
∙ AMPICILLIN FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 1 g / vial;
∙ 1998-08-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02227002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37492
∙ AMPICILLIN SODIUM FOR INJECTION BP
∙ ampicillin (ampicillin sodium) 1 g / vial;
∙ 2017-10-20;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02462338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95006
∙ AMPICILLIN SODIUM FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 2 g / vial;
∙ 1992-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01933353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12268
∙ AMPICILLIN FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 2 g / vial;
∙ 1998-07-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02226995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37491
∙ AMPICILLIN SODIUM FOR INJECTION BP
∙ ampicillin (ampicillin sodium) 2 g / vial;
∙ 2017-10-20;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02462346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95007
∙ AMPICILLIN SODIUM FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 250 mg / vial;
∙ 1992-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00872644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12261
∙ AMPICILLIN FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 250 mg / vial;
∙ 1998-08-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02227029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37494
∙ AMPICILLIN SODIUM FOR INJECTION BP
∙ ampicillin (ampicillin sodium) 250 mg / vial;
∙ 2017-10-20;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02462303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95004
∙ AMPICILLIN SODIUM FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 500 mg / vial;
∙ 1992-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00872652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12262
∙ AMPICILLIN FOR INJECTION, USP
∙ ampicillin (ampicillin sodium) 500 mg / vial;
∙ 1998-08-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02227010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37493
∙ AMPICILLIN SODIUM FOR INJECTION BP
∙ ampicillin (ampicillin sodium) 500 mg / vial;
∙ 2017-10-20;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02462311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95005
∙ TEVA-AMPICILLIN
∙ ampicillin (ampicillin trihydrate) 250 mg;
∙ 1971-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00020877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1125
∙ TEVA-AMPICILLIN
∙ ampicillin (ampicillin trihydrate) 500 mg;
∙ 1971-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.08 – AMINOPENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00020885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1124
∙ PMS-ANAGRELIDE
∙ anagrelide (anagrelide hydrochloride monohydrate) 0.5 mg;
∙ 2006-01-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.14 – PLATELET-REDUCING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02274949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76047
∙ AGRYLIN
∙ anagrelide (anagrelide hydrochloride) 0.5 mg;
∙ 1998-01-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 20:12.14 – PLATELET-REDUCING AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02236859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60149
∙ KINERET
∙ anakinra 150 mg / ml;
∙ 2002-05-29;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SWEDISH ORPHAN BIOVITRUM AB (PUBL);
∙ DIN: 02245913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70033
∙ ARIMIDEX TAB 1MG
∙ anastrozole 1 mg;
∙ 1996-08-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02224135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43395
∙ PMS-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02320738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80614
∙ SANDOZ ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02338467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82412
∙ JAMP-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02339080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82471
∙ ACH-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02351218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83640
∙ TARO-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02365650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85053
∙ APO-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02374420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85968
∙ MAR-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02379562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86544
∙ RIVA-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02392259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87753
∙ BIO-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2013-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02392488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87775
∙ MINT-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02393573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87879
∙ TEVA-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-10-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02394898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88004
∙ ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2012-11-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02395649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88072
∙ NAT-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2015-02-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02417855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90247
∙ ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02442736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92706
∙ CCP-ANASTROZOLE
∙ anastrozole 1 mg;
∙ 2017-07-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02458799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94594
∙ SIALOR
∙ anethole trithione 25.0 mg;
∙ 2000-08-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Ethical | Spécialité Médicale;
∙ PHARMASCIENCE INC;
∙ DIN: 02240344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63884
∙ ERAXIS
∙ anidulafungin 100 mg / vial;
∙ 2010-01-25;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02330695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81644
∙ WINRHO SDF
∙ anti-d (rh) immunoglobulin (human) 1500 unit / vial;
∙ 2008-06-16;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 80:04.00 – SERUMS;
∙ Schedule D | Annexe D;
∙ SAOL THERAPEUTICS RESEARCH LIMITED;
∙ DIN: 02302578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78788
∙ WINRHO SDF
∙ anti-d (rh) immunoglobulin (human) 5000 unit / vial;
∙ 2008-06-16;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 80:04.00 – SERUMS;
∙ Schedule D | Annexe D;
∙ SAOL THERAPEUTICS RESEARCH LIMITED;
∙ DIN: 02302594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78786
∙ WINRHO SDF
∙ anti-d (rh) immunoglobulin (human) 600 unit / vial;
∙ 2008-06-16;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 80:04.00 – SERUMS;
∙ Schedule D | Annexe D;
∙ SAOL THERAPEUTICS RESEARCH LIMITED;
∙ DIN: 02302551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78787
∙ FEIBA NF
∙ anti-inhibitor coagulant complex 1300 unit / vial;
∙ 1997-10-27;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02202581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42981
∙ FEIBA NF
∙ anti-inhibitor coagulant complex 3250 unit / vial;
∙ 2011-04-04;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02353903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83912
∙ THYMOGLOBULIN
∙ anti-thymocyte globulin (rabbit) 25 mg / vial;
∙ 2003-05-06;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02246805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71005
∙ JIVI
∙ antihemophilic factor (recombinant – b-domain deleted – pegylated) 1000 unit / vial;
∙ 2020-03-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02481774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97225
∙ JIVI
∙ antihemophilic factor (recombinant – b-domain deleted – pegylated) 2000 unit / vial;
∙ 2020-03-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02481782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97226
∙ JIVI
∙ antihemophilic factor (recombinant – b-domain deleted – pegylated) 3000 unit / vial;
∙ 2020-01-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02481790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97227
∙ JIVI
∙ antihemophilic factor (recombinant – b-domain deleted – pegylated) 500 unit / vial;
∙ 2020-04-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:00.00 – BLOOD FORMATION, COAGULATION AND THROMBOSIS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02481766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97224
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 1000 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91481
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 1500 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91482
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 2000 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91483
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 250 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91477
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 3000 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91484
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 500 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91479
∙ ELOCTATE
∙ antihemophilic factor (recombinant bdd) – fc fusion protein 750 unit / vial;
∙ 2016-01-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02430312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91480
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 1000 unit / vial;
∙ 2018-03-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02459051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94621
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 1000 unit / vial;
∙ 2021-08-13;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02498588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98834
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 2000 unit / vial;
∙ 2018-03-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02459078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94622
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 250 unit / vial;
∙ 2018-03-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02459035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94619
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 250 unit / vial;
∙ 2021-07-16;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02498537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98830
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 3000 unit / vial;
∙ 2020-09-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02498626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98837
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 500 unit / vial;
∙ 2018-03-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02459043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94620
∙ ADYNOVATE
∙ antihemophilic factor (recombinant) – pegylated 500 unit / vial;
∙ 2021-08-13;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02498545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98831
∙ KOVALTRY
∙ antihemophilic factor (recombinant) 1000 unit / vial;
∙ 2016-07-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02451476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93775
∙ KOVALTRY
∙ antihemophilic factor (recombinant) 2000 unit / vial;
∙ 2016-07-15;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02451484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93776
∙ KOVALTRY
∙ antihemophilic factor (recombinant) 250 unit / vial;
∙ 2016-07-20;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02451441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93773
∙ KOVALTRY
∙ antihemophilic factor (recombinant) 3000 unit / vial;
∙ 2016-08-18;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02451492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93777
∙ KOVALTRY
∙ antihemophilic factor (recombinant) 500 unit / vial;
∙ 2016-07-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ BAYER INC;
∙ DIN: 02451468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93774
∙ OBIZUR
∙ antihemophilic factor (recombinant) porcine sequence 500 unit / ml;
∙ 2016-11-30;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02447401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93300
∙ ANTITHROMBIN III NF
∙ antithrombin iii (human) 1100 unit / vial;
∙ 1999-07-05;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02237810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61169
∙ ANTITHROMBIN III NF
∙ antithrombin iii (human) 550 unit / vial;
∙ 1999-07-05;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02237811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61170
∙ ERLEADA
∙ apalutamide 60 mg;
∙ 2018-07-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02478374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96913
∙ PHARMALGEN HONEY BEE VENOM
∙ apis mellifera venom protein extract 120 mcg / vial;
∙ 1993-12-31;
∙ Intradermal , Subcutaneous | Intradermique , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO A/S;
∙ DIN: 01948911
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14601
∙ ELIQUIS
∙ apixaban 2.5 mg;
∙ 2012-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02377233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86287
∙ ELIQUIS
∙ apixaban 5 mg;
∙ 2012-12-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.04.14 – Direct Factor Xa Inhibitors;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02397714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88264
∙ KYNMOBI
∙ apomorphine hydrochloride 10 mg / film;
∙ 2020-11-17;
∙ Sublingual | Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02500264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98995
∙ MOVAPO
∙ apomorphine hydrochloride 10 mg / ml;
∙ 2017-09-07;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02459132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94632
∙ KYNMOBI
∙ apomorphine hydrochloride 15 mg / film;
∙ 2020-11-17;
∙ Sublingual | Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02500272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98997
∙ KYNMOBI
∙ apomorphine hydrochloride 20 mg / film;
∙ 2020-11-17;
∙ Sublingual | Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02500280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98998
∙ KYNMOBI
∙ apomorphine hydrochloride 25 mg / film;
∙ 2020-11-17;
∙ Sublingual | Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02500299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98999
∙ KYNMOBI
∙ apomorphine hydrochloride 30 mg / film;
∙ 2020-11-17;
∙ Sublingual | Sublinguale;
∙ Film, Soluble | Pellicule, Soluble;
∙ 28:36.20.08 – NONERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02500302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99000
∙ IOPIDINE
∙ apraclonidine (apraclonidine hydrochloride) 0.5 %;
∙ 1995-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02076306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18228
∙ IOPIDINE
∙ apraclonidine (apraclonidine hydrochloride) 1 %;
∙ 1992-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00888354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12993
∙ OTEZLA
∙ apremilast 30 mg;
∙ 2014-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02434334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91866
∙ EMEND
∙ aprepitant 125 mg;
∙ 2007-09-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02298805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78411
∙ EMEND
∙ aprepitant 80 mg;
∙ 2007-09-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02298791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78410
∙ ARGATROBAN
∙ argatroban 100 mg / ml;
∙ 2002-06-13;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02243835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67776
∙ L-ARGININE HYDROCHLORIDE INJECTION
∙ arginine hydrochloride 250 mg / ml;
∙ 1973-12-31;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 36:66.00 – PITUITARY FUNCTION;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00399736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3378
∙ ABILIFY
∙ aripiprazole 10 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80784
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94734
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95500
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96021
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96306
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96996
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97394
∙ ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97813
∙ ARIPIPRAZOLE
∙ aripiprazole 10 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99607
∙ ABILIFY
∙ aripiprazole 15 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80785
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94735
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95501
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96022
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96307
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96997
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97395
∙ ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97814
∙ ARIPIPRAZOLE
∙ aripiprazole 15 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99609
∙ ABILIFY
∙ aripiprazole 2 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80782
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94732
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95498
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96019
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96304
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96994
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2020-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97392
∙ ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97811
∙ ARIPIPRAZOLE
∙ aripiprazole 2 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99604
∙ ABILIFY
∙ aripiprazole 20 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80786
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94736
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95503
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96023
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96308
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96998
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483599
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97396
∙ ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97815
∙ ARIPIPRAZOLE
∙ aripiprazole 20 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99611
∙ ABILIFY
∙ aripiprazole 30 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80790
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94737
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95504
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96024
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96309
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96999
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97397
∙ ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488051
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97816
∙ ARIPIPRAZOLE
∙ aripiprazole 30 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99613
∙ ABILIFY MAINTENA
∙ aripiprazole 300 mg / vial;
∙ 2014-03-27;
∙ Intramuscular | Intramusculaire;
∙ Powder For Suspension, Sustained-Release , Kit | Poudre Pour Suspension, À Libération Prolongée , Trousse;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02420864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90545
∙ ABILIFY MAINTENA
∙ aripiprazole 400 mg / vial;
∙ 2014-03-27;
∙ Intramuscular | Intramusculaire;
∙ Powder For Suspension, Sustained-Release , Kit | Poudre Pour Suspension, À Libération Prolongée , Trousse;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02420872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90546
∙ ABILIFY
∙ aripiprazole 5 mg;
∙ 2009-09-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02322382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80783
∙ AURO-ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02460033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94733
∙ PMS-ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95499
∙ APO-ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2018-04-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02471094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96020
∙ SANDOZ ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2018-07-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02473666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96305
∙ RIVA-ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2018-08-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02479354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96995
∙ MINT-ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2020-04-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02483564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97393
∙ ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2019-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02488019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97812
∙ ARIPIPRAZOLE
∙ aripiprazole 5 mg;
∙ 2021-04-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02506718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99606
∙ ARSENIC TRIOXIDE FOR INJECTION
∙ arsenic trioxide 1 mg / ml;
∙ 2019-12-20;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02492768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98274
∙ TRISENOX
∙ arsenic trioxide 10 mg / 10 ml;
∙ 2013-09-09;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02407833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89255
∙ ARSENIC TRIOXIDE SOLUTION FOR INJECTION
∙ arsenic trioxide 10 mg / 10 ml;
∙ 2020-01-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHEBRA PTY LTD;
∙ DIN: 02487357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97753
∙ TRISENOX
∙ arsenic trioxide 12 mg / 6 ml;
∙ 2020-04-16;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02480387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97091
∙ VITAMIN C
∙ ascorbic acid (ascorbic acid) 500 mg / ml;
∙ 2002-05-29;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 88:12.00 – VITAMIN C;
∙ Ethical | Spécialité Médicale;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02245214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69229
∙ VITAMIN C
∙ ascorbic acid (sodium ascorbate) 250 mg / ml;
∙ 1989-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 88:12.00 – VITAMIN C;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00780634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9992
∙ ASCOR L 500
∙ ascorbic acid 500 mg / ml;
∙ 2014-09-11;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 88:12.00 – VITAMIN C;
∙ Ethical | Spécialité Médicale;
∙ MCGUFF PHARMACEUTICALS INC;
∙ DIN: 02355981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84117
∙ SAPHRIS
∙ asenapine (asenapine maleate) 10 mg;
∙ 2011-12-19;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02374811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86018
∙ SAPHRIS
∙ asenapine (asenapine maleate) 5 mg;
∙ 2011-12-19;
∙ Sublingual | Sublinguale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 02374803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86017
∙ STRENSIQ
∙ asfotase alfa 100 mg / ml;
∙ 2016-02-17;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALEXION PHARMA GMBH;
∙ DIN: 02444658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92972
∙ STRENSIQ
∙ asfotase alfa 40 mg / ml;
∙ 2015-10-20;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALEXION PHARMA GMBH;
∙ DIN: 02444615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92969
∙ STRENSIQ
∙ asfotase alfa 40 mg / ml;
∙ 2016-06-07;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALEXION PHARMA GMBH;
∙ DIN: 02444623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92970
∙ STRENSIQ
∙ asfotase alfa 40 mg / ml;
∙ 2016-06-01;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ALEXION PHARMA GMBH;
∙ DIN: 02444631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92971
∙ REYATAZ
∙ atazanavir (atazanavir sulfate) 150 mg;
∙ 2004-01-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02248610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72966
∙ TEVA-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 150 mg;
∙ 2017-04-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92854
∙ MYLAN-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 150 mg;
∙ 2017-05-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02456877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94389
∙ REYATAZ
∙ atazanavir (atazanavir sulfate) 200 mg;
∙ 2004-01-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02248611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72967
∙ TEVA-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 200 mg;
∙ 2017-04-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92856
∙ MYLAN-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 200 mg;
∙ 2017-05-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02456885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94390
∙ REYATAZ
∙ atazanavir (atazanavir sulfate) 300 mg;
∙ 2007-05-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ BRISTOL-MYERS SQUIBB CANADA;
∙ DIN: 02294176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77952
∙ TEVA-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 300 mg;
∙ 2017-04-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02443821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92857
∙ MYLAN-ATAZANAVIR
∙ atazanavir (atazanavir sulfate) 300 mg;
∙ 2017-05-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:18.08.08 – HIV PROTEASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02456893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94391
∙ APO-ATENOL TAB 100MG
∙ atenolol 100 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00773697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9175
∙ ATENOLOL
∙ atenolol 100 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00828793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9904
∙ TENORMIN
∙ atenolol 100 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02039540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17906
∙ TEVA-ATENOLOL
∙ atenolol 100 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02171805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19692
∙ PMS-ATENOLOL
∙ atenolol 100 mg;
∙ 1998-03-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02237601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60940
∙ ATENOLOL
∙ atenolol 100 mg;
∙ 1999-03-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02238318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61719
∙ RIVA-ATENOLOL 100 MG
∙ atenolol 100 mg;
∙ 2000-05-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65768
∙ TARO-ATENOLOL
∙ atenolol 100 mg;
∙ 2005-07-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02267993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75338
∙ JAMP-ATENOLOL
∙ atenolol 100 mg;
∙ 2011-06-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02367572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85241
∙ MINT-ATENOL
∙ atenolol 100 mg;
∙ 2011-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02368048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85285
∙ AG-ATENOLOL
∙ atenolol 100 mg;
∙ 2018-07-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85413
∙ MAR-ATENOLOL
∙ atenolol 100 mg;
∙ 2012-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85712
∙ ATENOLOL
∙ atenolol 100 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95483
∙ PMS-ATENOLOL
∙ atenolol 25 mg;
∙ 2002-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02246581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70768
∙ TEVA-ATENOLOL
∙ atenolol 25 mg;
∙ 2005-11-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02266660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75207
∙ RIVA-ATENOLOL
∙ atenolol 25 mg;
∙ 2006-07-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02277379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76301
∙ ATENOLOL
∙ atenolol 25 mg;
∙ 2009-06-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02326701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81205
∙ JAMP-ATENOLOL
∙ atenolol 25 mg;
∙ 2011-06-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02367556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85239
∙ MINT-ATENOL
∙ atenolol 25 mg;
∙ 2011-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02368013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85283
∙ AG-ATENOLOL
∙ atenolol 25 mg;
∙ 2018-07-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85411
∙ MAR-ATENOLOL
∙ atenolol 25 mg;
∙ 2012-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85710
∙ TARO-ATENOLOL
∙ atenolol 25 mg;
∙ 2012-01-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02373963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85918
∙ APO-ATENOL TAB 50MG
∙ atenolol 50 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00773689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9174
∙ ATENOLOL
∙ atenolol 50 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00828807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9905
∙ TENORMIN
∙ atenolol 50 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 02039532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17905
∙ TEVA-ATENOLOL
∙ atenolol 50 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02171791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19691
∙ PMS-ATENOLOL
∙ atenolol 50 mg;
∙ 1998-03-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02237600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60939
∙ ATENOLOL
∙ atenolol 50 mg;
∙ 1999-09-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02238316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61718
∙ RIVA-ATENOLOL 50 MG
∙ atenolol 50 mg;
∙ 2000-05-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65769
∙ TARO-ATENOLOL
∙ atenolol 50 mg;
∙ 2005-07-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02267985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75337
∙ JAMP-ATENOLOL
∙ atenolol 50 mg;
∙ 2011-06-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02367564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85240
∙ MINT-ATENOL
∙ atenolol 50 mg;
∙ 2011-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02368021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85284
∙ AG-ATENOLOL
∙ atenolol 50 mg;
∙ 2018-07-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02369184
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85412
∙ MAR-ATENOLOL
∙ atenolol 50 mg;
∙ 2012-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85711
∙ ATENOLOL
∙ atenolol 50 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95482
∙ TECENTRIQ
∙ atezolizumab 1200 mg / 20 ml;
∙ 2017-05-02;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02462990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95089
∙ TECENTRIQ
∙ atezolizumab 840 mg / 14 ml;
∙ 2019-10-16;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02492393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98241
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2005-02-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02262800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74816
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2010-09-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02314541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80008
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2011-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80353
∙ PMS-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02381028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86676
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87200
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02396904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88191
∙ RIVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2013-07-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02405962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89071
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2015-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93116
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95610
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 10 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96064
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 100 mg;
∙ 2010-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02279355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76496
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 100 mg;
∙ 2011-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80359
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 100 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87206
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 100 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95616
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 100 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96070
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2005-02-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02262819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74817
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2010-09-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02314568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80009
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2011-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80354
∙ PMS-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02381036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86677
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87201
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02396912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88192
∙ RIVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2013-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02405970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89072
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2015-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93118
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95611
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 18 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96065
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2005-03-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02262827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74820
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2010-09-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02314576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80010
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2011-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80355
∙ PMS-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02381044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86678
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87202
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02396920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88193
∙ RIVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2013-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02405989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89073
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2015-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93120
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95612
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 25 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96066
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2005-03-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02262835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74822
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2010-09-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02314584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80011
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2011-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80356
∙ PMS-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02381052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86679
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87203
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02396939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88194
∙ RIVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2013-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02405997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89074
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2015-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93121
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95613
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 40 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96067
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2005-03-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02262843
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74823
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2010-09-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02314592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80012
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2011-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80357
∙ PMS-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02381060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86680
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87204
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2012-11-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02396947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88195
∙ RIVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2013-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02406004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89075
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2015-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02445956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93122
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95614
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 60 mg;
∙ 2019-02-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96068
∙ STRATTERA
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2009-12-16;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02279347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76495
∙ APO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2011-07-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02318075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80358
∙ TEVA-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2014-02-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02362511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84752
∙ SANDOZ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2012-05-30;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02386461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87205
∙ ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2018-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02467801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95615
∙ AURO-ATOMOXETINE
∙ atomoxetine (atomoxetine hydrochloride) 80 mg;
∙ 2019-02-04;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02471531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96069
∙ APO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78058
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2010-05-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02346486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83185
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2010-05-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02348705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83405
∙ ATORVASTATIN-10
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg;
∙ 2013-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02411350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89596
∙ APO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78059
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2010-05-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02346494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83192
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2010-05-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02348713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83406
∙ ATORVASTATIN-20
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg;
∙ 2013-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02411369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89597
∙ APO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78060
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2010-05-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02346508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83193
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2010-05-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02348721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83407
∙ ATORVASTATIN-40
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg;
∙ 2013-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02411377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89598
∙ APO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02295318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78061
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2010-05-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02346516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83194
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2010-05-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02348748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83408
∙ ATORVASTATIN-80
∙ atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg;
∙ 2013-10-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02411385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89599
∙ LIPITOR
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 1997-03-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02230711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49973
∙ TEVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02310899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79651
∙ TARO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2010-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02313707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79921
∙ SANDOZ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02324946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81036
∙ JAMP-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2012-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02391058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87642
∙ MYLAN-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2014-06-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02392933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87820
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2013-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02399377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88426
∙ AURO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02407256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89196
∙ RIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2014-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02422751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90742
∙ MAR-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2017-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02454017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94054
∙ ACH-ATORVASTATIN CALCIUM
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2019-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02457741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94478
∙ M-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96027
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96530
∙ NRA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2019-07-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96687
∙ PMS-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2020-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02477149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96790
∙ AG-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2018-09-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02478145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96887
∙ MINT-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2020-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02479508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97017
∙ BIO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2019-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97130
∙ PRIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 10 mg;
∙ 2019-10-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02482886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97328
∙ LIPITOR
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 1997-03-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02230713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49974
∙ TEVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02310902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79652
∙ TARO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2010-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02313715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79922
∙ SANDOZ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02324954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81037
∙ JAMP-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2012-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02391066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87643
∙ MYLAN-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2014-06-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02392941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87821
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2013-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02399385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88427
∙ AURO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02407264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89197
∙ RIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2014-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02422778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90743
∙ MAR-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2017-05-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02454025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94055
∙ ACH-ATORVASTATIN CALCIUM
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2019-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02457768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94479
∙ M-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96028
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96531
∙ NRA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2019-07-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96688
∙ PMS-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2020-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02477157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96791
∙ AG-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2018-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02478153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96888
∙ MINT-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2020-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02479516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97018
∙ BIO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2019-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97131
∙ PRIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 20 mg;
∙ 2019-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02482894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97329
∙ LIPITOR
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 1997-03-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02230714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49975
∙ TEVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02310910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79653
∙ TARO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2010-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02313723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79923
∙ SANDOZ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02324962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81038
∙ JAMP-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2012-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02391074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87644
∙ MYLAN-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2014-06-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02392968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87822
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2013-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02399393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88428
∙ AURO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02407272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89198
∙ RIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2014-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02422786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90744
∙ MAR-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2018-10-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02454033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94056
∙ ACH-ATORVASTATIN CALCIUM
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2019-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02457776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94480
∙ M-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96029
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96532
∙ NRA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2019-07-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96689
∙ PMS-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2020-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02477165
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96792
∙ AG-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2018-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02478161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96889
∙ MINT-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2020-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02479524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97019
∙ BIO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2019-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97132
∙ PRIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 40 mg;
∙ 2019-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02482908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97330
∙ LIPITOR
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2001-06-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02243097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66964
∙ TEVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02310929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79654
∙ TARO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2010-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02313758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79925
∙ SANDOZ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2010-05-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02324970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81039
∙ JAMP-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2012-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02391082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87645
∙ MYLAN-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2014-06-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02392976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87823
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2013-03-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02399407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88429
∙ AURO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2013-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02407280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89199
∙ RIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2014-03-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02422794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90745
∙ MAR-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2018-10-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02454041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94057
∙ ACH-ATORVASTATIN CALCIUM
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2019-10-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02457784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94481
∙ M-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96030
∙ ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2018-05-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02475057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96533
∙ NRA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2019-07-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02476541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96690
∙ PMS-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2020-04-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02477173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96793
∙ AG-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2018-09-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02478188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96890
∙ BIO-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2019-09-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02481219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97133
∙ PRIVA-ATORVASTATIN
∙ atorvastatin (atorvastatin calcium) 80 mg;
∙ 2019-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:06.08 – HMG-COA REDUCTASE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02482916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97331
∙ MEPRON
∙ atovaquone 750 mg / 5 ml;
∙ 1996-09-10;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02217422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43212
∙ ATROPINE SULFATE INJECTION USP
∙ atropine sulfate .6 mg / ml;
∙ 1979-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00392693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3553
∙ ATROPINE SULFATE INJECTION USP
∙ atropine sulfate 0.4 mg / ml;
∙ 1979-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00392782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3554
∙ ATROPINE INJECTION BP
∙ atropine sulfate 0.4 mg / ml;
∙ 2015-12-04;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02432188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91662
∙ ATROPINE SULFATE INJECTION
∙ atropine sulfate 0.5 mg / 5 ml;
∙ 2015-01-20;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ BIOSYENT PHARMA INC;
∙ DIN: 02426269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91086
∙ ATROPINE SULFATE INJECTION USP
∙ atropine sulfate 0.5 mg / 5 ml;
∙ 2020-03-25;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02472171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96149
∙ ATROPINE INJECTION BP
∙ atropine sulfate 0.6 mg / ml;
∙ 2016-01-28;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02432196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91663
∙ ATROPINE
∙ atropine sulfate 1 %;
∙ 1994-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:24.00 – MYDRIATICS;
∙ Prescription | Prescription;
∙ PHARMA STULLN INC.;
∙ DIN: 02023695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16476
∙ ISOPTO ATROPINE
∙ atropine sulfate 1 % / w/v;
∙ 1964-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:24.00 – MYDRIATICS;
∙ Prescription | Prescription;
∙ ALCON CANADA INC;
∙ DIN: 00035017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=254
∙ MINIMS ATROPINE SULPHATE
∙ atropine sulfate 1 % / w/v;
∙ 1995-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:24.00 – MYDRIATICS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02148358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18862
∙ ATROPINE SULFATE INJECTION USP
∙ atropine sulfate 1 mg / 10 ml;
∙ 1975-12-31;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00328154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2390
∙ ATROPINE SULFATE INJECTION
∙ atropine sulfate 1 mg / 5 ml;
∙ 2015-01-20;
∙ Intramuscular , Intravenous , Subcutaneous | Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Solution | Solution;
∙ 12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
∙ Prescription | Prescription;
∙ BIOSYENT PHARMA INC;
∙ DIN: 02426277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91087
∙ RIDAURA
∙ auranofin 3 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 60:00.00 – GOLD COMPOUNDS;
∙ Prescription | Prescription;
∙ XEDITON PHARMACEUTICALS INC;
∙ DIN: 01916823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15902
∙ BAVENCIO
∙ avelumab 20 mg / ml;
∙ 2017-12-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02469723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95856
∙ YESCARTA
∙ axicabtagene ciloleucel 200000000 cells / bag;
∙ 2019-11-27;
∙ Intravenous | Intraveineuse;
∙ Suspension | Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02485648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97587
∙ INLYTA
∙ axitinib 1 mg;
∙ 2012-08-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02389630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87513
∙ INLYTA
∙ axitinib 5 mg;
∙ 2012-08-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02389649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87514
∙ VIDAZA
∙ azacitidine 100 mg / vial;
∙ 2010-01-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02336707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82233
∙ AZACITIDINE FOR INJECTION
∙ azacitidine 100 mg / vial;
∙ 2017-10-25;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02462826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95068
∙ ONUREG
∙ azacitidine 200 mg;
∙ 2021-03-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02510197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99943
∙ ONUREG
∙ azacitidine 300 mg;
∙ 2021-03-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CELGENE INC;
∙ DIN: 02510200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99944
∙ IMURAN
∙ azathioprine (azathioprine sodium) 50 mg / vial;
∙ 2001-12-20;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02244895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68893
∙ IMURAN
∙ azathioprine 50 mg;
∙ 1966-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00004596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1192
∙ TEVA-AZATHIOPRINE
∙ azathioprine 50 mg;
∙ 1998-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02236819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60109
∙ APO-AZATHIOPRINE
∙ azathioprine 50 mg;
∙ 2000-10-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02242907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66740
∙ AZATHIOPRINE-50
∙ azathioprine 50 mg;
∙ 2009-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02243371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67279
∙ FINACEA
∙ azelaic acid 15 % / w/w;
∙ 2010-06-15;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 02270811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75617
∙ EDARBI
∙ azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg;
∙ 2012-11-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02381389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86721
∙ EDARBI
∙ azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg;
∙ 2012-11-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02381397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86722
∙ AURO-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 100 mg / 5 ml;
∙ 2019-10-30;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02482363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97283
∙ AURO-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 200 mg / 5 ml;
∙ 2019-10-30;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02482371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97284
∙ SANDOZ AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2005-11-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02265826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75127
∙ RIVA-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2006-03-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02275309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76094
∙ AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2010-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02330881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81664
∙ APO-AZITHROMYCIN Z
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2014-03-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02415542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90013
∙ AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92678
∙ JAMP-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2016-09-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02452308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93868
∙ MAR-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2016-10-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02452324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93870
∙ NRA-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2019-05-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02479680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96991
∙ AG-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2018-09-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02480700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97120
∙ M-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 250 mg;
∙ 2021-01-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02502038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99162
∙ AZITHROMYCIN FOR INJECTION USP
∙ azithromycin (azithromycin dihydrate) 500 mg / vial;
∙ 2019-04-16;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02483890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97419
∙ AG-AZITHROMYCIN
∙ azithromycin (azithromycin dihydrate) 600 mg;
∙ 2018-09-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02480719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97121
∙ TEVA-AZITHROMYCIN
∙ azithromycin (azithromycin monohydrate hemiethanolate) 250 mg;
∙ 2005-12-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02267845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75325
∙ PRO-AZITHROMYCINE
∙ azithromycin (azithromycin monohydrate hemiethanolate) 250 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02310600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79623
∙ SANDOZ AZITHROMYCIN
∙ azithromycin (azithromycin monohydrate) 100 mg / 5 ml;
∙ 2009-09-08;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02332388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81804
∙ SANDOZ AZITHROMYCIN
∙ azithromycin (azithromycin monohydrate) 200 mg / 5 ml;
∙ 2009-09-08;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02332396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81805
∙ AZITHROMYCIN FOR INJECTION, USP
∙ azithromycin (azithromycin monohydrate) 500 mg / vial;
∙ 2017-10-25;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02465604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95383
∙ ZITHROMAX – PWS ORL 100MG/5ML
∙ azithromycin 100 mg / 5 ml;
∙ 1996-09-26;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02223716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43386
∙ ZITHROMAX
∙ azithromycin 200 mg / 5 ml;
∙ 1996-09-26;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02223724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43387
∙ ZITHROMAX
∙ azithromycin 250 mg;
∙ 1999-03-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02212021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43063
∙ PMS-AZITHROMYCIN
∙ azithromycin 250 mg;
∙ 2006-01-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02261634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74701
∙ ZITHROMAX FOR INTRAVENOUS INJECTION
∙ azithromycin 500 mg / vial;
∙ 1999-08-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02239952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63455
∙ PMS-AZITHROMYCIN
∙ azithromycin 600 mg;
∙ 2006-01-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02261642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74702
∙ CAYSTON
∙ aztreonam 75 mg / vial;
∙ 2009-11-11;
∙ Inhalation | Inhalation;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.16 – MONOBACTAMS;
∙ Prescription | Prescription;
∙ GILEAD SCIENCES CANADA INC;
∙ DIN: 02329840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81558
∙ ONCOTICE
∙ bacillus calmette-guerin (bcg) strain tice 800000000 unit / vial;
∙ 1995-12-31;
∙ Intravesical | Intravésicale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02153513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19802
∙ BACITIN
∙ bacitracin 500 unit / g;
∙ 1984-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00584908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5863
∙ BACIJECT 50,000 UNITS/VIAL
∙ bacitracin 50000 unit / vial;
∙ 2003-08-28;
∙ Intramuscular , Topical | Intramusculaire , Topique;
∙ Powder For Solution | Poudre Pour Solution;
∙ 84:04.04 – ANTIBIOTICS , 08:12.28.08 – BACITRACINS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02245571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69667
∙ FIRST AID ANTIBIOTIC OINTMENT
∙ bacitracin zinc 500 unit / g;
∙ 2011-02-01;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ ZEE MEDICAL;
∙ DIN: 02352079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83729
∙ BACITRACIN ZINC OINTMENT USP
∙ bacitracin zinc 500 unit / g;
∙ 2011-11-03;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:04.04 – ANTIBIOTICS;
∙ Otc | En Vente Libre;
∙ DYNAREX CORPORATION;
∙ DIN: 02374390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85960
∙ BACITRACIN ZINC OINTMENT USP
∙ bacitracin zinc 500 unit / g;
∙ 2020-07-30;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 08:12.28.08 – BACITRACINS;
∙ Otc | En Vente Libre;
∙ WATER-JEL TECHNOLOGIES, LLC;
∙ DIN: 02481812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97229
∙ LIORESAL INTRATHECAL 0.05MG/ML
∙ baclofen 0.05 mg / ml;
∙ 1994-12-31;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02131048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17277
∙ BACLOFEN INJECTION
∙ baclofen 0.05 mg / ml;
∙ 2017-08-25;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02457059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94414
∙ BACLOFEN INJECTION
∙ baclofen 0.05 mg / 1 ml;
∙ 2014-06-06;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02413620
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89827
∙ LIORESAL INTRATHECAL 0.5MG/ML
∙ baclofen 0.5 mg / ml;
∙ 1994-12-31;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02131056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17954
∙ BACLOFEN INJECTION
∙ baclofen 0.5 mg / ml;
∙ 2017-08-25;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02457067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94415
∙ BACLOFEN INTRATHECAL
∙ baclofen 0.5 mg / ml;
∙ 2021-07-20;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02485508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97574
∙ PMS-BACLOFEN
∙ baclofen 10 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02063735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15547
∙ MYLAN-BACLOFEN
∙ baclofen 10 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02088398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16534
∙ APO-BACLOFEN
∙ baclofen 10 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02139332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17246
∙ BACLOFEN-10
∙ baclofen 10 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02152584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20308
∙ RIVA-BACLOFEN
∙ baclofen 10 mg;
∙ 2003-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65828
∙ BACLOFEN
∙ baclofen 10 mg;
∙ 2010-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02287021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77246
∙ BACLOFEN INJECTION
∙ baclofen 10 mg / 20 ml;
∙ 2014-06-06;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02413639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89828
∙ BACLOFEN INJECTION
∙ baclofen 10 mg / 5 ml;
∙ 2014-06-06;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02413647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89829
∙ LIORESAL INTRATHECAL 2MG/ML
∙ baclofen 2 mg / ml;
∙ 1994-12-31;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02131064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17276
∙ BACLOFEN INJECTION
∙ baclofen 2 mg / ml;
∙ 2017-08-25;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02457075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94416
∙ BACLOFEN INTRATHECAL
∙ baclofen 2 mg / ml;
∙ 2021-07-20;
∙ Intrathecal | Intrathécale;
∙ Solution | Solution;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02485516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97575
∙ PMS-BACLOFEN
∙ baclofen 20 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02063743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15548
∙ MYLAN-BACLOFEN
∙ baclofen 20 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02088401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16532
∙ APO-BACLOFEN
∙ baclofen 20 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02139391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17247
∙ BACLOFEN-20
∙ baclofen 20 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02152592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20309
∙ RIVA-BACLOFEN
∙ baclofen 20 mg;
∙ 2003-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65829
∙ BACLOFEN
∙ baclofen 20 mg;
∙ 2010-02-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:20.12 – GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02287048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77247
∙ BAMLANIVIMAB
∙ bamlanivimab 700 mg / 20 ml;
∙ 2020-12-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.24 – MONOCLONAL ANTIBODIES;
∙ Covid-19 – Io – Authorization , Prescription , Schedule D | Covid-19 – Au – Autorisation , Prescription , Annexe D;
∙ ELI LILLY CANADA INC;
∙ DIN: 02508176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99754
∙ OLUMIANT
∙ baricitinib 2 mg;
∙ 2018-09-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ ELI LILLY CANADA INC;
∙ DIN: 02480018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97056
∙ SIMULECT
∙ basiliximab 20 mg / vial;
∙ 2000-10-23;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02242815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66643
∙ PROPADERM
∙ beclomethasone dipropionate 0.025 % / w/w;
∙ 1998-03-30;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02089602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28440
∙ QVAR
∙ beclomethasone dipropionate 100 mcg / act;
∙ 2000-05-29;
∙ Inhalation | Inhalation;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02242030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65701
∙ MYLAN-BECLO AQ
∙ beclomethasone dipropionate 50 mcg / act;
∙ 1995-12-31;
∙ Nasal | Nasale;
∙ Metered-Dose Aerosol , Suspension | Aérosol À Dose Mesurée , Suspension;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02172712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18874
∙ APO-BECLOMETHASONE NASAL SPRAY
∙ beclomethasone dipropionate 50 mcg / act;
∙ 1998-10-07;
∙ Nasal | Nasale;
∙ Suspension | Suspension;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02238796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62232
∙ QVAR
∙ beclomethasone dipropionate 50 mcg / act;
∙ 2000-05-29;
∙ Inhalation | Inhalation;
∙ Metered-Dose Aerosol | Aérosol À Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02242029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65700
∙ BENLYSTA
∙ belimumab 120 mg / vial;
∙ 2011-08-24;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02370050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85508
∙ BENLYSTA
∙ belimumab 200 mg / 1 ml;
∙ 2018-05-14;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02470489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95946
∙ BENLYSTA
∙ belimumab 400 mg / vial;
∙ 2011-08-24;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02370069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85509
∙ BENAZEPRIL
∙ benazepril hydrochloride 10 mg;
∙ 2007-05-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02290340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77564
∙ BENAZEPRIL
∙ benazepril hydrochloride 20 mg;
∙ 2006-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02273918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75937
∙ BENAZEPRIL
∙ benazepril hydrochloride 5 mg;
∙ 2007-05-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02290332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77563
∙ TREANDA
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2012-09-12;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02392569
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87782
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2021-03-02;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02496860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98671
∙ NAT-BENDAMUSTINE
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2021-02-25;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02496895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98674
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2021-03-12;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02498111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98790
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2021-05-06;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02509172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99848
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 100 mg / vial;
∙ 2021-03-02;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02509261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99857
∙ TREANDA
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2012-09-12;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02392550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87781
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2021-03-02;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02496852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98670
∙ NAT-BENDAMUSTINE
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2021-02-25;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02496887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98673
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2021-05-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02498103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98789
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2021-05-06;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02509164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99847
∙ BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
∙ bendamustine hydrochloride 25 mg / vial;
∙ 2021-03-02;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02509253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99856
∙ FASENRA
∙ benralizumab 30 mg / ml;
∙ 2018-03-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 48:10.20 – INTERLEUKIN ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02473232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96262
∙ FASENRA PEN
∙ benralizumab 30 mg / ml;
∙ 2021-01-13;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 48:10.20 – INTERLEUKIN ANTAGONISTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02496135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98601
∙ DIGISAN E FOAM HAND SANITIZER
∙ benzalkonium chloride 0.1 %;
∙ 2001-03-01;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02242842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66672
∙ KEYSTONE FOAM HAND SANITIZER
∙ benzalkonium chloride 0.1 %;
∙ 2003-08-01;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02246427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70601
∙ SCOTT ANTIMICROBIAL FOAM SKIN CLEANSER
∙ benzalkonium chloride 0.1 %;
∙ 2019-03-27;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ KIMBERLY-CLARK GLOBAL SALES LLC;
∙ DIN: 02480816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97147
∙ SUNSHINE HAND SANITIZER
∙ benzalkonium chloride 0.1 % / v/v;
∙ 2020-08-11;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 2235721 ALBERTA LTD. / SUNSHINE ENVIRONMENTAL;
∙ DIN: 02501341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99097
∙ LIFEBUOY ANTIBACTERIAL WET WIPES
∙ benzalkonium chloride 0.1 % / w/w;
∙ 2020-09-30;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ UNILEVER CANADA;
∙ DIN: 02500256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98996
∙ SANI HANDS FOAM
∙ benzalkonium chloride 0.1 % / w/w;
∙ 2021-03-08;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OSTREM CHEMICAL CO LTD.;
∙ DIN: 02513226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100244
∙ HAND SANITIZING WIPES
∙ benzalkonium chloride 0.12 %;
∙ 2013-09-01;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ATHEA LABORATORIES INC;
∙ DIN: 02399350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88424
∙ ADVANTAGE SANITIZING WIPES
∙ benzalkonium chloride 0.12 % / w/v;
∙ 2019-05-19;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 2XL CORPORATION;
∙ DIN: 02486431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97664
∙ TRIPLE RAIN HAND SANITIZER
∙ benzalkonium chloride 0.125 % / v/v;
∙ 2020-09-07;
∙ Topical (Household) | Topique (Maison);
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ KIKSTICK SAFETY LTD;
∙ DIN: 02502267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99184
∙ AVMOR ANTIBACTERIAL FOAMING HAND SOAP/ AVMOR SAVON MOUSSANT ANTIBACTÉRIEN POUR LES MAINS
∙ benzalkonium chloride 0.125 % / w/w;
∙ 2019-07-08;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ AVMOR LTD;
∙ DIN: 02486288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97650
∙ ECOCARE 360
∙ benzalkonium chloride 0.13 %;
∙ 1999-04-20;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02239318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62787
∙ PURELL SANITIZING WIPES
∙ benzalkonium chloride 0.13 %;
∙ 2013-07-10;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GOJO CANADA INC;
∙ DIN: 02403471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88828
∙ DIAL COMPLETE 2 IN 1 MOISTURIZING & ANTIBACTERIAL FOAMING HAND WASH MANUKA HONEY
∙ benzalkonium chloride 0.13 %;
∙ 2018-02-26;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HENKEL CANADA CORPORATION;
∙ DIN: 02469197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95787
∙ DIAL COMPLETE 2 IN 1 MOISTURIZING & ANTIBACTERIAL FOAMING HAND WASH PEARL ESSENCE
∙ benzalkonium chloride 0.13 %;
∙ 2018-02-26;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HENKEL CANADA CORPORATION;
∙ DIN: 02469200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95788
∙ TRANQUIL MEADOWS AB
∙ benzalkonium chloride 0.13 %;
∙ 2020-04-01;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02472198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96148
∙ FUZION AB FOAMING HAND SOAP
∙ benzalkonium chloride 0.13 %;
∙ 2018-06-27;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02472236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96151
∙ ACCLAIM AB
∙ benzalkonium chloride 0.13 %;
∙ 2019-08-19;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02472287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96159
∙ PEAR AB HAND SOAP
∙ benzalkonium chloride 0.13 %;
∙ 2019-10-30;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02473798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96343
∙ SCOTT FOAM HAND SANITIZER
∙ benzalkonium chloride 0.13 %;
∙ 2019-02-18;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ KIMBERLY-CLARK GLOBAL SALES LLC;
∙ DIN: 02481456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97189
∙ LORIS 0.13% BZK
∙ benzalkonium chloride 0.13 % / v/v;
∙ 2011-12-06;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LERNAPHARM (LORIS) INC.;
∙ DIN: 02354543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83971
∙ ANTIBACTERIAL HAND SOAP WITH LIGHT MOISTURIZERS
∙ benzalkonium chloride 0.13 % / v/v;
∙ 2020-05-16;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ APOLLO HEALTH AND BEAUTY CARE;
∙ DIN: 02497905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98770
∙ ENEVRA NON-ALCOHOLIC HAND SANITIZER
∙ benzalkonium chloride 0.13 % / v/v;
∙ 2020-07-15;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GLOBARA LABORATORIES INC.;
∙ DIN: 02498995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98871
∙ DYMON ANTIBACTERIAL HAND SOAP WITH MOISTURIZERS
∙ benzalkonium chloride 0.13 % / v/v;
∙ 2020-06-14;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ -;
∙ Otc | En Vente Libre;
∙ APOLLO HEALTH AND BEAUTY CARE;
∙ DIN: 02499444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98916
∙ SPX HEALTH HAND WASH
∙ benzalkonium chloride 0.13 % / v/v;
∙ 2021-01-08;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ TOTAL BODY CARE INC.;
∙ DIN: 02510022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99928
∙ COVALONGUARD SPRAY
∙ benzalkonium chloride 0.13 % / w/v;
∙ 2020-06-26;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ COVALON TECHNOLOGIES INC;
∙ DIN: 02499754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98946
∙ X3 CLEAN GERM ATTACK HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2007-09-25;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ NATURAL ESSENTIALS INC;
∙ DIN: 02290855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77627
∙ FRAGRANCE FOAM
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2011-02-01;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SCENTSY INC;
∙ DIN: 02354780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83994
∙ BENZALKONIUM CHLORIDE ANTISEPTIC TOWELETTE
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2012-06-07;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02355736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84093
∙ X3 ON-THE-GO ANTISEPTIC SPRAY
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2012-04-24;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ NATURAL ESSENTIALS INC;
∙ DIN: 02369575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85450
∙ SOFTSOAP ANTIBACTERIAL
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2014-01-20;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02406802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89148
∙ SANIMOR ASSAINISSEUR MOUSSANT SANS ALCOOL POUR LES MAINS | SANIMOR ALCOHOL FREE FOAMING HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2015-04-10;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ AVMOR LTD;
∙ DIN: 02432749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91715
∙ PURELL HAND SANITIZING WIPES
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2016-04-01;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GOJO CANADA INC;
∙ DIN: 02437384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92173
∙ ALOE-CARE ANTIBACTERIAL LOTION SOAP, BENZALKONIUM CHLORIDE LOTION 0.13% W/W
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2015-11-02;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02443163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92774
∙ KLEENEX FOAM HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2016-04-14;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ KIMBERLY-CLARK GLOBAL SALES LLC;
∙ DIN: 02443252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92785
∙ HAND SANITIZER FOAM
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2017-03-16;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02459272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94646
∙ DIAL COMPLETE ANTIBACTERIAL FOAMING HAND WASH
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2017-11-06;
∙ Topical (Household) | Topique (Maison);
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HENKEL CANADA CORPORATION;
∙ DIN: 02464802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95295
∙ DIAL ANTIBACTERIAL HYDRATING HAND SOAP
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2017-11-06;
∙ Topical (Household) | Topique (Maison);
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HENKEL CANADA CORPORATION;
∙ DIN: 02464829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95297
∙ ALCOHOL FREE FOAMING HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-03-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ VI-JON, LLC;
∙ DIN: 02479729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97037
∙ DYE FREE FRAGRANCE FREE ANTIBACTERIAL FOAMING HAND SOAP
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2019-11-14;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ VI-JON, LLC;
∙ DIN: 02480336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97086
∙ CERTAINTY WIPES HAND SANITIZING WIPES
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-06-26;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ INNOCORE SALES & MARKETING;
∙ DIN: 02497522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98734
∙ HOME HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-04-30;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HOME HARDWARE STORES LIMITED;
∙ DIN: 02498170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98795
∙ CERTAINTY FOAMING HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-06-04;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ INNOCORE SALES & MARKETING;
∙ DIN: 02499037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98880
∙ MARCELLE ULTRA GENTLE HAND SANITIZING GEL
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-06-23;
∙ Topical (Household) | Topique (Maison);
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GROUPE MARCELLE INC;
∙ DIN: 02499045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98881
∙ STRONGARM HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-07-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ARMSTRONG MANUFACTURING INC;
∙ DIN: 02499150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98890
∙ FOAM-CARE ULTRA
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-06-15;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LES CHIMIQUES B.O.D. INC;
∙ DIN: 02500124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98983
∙ HAMOL
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-11-27;
∙ Topical (Household) | Topique (Maison);
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ AK-PAK RICCI;
∙ DIN: 02500604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99027
∙ DOVE CARE & PROTECT HAND WASH ANTIBACTERIAL
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2021-01-08;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ UNILEVER CANADA;
∙ DIN: 02501368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99098
∙ ELEMENTAL HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-07-23;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EASY WAY CLEANING PRODUCTS LIMITED;
∙ DIN: 02502100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99164
∙ FS ANTIMICROBIAL HAND WASH
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-11-04;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02502852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99238
∙ SPA SOAP 2 X ULTRA CLEANSING LIQUID SOAP
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2021-06-01;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 38:00.00 – DISINFECTANTS (FOR AGENTS USED ON OBJECT);
∙ Otc | En Vente Libre;
∙ SANTE MANUFACTURING INC.;
∙ DIN: 02503042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99255
∙ SPA SOAP LIQUID SOAP
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2020-11-18;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ -;
∙ Otc | En Vente Libre;
∙ SANTE MANUFACTURING INC.;
∙ DIN: 02503050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99256
∙ SOFTSOAP ANTIBACTERIAL WHITE TEA & BERRY
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2021-02-25;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02508168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99755
∙ MEDISANI ANTI-BACTERIAL HAND SANITIZER
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2021-03-02;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ MEDISANI SOLUTIONS INC.;
∙ DIN: 02510189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99942
∙ GERMS BE GONE ANTIBACTERIAL HAND SOAP
∙ benzalkonium chloride 0.13 % / w/w;
∙ 2021-04-29;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BRANDS INTERNATIONAL CORPORATION;
∙ DIN: 02510650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99985
∙ RITUAL
∙ benzalkonium chloride 0.15 % / v/v;
∙ 2014-08-19;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ATOMS F.D. INC;
∙ DIN: 02359715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84471
∙ ANTI-MICROBE M
∙ benzalkonium chloride 0.15 % / v/v;
∙ 2020-07-16;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ATOMS F.D. INC;
∙ DIN: 02502178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99175
∙ BIO-ODEUR
∙ benzalkonium chloride 0.15 % / v/v;
∙ 2020-11-23;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PRODUITS BIO-EXPERT INC.;
∙ DIN: 02508370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99774
∙ SOAPOPULAR
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2005-11-01;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SOAPOPULAR INC;
∙ DIN: 02270420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75580
∙ KLERE
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2010-05-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BIOCHEM ENVIRONMENTAL SOLUTIONS INC.;
∙ DIN: 02329891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81564
∙ EZ PUR HAND SANITIZER
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2020-05-15;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PRELAM ENTERPRISES LIMITED;
∙ DIN: 02499274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98901
∙ HAND SANITIZER
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2020-08-28;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CONTRACT PACKAGING DISTRIBUTION INC.;
∙ DIN: 02502208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99178
∙ ALCOHOL-FREE GEL HAND SANITIZER
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2021-05-11;
∙ Topical (Household) | Topique (Maison);
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LES ENTREPRISES STEFMAR INC.;
∙ DIN: 02508206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99758
∙ ENVIRO FRESH HAND SANITIZER
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2021-03-29;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ENVIRO FRESH;
∙ DIN: 02511436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100063
∙ EZ PUR HAND SANITIZER FOR KIDS
∙ benzalkonium chloride 0.15 % / w/w;
∙ 2021-04-05;
∙ Topical (Household) | Topique (Maison);
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PRELAM ENTERPRISES LIMITED;
∙ DIN: 02512378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100166
∙ ANTI-MICROBE
∙ benzalkonium chloride 0.3 %;
∙ 2004-03-09;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ATOMS F.D. INC;
∙ DIN: 02248351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72696
∙ VINDA ANTIBACTERIAL WIPES
∙ benzethonium chloride 0.13 % / w/w;
∙ 2020-07-20;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GRAND OCEAN INTERNATIONAL TRADING LTD;
∙ DIN: 02501074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99072
∙ ECOLOGICAL HAND SANITIZER WITH CONDITIONING ALOE
∙ benzethonium chloride 0.15 % / v/v;
∙ 2020-05-13;
∙ Topical (Household) | Topique (Maison);
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ HUNTER AMENITIES INTERNATIONAL LIMITED;
∙ DIN: 02498138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98791
∙ ZEP FOAM SAN
∙ benzethonium chloride 0.2 %;
∙ 2004-02-09;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02248971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73352
∙ WINNING HANDS ALCOHOL FREE HAND SANITIZER
∙ benzethonium chloride 0.2 %;
∙ 2004-05-01;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BETCO CORPORATION;
∙ DIN: 02250977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73590
∙ INO-F-SAN INSTANT HAND SANITIZER
∙ benzethonium chloride 0.2 %;
∙ 2005-04-21;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GROUPE DISSAN INC.;
∙ DIN: 02267365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75279
∙ GENTLE FRESH SANITIZER
∙ benzethonium chloride 0.2 %;
∙ 2006-07-14;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ STATE INDUSTRIAL PRODUCTS;
∙ DIN: 02280841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76652
∙ FOAM SANITIZER
∙ benzethonium chloride 0.2 % / w/w;
∙ 2012-01-23;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02377896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86369
∙ FINIPIL LAIT 50
∙ benzethonium chloride 0.2 % / w/w;
∙ 2018-03-29;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EQUIBAL LABS INC;
∙ DIN: 02470837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95990
∙ FINIPIL
∙ benzethonium chloride 0.2 % / w/w;
∙ 2018-03-29;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EQUIBAL LABS INC;
∙ DIN: 02470853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95992
∙ FINIPIL 4 MEN ONLY
∙ benzethonium chloride 0.2 % / w/w;
∙ 2019-05-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EQUIBAL LABS INC;
∙ DIN: 02481480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97192
∙ WET ONES
∙ benzethonium chloride 0.3 % / w/w;
∙ 2008-04-22;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02304112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78942
∙ BENZAC W WASH GEL 10%
∙ benzoyl peroxide 10 %;
∙ 1991-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 01925199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11862
∙ RENEWAL CLEANSER
∙ benzoyl peroxide 2.5 %;
∙ 2015-12-10;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02433486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91785
∙ SPOT CLEARING LOTION
∙ benzoyl peroxide 2.5 %;
∙ 2016-08-30;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ ALUMIER EUROPE LTD;
∙ DIN: 02445247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93048
∙ CLINIQUE ACNE SOLUTIONS ALL-OVER CLEARING TREATMENT
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2007-07-03;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02290561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77590
∙ BENZAGEL SPOT-ON ACNE GEL
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2011-08-22;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ COLUMBIA LABORATORIES CANADA INC;
∙ DIN: 02361949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84698
∙ PROACTIV TREAT
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2013-08-08;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02390396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87583
∙ PROACTIV CLEANSE
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2013-08-08;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02391015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87639
∙ PROACTIV+ SKIN SMOOTHING EXFOLIATOR
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2014-06-20;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02394421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87959
∙ PROACTIV + PORE TARGETING SOLUTION
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2014-06-20;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02411245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89587
∙ DUAL INTENSIVE ACNE TREATMENT
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2015-02-02;
∙ Topical | Topique;
∙ Gel , Lotion | Gel , Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02414309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89896
∙ REPAIRING TREATMENT
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2015-12-10;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02433494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91786
∙ STUBBORN ACNE DAILY LEAVE-ON MASK
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2016-01-18;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02440520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92489
∙ ACNE CLEARING TREATMENT
∙ benzoyl peroxide 2.5 % / w/w;
∙ 2019-04-09;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02463202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95111
∙ CLEAR CELL MEDICATED ACNE FACIAL SCRUB
∙ benzoyl peroxide 3 % / w/w;
∙ 2015-02-17;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ IMAGE INTERNATIONAL MANUFACTURING LLC;
∙ DIN: 02437562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92189
∙ STUBBORN ACNE CLEANSER
∙ benzoyl peroxide 3.5 % / w/w;
∙ 2017-01-30;
∙ Topical | Topique;
∙ Paste | Pâte;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02440881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92524
∙ BENZAGEL 5 WASH
∙ benzoyl peroxide 5 %;
∙ 1996-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ COLUMBIA LABORATORIES CANADA INC;
∙ DIN: 02162121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20299
∙ BENZAGEL 5 GEL
∙ benzoyl peroxide 5 %;
∙ 1996-08-29;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ COLUMBIA LABORATORIES CANADA INC;
∙ DIN: 02162113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34258
∙ CLEAN & CLEAR PERSA-GEL 5
∙ benzoyl peroxide 5 %;
∙ 2000-03-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02236396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59870
∙ ADASEPT B.P.5 ACNE GEL
∙ benzoyl peroxide 5 %;
∙ 2007-09-25;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02290081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77539
∙ BENZOYL PEROXIDE ACNE TREATMENT 5%
∙ benzoyl peroxide 5 %;
∙ 2014-10-24;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ CRLS;
∙ DIN: 02412012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89660
∙ CLEAR CELL MEDICATED ACNE LOTION
∙ benzoyl peroxide 5 %;
∙ 2016-07-27;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ IMAGE INTERNATIONAL MANUFACTURING LLC;
∙ DIN: 02456656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94364
∙ DEEP PORE ACNE VANISHING TREATMENT
∙ benzoyl peroxide 5 % / w/w;
∙ 1998-07-15;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE MENTHOLATUM COMPANY OF CANADA LTD;
∙ DIN: 02236796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60085
∙ CONTINUOUS CONTROL ACNE CLEANSER
∙ benzoyl peroxide 5 % / w/w;
∙ 2001-08-01;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02242134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65812
∙ MEDICATED ACNE GEL
∙ benzoyl peroxide 5 % / w/w;
∙ 2006-01-03;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ PRIME ENTERPRISES INC;
∙ DIN: 02268817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75421
∙ EMERGENCY ACNE VANISHING FACIAL CLEANSER
∙ benzoyl peroxide 5 % / w/w;
∙ 2009-06-02;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE MENTHOLATUM COMPANY OF CANADA LTD;
∙ DIN: 02321874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80728
∙ ACNE TREATMENT LOTION
∙ benzoyl peroxide 5 % / w/w;
∙ 2011-06-07;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ VIVIER CANADA INCORPORATED;
∙ DIN: 02336812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82243
∙ PROACTIV EMERGENCY BLEMISH RELIEF
∙ benzoyl peroxide 5 % / w/w;
∙ 2014-10-27;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ THE PROACTIV COMPANY, LLC;
∙ DIN: 02413655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89830
∙ STUBBORN ACNE SPOT GEL
∙ benzoyl peroxide 5 % / w/w;
∙ 2016-01-18;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02440512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92488
∙ DAILY ACNE WASH
∙ benzoyl peroxide 5 % / w/w;
∙ 2019-04-09;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02463210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95112
∙ BPO5
∙ benzoyl peroxide 5 % / w/w;
∙ 2020-04-03;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ RGR PHARMA LTD.;
∙ DIN: 02490285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98034
∙ BLEMISH GEL 5%
∙ benzoyl peroxide 5.0 %;
∙ 2004-07-17;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:28.00 – KERATOLYTIC AGENTS;
∙ Otc | En Vente Libre;
∙ KAMINS DERMATOLOGICS INC;
∙ DIN: 02248217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72553
∙ PDP-BENZTROPINE
∙ benztropine mesylate 1 mg;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.08 – ANTICHOLINERGIC AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00706531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8060
∙ BENZTROPINE OMEGA
∙ benztropine mesylate 1 mg / ml;
∙ 1999-05-28;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 28:36.08 – ANTICHOLINERGIC AGENTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02238903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62344
∙ VPI-BENZTROPINE
∙ benztropine mesylate 2 mg / 2 ml;
∙ 2019-12-03;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 28:36.08 – ANTICHOLINERGIC AGENTS;
∙ Prescription | Prescription;
∙ VPI PHARMACEUTICALS INC;
∙ DIN: 02486822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97699
∙ PHARIXIA
∙ benzydamine hydrochloride 0.15 % / w/v;
∙ 1996-12-02;
∙ Buccal | Buccale;
∙ Mouthwash/Gargle | Rince-Bouche/Gargarisme;
∙ 52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02229777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48059
∙ PMS-BENZYDAMINE
∙ benzydamine hydrochloride 0.15 % / w/v;
∙ 1999-04-30;
∙ Buccal | Buccale;
∙ Mouthwash/Gargle | Rince-Bouche/Gargarisme;
∙ 52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02239537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63013
∙ ODAN-BENZYDAMINE
∙ benzydamine hydrochloride 0.15 % / w/v;
∙ 2017-08-11;
∙ Buccal | Buccale;
∙ Mouthwash/Gargle | Rince-Bouche/Gargarisme;
∙ 52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02463105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95103
∙ PHARIXIA ALCOHOL FREE
∙ benzydamine hydrochloride 0.15 % / w/v;
∙ 2020-07-13;
∙ Buccal | Buccale;
∙ Mouthwash/Gargle | Rince-Bouche/Gargarisme;
∙ 52:28.00 – MOUTHWASHES AND GARGLES , 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02494434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98444
∙ PRE-PEN
∙ benzylpenicilloyl-polylysine 0.000060 m / amp;
∙ 1975-12-31;
∙ Intradermal | Intradermique;
∙ Solution | Solution;
∙ 36:30.00 – DRUG HYPERSENSITIVITY;
∙ Prescription | Prescription;
∙ ALK-ABELLO INC;
∙ DIN: 00328693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2175
∙ BEPREVE
∙ bepotastine besilate 1.5 % / w/v;
∙ 2017-03-23;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:02.00 – ANTIALLERGIC AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH & LOMB INC;
∙ DIN: 02456532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94350
∙ SURVANTA
∙ beractant 25 mg / ml;
∙ 1993-12-31;
∙ Intratracheal | Intratrachéale;
∙ Suspension | Suspension;
∙ 48:36.00 – PULMONARY SURFACTANTS;
∙ Prescription | Prescription;
∙ ABBVIE CORPORATION;
∙ DIN: 02016109
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14318
∙ BESIVANCE
∙ besifloxacin (besifloxacin hydrochloride) 0.6 % / w/v;
∙ 2010-01-27;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ BAUSCH & LOMB INC;
∙ DIN: 02336847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82246
∙ SERC
∙ betahistine hydrochloride 16 mg;
∙ 2001-08-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02243878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67819
∙ TEVA-BETAHISTINE
∙ betahistine hydrochloride 16 mg;
∙ 2006-08-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02280191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76587
∙ PMS-BETAHISTINE
∙ betahistine hydrochloride 16 mg;
∙ 2014-01-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02330210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81597
∙ AURO-BETAHISTINE
∙ betahistine hydrochloride 16 mg;
∙ 2015-11-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02449153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93497
∙ BETAHISTINE
∙ betahistine hydrochloride 16 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95480
∙ SERC
∙ betahistine hydrochloride 24 mg;
∙ 2003-12-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02247998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72312
∙ TEVA-BETAHISTINE
∙ betahistine hydrochloride 24 mg;
∙ 2006-08-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02280205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76588
∙ PMS-BETAHISTINE
∙ betahistine hydrochloride 24 mg;
∙ 2014-01-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02330237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81599
∙ AURO-BETAHISTINE
∙ betahistine hydrochloride 24 mg;
∙ 2015-11-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02449161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93498
∙ BETAHISTINE
∙ betahistine hydrochloride 24 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95481
∙ TEVA-BETAHISTINE
∙ betahistine hydrochloride 8 mg;
∙ 2010-12-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02280183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76586
∙ AURO-BETAHISTINE
∙ betahistine hydrochloride 8 mg;
∙ 2015-11-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02449145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93496
∙ CYSTADANE
∙ betaine 1 g / 1.7 cc;
∙ 1998-08-11;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ RECORDATI RARE DISEASES CANADA INC;
∙ DIN: 02238526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61949
∙ TEVA-TOPILENE
∙ betamethasone (betamethasone dipropionate) 0.05 %;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00849669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10940
∙ TARO-SONE
∙ betamethasone (betamethasone dipropionate) 0.05 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 01925350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12272
∙ TEVA-TOPILENE
∙ betamethasone (betamethasone dipropionate) 0.05 %;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01927914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13690
∙ TEVA-TOPILENE
∙ betamethasone (betamethasone dipropionate) 0.05 %;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00849650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14445
∙ DIPROSONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1975-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00323071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2071
∙ DIPROSONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1976-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00344923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2272
∙ DIPROSONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1977-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00417246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2870
∙ DIPROLENE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1985-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ ORGANON CANADA INC.;
∙ DIN: 00629367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6529
∙ TEVA-TOPISONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00809187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10941
∙ TEVA-TOPISONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00805009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13888
∙ TEVA-TOPISONE
∙ betamethasone (betamethasone dipropionate) 0.05 % / w/w;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00804991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13889
∙ BETNESOL RETENTION ENEMA 5MG/100ML
∙ betamethasone (betamethasone sodium phosphate) 5 mg / 100 ml;
∙ 1997-04-01;
∙ Rectal | Rectale;
∙ Enema | Lavement;
∙ 68:04.00 – ADRENALS , 56:36.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 02060884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27517
∙ TEVA-ECTOSONE
∙ betamethasone (betamethasone valerate) 0.05 %;
∙ 1981-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00535427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4521
∙ TEVA-ECTOSONE
∙ betamethasone (betamethasone valerate) 0.05 %;
∙ 1986-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00653209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6822
∙ BETADERM CRM 0.05%
∙ betamethasone (betamethasone valerate) 0.05 %;
∙ 1979-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8972
∙ BETADERM ONT 0.05%
∙ betamethasone (betamethasone valerate) 0.05 %;
∙ 1979-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9270
∙ TEVA-ECTOSONE
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1981-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00535435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4522
∙ TEVA-ECTOSONE
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1986-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00653217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6620
∙ BETADERM ONT 0.1%
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1988-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8973
∙ BETADERM CRM 0.1%
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1979-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9268
∙ BETADERM LOTION 0.1%
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1979-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00716634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9269
∙ TEVA-ECTOSONE
∙ betamethasone (betamethasone valerate) 0.1 %;
∙ 1987-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00750050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19225
∙ BETOPTIC S
∙ betaxolol (betaxolol hydrochloride) 0.25 % / w/v;
∙ 1994-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:40.08 – BETA-ADRENERGIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 01908448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15625
∙ DUVOID TABLETS 10 MG
∙ bethanechol chloride 10 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 01947958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12746
∙ DUVOID TABLETS 25 MG
∙ bethanechol chloride 25 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 01947931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12745
∙ DUVOID TABLETS 50 MG
∙ bethanechol chloride 50 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
∙ Prescription | Prescription;
∙ PALADIN LABS INC.;
∙ DIN: 01947923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12887
∙ ZIRABEV
∙ bevacizumab 100 mg / 4 ml;
∙ 2019-09-25;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02489430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97952
∙ AVASTIN
∙ bevacizumab 25 mg / ml;
∙ 2005-11-02;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02270994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75642
∙ MVASI
∙ bevacizumab 25 mg / ml;
∙ 2019-08-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02470748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95974
∙ MVASI
∙ bevacizumab 25 mg / ml;
∙ 2019-08-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02470756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95975
∙ ZIRABEV
∙ bevacizumab 400 mg / 16 ml;
∙ 2019-09-25;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02489449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97953
∙ BEZALIP SR
∙ bezafibrate 400 mg;
∙ 1994-12-21;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02083523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16968
∙ JAMP-BEZAFIBRATE SR
∙ bezafibrate 400 mg;
∙ 2016-04-06;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 24:06.06 – FRIBIC ACID DERIVATIVES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02453312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93984
∙ CASODEX
∙ bicalutamide 50 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02184478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19647
∙ TEVA-BICALUTAMIDE
∙ bicalutamide 50 mg;
∙ 2006-02-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02270226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75561
∙ PMS-BICALUTAMIDE
∙ bicalutamide 50 mg;
∙ 2006-02-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02275589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76122
∙ APO-BICALUTAMIDE
∙ bicalutamide 50 mg;
∙ 2007-11-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02296063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78142
∙ PRO-BICALUTAMIDE – 50
∙ bicalutamide 50 mg;
∙ 2008-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02311038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79663
∙ ACH-BICALUTAMIDE
∙ bicalutamide 50 mg;
∙ 2010-05-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02325985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81133
∙ JAMP-BICALUTAMIDE
∙ bicalutamide 50 mg;
∙ 2010-10-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02357216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84234
∙ BLEXTEN
∙ bilastine 20 mg;
∙ 2016-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 02454130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94066
∙ LUMIGAN RC
∙ bimatoprost 0.01 % / w/v;
∙ 2009-06-16;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02324997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81041
∙ LATISSE
∙ bimatoprost 0.03 % / w/v;
∙ 2010-11-01;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02350939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83612
∙ VISTITAN
∙ bimatoprost 0.03 % / w/v;
∙ 2016-05-13;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.28 – PROSTAGLANDIN ANALOGS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02429063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91352
∙ DULCOLAX
∙ bisacodyl 10 mg;
∙ 1958-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 00003875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1555
∙ THE MAGIC BULLET
∙ bisacodyl 10 mg;
∙ 1999-11-25;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ D & C MOBILITY SOLUTIONS INC.;
∙ DIN: 02241091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64686
∙ SILVER BULLET SUPPOSITORY
∙ bisacodyl 10 mg;
∙ 2007-12-15;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ D & C MOBILITY SOLUTIONS INC.;
∙ DIN: 02280566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76622
∙ BISACODYL SUPPOSITORY
∙ bisacodyl 10 mg;
∙ 2013-12-18;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02361450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84651
∙ BISACODYL SUPPOSITORY
∙ bisacodyl 10 mg;
∙ 2020-01-27;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ ANGITA PHARMA INC.;
∙ DIN: 02489090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97915
∙ DULCOLAX
∙ bisacodyl 5 mg;
∙ 1958-12-31;
∙ Oral | Orale;
∙ Tablet (Enteric-Coated) | Comprimé (Entérosoluble);
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 00254142
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1553
∙ CARTER’S LITTLE PILLS
∙ bisacodyl 5 mg;
∙ 1998-01-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ CHURCH & DWIGHT CANADA CORP;
∙ DIN: 02219190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37161
∙ CODULAX TABLETS
∙ bisacodyl 5 mg;
∙ 1999-07-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02238155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61546
∙ BISACODYL TABLETS 5MG
∙ bisacodyl 5 mg;
∙ 2003-04-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02243838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67779
∙ JAMP-BISACODYL
∙ bisacodyl 5 mg;
∙ 2006-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02246039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70170
∙ BISACODYL-ODAN
∙ bisacodyl 5 mg;
∙ 2005-12-07;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) | Comprimé (À Libération Retardée);
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02273411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75889
∙ DULCOLAX FOR WOMEN
∙ bisacodyl 5 mg;
∙ 2013-08-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC;
∙ DIN: 02397854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88276
∙ BISACODYL TABLETS
∙ bisacodyl 5 mg;
∙ 2014-04-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02417413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90204
∙ LAXATIVE FOR WOMEN
∙ bisacodyl 5 mg;
∙ 2016-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Otc | En Vente Libre;
∙ TANTA PHARMACEUTICALS INC;
∙ DIN: 02450232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93629
∙ NEO-LARYNGOBIS
∙ bismuth dipropylacetate 135 mg;
∙ 1950-12-31;
∙ Rectal | Rectale;
∙ Suppository | Suppositoire;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00065927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1090
∙ DEVROM CHEW TAB 200MG
∙ bismuth subgallate 200 mg;
∙ 1978-12-31;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ THE PARTHENON COMPANY INC.;
∙ DIN: 00452696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3166
∙ BISMUTH SUBSALICYLATE LIQUID
∙ bismuth subsalicylate 17.5 mg / ml;
∙ 2008-12-12;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ GUARDIAN DRUG COMPANY INC;
∙ DIN: 02313162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79869
∙ REGULAR STRENGTH BISMUTH
∙ bismuth subsalicylate 17.5 mg / ml;
∙ 2018-07-17;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02468646
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95706
∙ PEPTO-BISMOL
∙ bismuth subsalicylate 17.6 mg / ml;
∙ 1987-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02097079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42395
∙ PEPTO BISMOL CAPLET – 262MG/CAPLET
∙ bismuth subsalicylate 262 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02177994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42736
∙ BISMUTH SUBSALICYLATE CAPLETS
∙ bismuth subsalicylate 262 mg;
∙ 2010-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ GUARDIAN DRUG COMPANY INC;
∙ DIN: 02326582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81194
∙ BISMUTH CAPLETS
∙ bismuth subsalicylate 262 mg;
∙ 2018-09-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02457121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94421
∙ PEPTO BISMOL LIQUICAPS
∙ bismuth subsalicylate 262 mg;
∙ 2021-03-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02499991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98971
∙ EXTRA STRENGTH BISMUTH SUBSALICYLATE LIQUID
∙ bismuth subsalicylate 35 mg / ml;
∙ 2010-07-01;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS , 56:08.00 – ANTIDIARRHEA AGENTS;
∙ Otc | En Vente Libre;
∙ GUARDIAN DRUG COMPANY INC;
∙ DIN: 02328453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81398
∙ PEPTO-BISMOL EXTRA
∙ bismuth subsalicylate 35.2 mg / ml;
∙ 2000-02-01;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02229668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47656
∙ EXTRA STRENGTH BISMUTH
∙ bismuth subsalicylate 35.2 mg / ml;
∙ 2020-09-11;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ JUNO OTC INC;
∙ DIN: 02475855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96658
∙ SANDOZ BISOPROLOL
∙ bisoprolol fumarate 10 mg;
∙ 2003-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02247440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71686
∙ APO-BISOPROLOL
∙ bisoprolol fumarate 10 mg;
∙ 2004-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02256177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74140
∙ TEVA-BISOPROLOL
∙ bisoprolol fumarate 10 mg;
∙ 2005-10-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02267489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75289
∙ PRO-BISOPROLOL – 10
∙ bisoprolol fumarate 10 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02307006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79268
∙ BISOPROLOL
∙ bisoprolol fumarate 10 mg;
∙ 2012-10-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02391597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87692
∙ MINT-BISOPROLOL
∙ bisoprolol fumarate 10 mg;
∙ 2019-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02465620
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95385
∙ SANDOZ BISOPROLOL TABLETS
∙ bisoprolol fumarate 10 mg;
∙ 2019-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02494043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98406
∙ BISOPROLOL TABLETS
∙ bisoprolol fumarate 10 mg;
∙ 2020-05-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02495570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98547
∙ SANDOZ BISOPROLOL
∙ bisoprolol fumarate 5 mg;
∙ 2003-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02247439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71685
∙ APO-BISOPROLOL
∙ bisoprolol fumarate 5 mg;
∙ 2004-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02256134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74136
∙ TEVA-BISOPROLOL
∙ bisoprolol fumarate 5 mg;
∙ 2005-10-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02267470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75288
∙ PRO-BISOPROLOL – 5
∙ bisoprolol fumarate 5 mg;
∙ 2008-07-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02306999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79267
∙ BISOPROLOL
∙ bisoprolol fumarate 5 mg;
∙ 2012-10-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02391589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87691
∙ MINT-BISOPROLOL
∙ bisoprolol fumarate 5 mg;
∙ 2019-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02465612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95384
∙ SANDOZ BISOPROLOL TABLETS
∙ bisoprolol fumarate 5 mg;
∙ 2019-11-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02494035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98405
∙ BISOPROLOL TABLETS
∙ bisoprolol fumarate 5 mg;
∙ 2020-05-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02495562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98546
∙ ANGIOMAX
∙ bivalirudin 250 mg / vial;
∙ 2003-05-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02246533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70715
∙ BIVALIRUDIN FOR INJECTION
∙ bivalirudin 250 mg / vial;
∙ 2019-04-23;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02435268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91953
∙ BIVALIRUDIN INJECTION
∙ bivalirudin 5 mg / ml;
∙ 2021-03-05;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 20:12.04.12 – DIRECT THROMBIN INHIBITORS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02505517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99489
∙ BLEOMYCIN FOR INJECTION USP
∙ bleomycin (bleomycin sulfate) 15 unit / vial;
∙ 1998-03-12;
∙ Intra-Arterial , Intracavitary , Intramuscular , Intravenous , Subcutaneous | Intra-Artérielle , Intracavitaire , Intramusculaire , Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02131692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43892
∙ BLEOMYCIN FOR INJECTION
∙ bleomycin (bleomycin sulfate) 15 unit / vial;
∙ 2009-03-20;
∙ Intramuscular , Intrapleural , Intravenous , Subcutaneous | Intramusculaire , Intrapleurale , Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02265982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75142
∙ BLINCYTO
∙ blinatumomab 38.5 mcg / vial;
∙ 2016-03-17;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ AMGEN CANADA INC;
∙ DIN: 02450283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93642
∙ BORTEZOMIB FOR INJECTION
∙ bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial;
∙ 2020-06-23;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02467003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95541
∙ BORTEZOMIB FOR INJECTION
∙ bortezomib (bortezomib mannitol boronic ester) 2.5 mg / vial;
∙ 2020-10-05;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02494930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98491
∙ VELCADE
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2005-02-01;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02262452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74782
∙ BORTEZOMIB FOR INJECTION
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2015-01-06;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02423405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90813
∙ ACT BORTEZOMIB
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2015-11-17;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02438399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92278
∙ BORTEZOMIB FOR INJECTION
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2017-03-21;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02452456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93883
∙ BORTEZOMIB
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2019-03-25;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02456176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94301
∙ PMS-BORTEZOMIB
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2018-06-05;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02466708
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95502
∙ BORTEZOMIB FOR INJECTION
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2020-05-19;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02493306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98328
∙ TARO-BORTEZOMIB
∙ bortezomib (bortezomib mannitol boronic ester) 3.5 mg / vial;
∙ 2021-04-12;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02499061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98883
∙ TRACLEER
∙ bosentan (bosentan monohydrate) 125 mg;
∙ 2001-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02244982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68980
∙ PMS-BOSENTAN
∙ bosentan (bosentan monohydrate) 125 mg;
∙ 2012-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02383020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86881
∙ NAT-BOSENTAN
∙ bosentan (bosentan monohydrate) 125 mg;
∙ 2020-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02467992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95636
∙ TRACLEER
∙ bosentan (bosentan monohydrate) 62.5 mg;
∙ 2001-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02244981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68979
∙ PMS-BOSENTAN
∙ bosentan (bosentan monohydrate) 62.5 mg;
∙ 2012-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02383012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86880
∙ NAT-BOSENTAN
∙ bosentan (bosentan monohydrate) 62.5 mg;
∙ 2020-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02467984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95635
∙ TARO-BOSENTAN
∙ bosentan (bosentan monohydrate) 62.5 mg;
∙ 2020-05-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 48:48.00 – VASODILATING AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02483130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97359
∙ BOSULIF
∙ bosutinib (bosutinib monohydrate) 100 mg;
∙ 2014-04-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02419149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90368
∙ BOSULIF
∙ bosutinib (bosutinib monohydrate) 500 mg;
∙ 2014-03-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02419157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90369
∙ ADCETRIS
∙ brentuximab vedotin 50 mg / vial;
∙ 2013-02-19;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SEAGEN INC.;
∙ DIN: 02401347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88626
∙ REXULTI
∙ brexpiprazole 0.25 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94950
∙ REXULTI
∙ brexpiprazole 0.5 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94951
∙ REXULTI
∙ brexpiprazole 1 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94952
∙ REXULTI
∙ brexpiprazole 2 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94953
∙ REXULTI
∙ brexpiprazole 3 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94954
∙ REXULTI
∙ brexpiprazole 4 mg;
∙ 2017-04-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ OTSUKA PHARMACEUTICAL CO LTD;
∙ DIN: 02461803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94955
∙ ALUNBRIG
∙ brigatinib 180 mg;
∙ 2018-08-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02479222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96984
∙ ALUNBRIG
∙ brigatinib 30 mg;
∙ 2018-08-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02479206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96982
∙ ALUNBRIG
∙ brigatinib 90 mg;
∙ 2018-08-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TAKEDA CANADA INC;
∙ DIN: 02479214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96983
∙ ONRELTEA
∙ brimonidine (brimonidine tartrate) 0.33 % / w/w;
∙ 2014-03-24;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02421208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90580
∙ ALPHAGAN P
∙ brimonidine tartrate 0.15 %;
∙ 2003-11-05;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02248151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72483
∙ ALPHAGAN
∙ brimonidine tartrate 0.2 %;
∙ 1997-12-02;
∙ Ophthalmic | Ophtalmique;
∙ Liquid | Liquide;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ ALLERGAN INC;
∙ DIN: 02236876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60166
∙ SANDOZ BRIMONIDINE
∙ brimonidine tartrate 0.2 %;
∙ 2008-02-08;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02305429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79097
∙ RIVA-BRIMONIDINE
∙ brimonidine tartrate 0.2 % / w/v;
∙ 2021-07-20;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:40.04 – ALPHA-ADRENERGIC AGONISTS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02515350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100474
∙ AZOPT
∙ brinzolamide 1 % / w/v;
∙ 1998-11-11;
∙ Ophthalmic | Ophtalmique;
∙ Suspension | Suspension;
∙ 52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02238873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62313
∙ BRIVLERA
∙ brivaracetam 10 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93933
∙ BRIVLERA
∙ brivaracetam 10 mg / ml;
∙ 2020-04-06;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93938
∙ BRIVLERA
∙ brivaracetam 10 mg / ml;
∙ 2018-10-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93939
∙ BRIVLERA
∙ brivaracetam 100 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93937
∙ BRIVLERA
∙ brivaracetam 25 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93934
∙ BRIVLERA
∙ brivaracetam 50 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93935
∙ BRIVLERA
∙ brivaracetam 75 mg;
∙ 2016-05-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ UCB CANADA INC;
∙ DIN: 02452960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93936
∙ SILIQ
∙ brodalumab 210 mg / 1.5 ml;
∙ 2018-07-05;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Schedule D | Annexe D;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02473623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96302
∙ BEOVU
∙ brolucizumab 6 mg / 0.05 ml;
∙ 2020-05-15;
∙ Intravitreal | Intravitreuse;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02496976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98684
∙ APO-BROMAZEPAM – TAB 3MG
∙ bromazepam 3 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02177161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19056
∙ TEVA-BROMAZEPAM
∙ bromazepam 3 mg;
∙ 1997-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 02230584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49693
∙ APO-BROMAZEPAM – TAB 6MG
∙ bromazepam 6 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02177188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19047
∙ TEVA-BROMAZEPAM
∙ bromazepam 6 mg;
∙ 1997-03-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 02230585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49694
∙ PROLENSA
∙ bromfenac (bromfenac sodium sesquihydrate) 0.07 % / w/v;
∙ 2015-09-25;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ BAUSCH & LOMB INC;
∙ DIN: 02439123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92351
∙ BROMOCRIPTINE
∙ bromocriptine (bromocriptine mesylate) 2.5 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02087324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16195
∙ BROMOCRIPTINE
∙ bromocriptine (bromocriptine mesylate) 5 mg;
∙ 1997-01-08;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02230454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49403
∙ PULMICORT NEBUAMP 0.125 MG/ML
∙ budesonide 0.125 mg / ml;
∙ 1997-06-16;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02229099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43511
∙ TEVA-BUDESONIDE
∙ budesonide 0.125 mg / ml;
∙ 2017-11-08;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02465949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95417
∙ TARO-BUDESONIDE
∙ budesonide 0.125 mg / ml;
∙ 2021-06-04;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02494264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98429
∙ PULMICORT NEBUAMP 0.25 MG/ML
∙ budesonide 0.25 mg / ml;
∙ 1992-12-31;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 01978918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13191
∙ PULMICORT NEBUAMP 0.5 MG/ML
∙ budesonide 0.5 mg / ml;
∙ 1992-12-31;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 01978926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13190
∙ TEVA-BUDESONIDE
∙ budesonide 0.5 mg / ml;
∙ 2017-11-08;
∙ Inhalation | Inhalation;
∙ Suspension | Suspension;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02465957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95418
∙ JORVEZA
∙ budesonide 1 mg;
∙ 2021-01-07;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02493675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98367
∙ PULMICORT TURBUHALER
∙ budesonide 100 mcg / act;
∙ 1990-12-31;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 00852074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10667
∙ MYLAN-BUDESONIDE AQ
∙ budesonide 100 mcg / act;
∙ 1997-02-12;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02230648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49895
∙ PULMICORT TURBUHALER
∙ budesonide 200 mcg / act;
∙ 1990-12-31;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 00851752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10666
∙ ENTOCORT
∙ budesonide 3 mg;
∙ 1997-01-30;
∙ Oral | Orale;
∙ Capsule (Sustained-Release) | Capsule (À Action Soutenue);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ TILLOTTS PHARMA GMBH;
∙ DIN: 02229293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43534
∙ PULMICORT TURBUHALER
∙ budesonide 400 mcg / act;
∙ 1992-12-31;
∙ Inhalation | Inhalation;
∙ Powder (Metered Dose) | Poudre (À Dose Mesurée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 00851760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12182
∙ RHINOCORT AQUA
∙ budesonide 64 mcg / act;
∙ 1997-09-17;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02231923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51375
∙ MYLAN-BUDESONIDE AQ
∙ budesonide 64 mcg / act;
∙ 1999-11-23;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02241003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64595
∙ CORTIMENT
∙ budesonide 9 mg;
∙ 2016-07-25;
∙ Oral | Orale;
∙ Tablet (Delayed And Extended Release) | Comprimé (À Libération Retardée Et Prolongée);
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02455889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94275
∙ BURINEX
∙ bumetanide 1 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ KNIGHT THERAPEUTICS INC.;
∙ DIN: 00728284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14334
∙ BURINEX
∙ bumetanide 5 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.08 – LOOP DIURETICS;
∙ Prescription | Prescription;
∙ KNIGHT THERAPEUTICS INC.;
∙ DIN: 00728276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14322
∙ MARCAINE SPINAL
∙ bupivacaine hydrochloride 15 mg / 2 ml;
∙ 2000-12-01;
∙ Intraspinal | Intrarachidienne;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02241914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65584
∙ MARCAINE
∙ bupivacaine hydrochloride 150 mg / 20 ml;
∙ 2001-09-15;
∙ Retrobulbar , Epidural | Rétrobulbaire , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02241917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65587
∙ SENSORCAINE
∙ bupivacaine hydrochloride 2.5 mg / ml;
∙ 1994-12-31;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 01976141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16161
∙ BUPIVACAINE INJECTION BP
∙ bupivacaine hydrochloride 2.5 mg / ml;
∙ 2016-05-20;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02443686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92837
∙ MARCAINE
∙ bupivacaine hydrochloride 250 mg / 50 ml;
∙ 2008-09-17;
∙ Block/Infiltration | Bloc/Infiltration;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 02305909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79145
∙ SENSORCAINE
∙ bupivacaine hydrochloride 5 mg / ml;
∙ 1994-12-31;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 01976168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16164
∙ BUPIVACAINE INJECTION BP
∙ bupivacaine hydrochloride 5 mg / ml;
∙ 2016-05-20;
∙ Block/Infiltration , Epidural | Bloc/Infiltration , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02443694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92838
∙ BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
∙ bupivacaine hydrochloride 7.5 mg / ml;
∙ 2018-03-13;
∙ Intraspinal | Intrarachidienne;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02460645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94807
∙ BUPIVACAINE HYDROCHLORIDE INJECTION, USP
∙ bupivacaine hydrochloride 7.5 mg / ml;
∙ 2021-08-23;
∙ Retrobulbar , Epidural | Rétrobulbaire , Épidurale;
∙ Solution | Solution;
∙ 72:00.00 – LOCAL ANESTHETICS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02504979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99434
∙ BUTRANS 10
∙ buprenorphine 10 mcg / hour;
∙ 2010-05-26;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02341212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82675
∙ SUBLOCADE
∙ buprenorphine 100 mg / 0.5 ml;
∙ 2020-02-03;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution (Extended Release) | Solution (À Libération Prolongée);
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02483084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97348
∙ BUTRANS 15
∙ buprenorphine 15 mcg / hour;
∙ 2016-06-15;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02450771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93692
∙ BUTRANS 20
∙ buprenorphine 20 mcg / hour;
∙ 2010-05-26;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02341220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82676
∙ SUBLOCADE
∙ buprenorphine 300 mg / 1.5 ml;
∙ 2020-02-03;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution (Extended Release) | Solution (À Libération Prolongée);
∙ 28:08.08 – OPIATE AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ INDIVIOR UK LIMITED;
∙ DIN: 02483092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97349
∙ BUTRANS 5
∙ buprenorphine 5 mcg / hour;
∙ 2010-05-26;
∙ Transdermal | Transdermique;
∙ Patch | Timbre;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ PURDUE PHARMA;
∙ DIN: 02341174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82671
∙ PROBUPHINE
∙ buprenorphine hydrochloride 80 mg;
∙ 2018-11-22;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ KNIGHT THERAPEUTICS INC.;
∙ DIN: 02474921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96515
∙ ODAN BUPROPION SR
∙ bupropion hydrochloride 100 mg;
∙ 2006-06-23;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02275074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76058
∙ BUPROPION SR
∙ bupropion hydrochloride 100 mg;
∙ 2012-10-01;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02391562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87689
∙ ZYBAN
∙ bupropion hydrochloride 150 mg;
∙ 1998-08-10;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02238441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61860
∙ ODAN BUPROPION SR
∙ bupropion hydrochloride 150 mg;
∙ 2006-06-23;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02275082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76059
∙ WELLBUTRIN XL
∙ bupropion hydrochloride 150 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02275090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76060
∙ MYLAN-BUPROPION XL
∙ bupropion hydrochloride 150 mg;
∙ 2013-09-17;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02382075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86794
∙ BUPROPION SR
∙ bupropion hydrochloride 150 mg;
∙ 2012-10-01;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02391570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87690
∙ TEVA-BUPROPION XL
∙ bupropion hydrochloride 150 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02439654
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92405
∙ TARO-BUPROPION XL
∙ bupropion hydrochloride 150 mg;
∙ 2019-05-15;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02475804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96647
∙ WELLBUTRIN XL
∙ bupropion hydrochloride 300 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02275104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76061
∙ MYLAN-BUPROPION XL
∙ bupropion hydrochloride 300 mg;
∙ 2013-09-17;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02382083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86795
∙ TEVA-BUPROPION XL
∙ bupropion hydrochloride 300 mg;
∙ 2016-05-03;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02439662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92406
∙ TARO-BUPROPION XL
∙ bupropion hydrochloride 300 mg;
∙ 2019-05-15;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02475812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96648
∙ CRYSVITA
∙ burosumab 10 mg / ml;
∙ 2019-01-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ KYOWA KIRIN LIMITED;
∙ DIN: 02483629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97399
∙ CRYSVITA
∙ burosumab 20 mg / ml;
∙ 2019-01-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ KYOWA KIRIN LIMITED;
∙ DIN: 02483637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97400
∙ CRYSVITA
∙ burosumab 30 mg / ml;
∙ 2019-01-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 40:92.00 – ELECTROLYTIC, CALORIC AND WATER BALANCE AGENTS, MISCELLANOUS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ KYOWA KIRIN LIMITED;
∙ DIN: 02483645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97401
∙ SUPREFACT
∙ buserelin (buserelin acetate) 1 mg / ml;
∙ 1998-05-05;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02225166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43417
∙ SUPREFACT
∙ buserelin (buserelin acetate) 100 mcg / act;
∙ 1998-02-03;
∙ Nasal | Nasale;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02225158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43416
∙ SUPREFACT DEPOT 2 MONTHS
∙ buserelin (buserelin acetate) 6.3 mg;
∙ 1997-02-10;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02228955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43499
∙ SUPREFACT DEPOT 3 MONTHS
∙ buserelin (buserelin acetate) 9.45 mg;
∙ 2000-02-24;
∙ Subcutaneous | Sous-Cutanée;
∙ Implant | Implant;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 02240749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64338
∙ APO-BUSPIRONE
∙ buspirone hydrochloride 10 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02211076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20011
∙ BUSPIRONE-10
∙ buspirone hydrochloride 10 mg;
∙ 1997-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02223163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43349
∙ PMS-BUSPIRONE
∙ buspirone hydrochloride 10 mg;
∙ 1997-05-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02230942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50220
∙ TEVA-BUSPIRONE
∙ buspirone hydrochloride 10 mg;
∙ 1997-09-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02231492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50822
∙ BUSPIRONE
∙ buspirone hydrochloride 10 mg;
∙ 2016-02-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02447851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93348
∙ AURO-BUSPIRONE
∙ buspirone hydrochloride 10 mg;
∙ 2020-10-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02500213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98992
∙ MYLERAN
∙ busulfan 2 mg;
∙ 1954-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00004618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=959
∙ PMS-BUSULFAN
∙ busulfan 6 mg / ml;
∙ 2019-03-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02477343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96833
∙ BUSULFAN FOR INJECTION
∙ busulfan 60 mg / 10 ml;
∙ 2017-10-04;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02463733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95184
∙ BUTORPHANOL NASAL SPRAY
∙ butorphanol tartrate 10 mg / ml;
∙ 2000-08-01;
∙ Nasal | Nasale;
∙ Solution | Solution;
∙ 28:08.12 – OPIATE PARTIAL AGONISTS;
∙ Schedule G (Cdsa Iv) | Annexe G (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 02242504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66247
∙ BERINERT 1500
∙ c1 esterase inhibitor (human) 1500 unit / vial;
∙ 2015-05-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02436078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92040
∙ HAEGARDA
∙ c1 esterase inhibitor (human) 2000 unit / vial;
∙ 2020-01-23;
∙ Subcutaneous | Sous-Cutanée;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02468069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95643
∙ HAEGARDA
∙ c1 esterase inhibitor (human) 3000 unit / vial;
∙ 2020-01-23;
∙ Subcutaneous | Sous-Cutanée;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02468077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95644
∙ BERINERT 500
∙ c1 esterase inhibitor (human) 500 unit / vial;
∙ 2010-10-06;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02352575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83783
∙ CINRYZE
∙ c1 esterase inhibitor (human) 500 unit / vial;
∙ 2016-03-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:32.00 – COMPLEMENT INHIBITORS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02395371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88048
∙ JEVTANA
∙ cabazitaxel 40 mg / ml;
∙ 2011-08-23;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02369524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85445
∙ CABAZITAXEL FOR INJECTION
∙ cabazitaxel 40 mg / ml;
∙ 2020-06-01;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ DR REDDY’S LABORATORIES LTD;
∙ DIN: 02495635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98553
∙ CABAZITAXEL FOR INJECTION
∙ cabazitaxel 45 mg / 4.5 ml;
∙ 2019-12-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ #N/A;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02487497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97765
∙ CABAZITAXEL FOR INJECTION
∙ cabazitaxel 60 mg / 6 ml;
∙ 2019-12-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02487500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97766
∙ DOSTINEX
∙ cabergoline 0.5 mg;
∙ 2000-06-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02242471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66198
∙ APO-CABERGOLINE
∙ cabergoline 0.5 mg;
∙ 2017-03-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:36.20.04 – ERGOT-DERIVATIVE DOPAMINE RECEPTOR AGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02455897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94276
∙ VOCABRIA
∙ cabotegravir (cabotegravir sodium) 30 mg;
∙ 2020-09-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:18.08.12 – HIV INTEGRASE INHIBITORS;
∙ Prescription | Prescription;
∙ VIIV HEALTHCARE ULC;
∙ DIN: 02497204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98705
∙ CABOMETYX
∙ cabozantinib (cabozantinib malate) 20 mg;
∙ 2018-10-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02480824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97148
∙ CABOMETYX
∙ cabozantinib (cabozantinib malate) 40 mg;
∙ 2018-10-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02480832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97149
∙ CABOMETYX
∙ cabozantinib (cabozantinib malate) 60 mg;
∙ 2018-10-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ IPSEN BIOPHARMACEUTICALS CANADA INC;
∙ DIN: 02480840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97150
∙ PEYONA
∙ caffeine citrate 20 mg / ml;
∙ 2020-07-13;
∙ Intravenous , Oral | Intraveineuse , Orale;
∙ Solution | Solution;
∙ 28:20.32 – Respiratory and CNS Stimulants;
∙ Prescription Recommended | Prescription (Recommandé);
∙ CHIESI FARMACEUTICI S.P.A.;
∙ DIN: 02496771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98662
∙ DOVONEX
∙ calcipotriol 50 mcg / g;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ LEO PHARMA INC;
∙ DIN: 01976133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13340
∙ CALCIMAR
∙ calcitonin (salmon synthetic) 200 unit / ml;
∙ 1983-12-31;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Solution | Solution;
∙ 68:24.00 – PARATHYROID AND ANTIPARATHYROID AGENTS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 01926691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12837
∙ ROCALTROL
∙ calcitriol 0.25 mcg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 00481823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3430
∙ CALCITRIOL-ODAN
∙ calcitriol 0.25 mcg;
∙ 2014-10-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02431637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91612
∙ TARO-CALCITRIOL
∙ calcitriol 0.25 mcg;
∙ 2019-06-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02485710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97594
∙ CALCITRIOL CAPSULES
∙ calcitriol 0.25 mcg;
∙ 2020-03-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ STRIDES PHARMA CANADA INC;
∙ DIN: 02495899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98579
∙ ROCALTROL
∙ calcitriol 0.5 mcg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ SEARCHLIGHT PHARMA INC;
∙ DIN: 00481815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3429
∙ CALCITRIOL-ODAN
∙ calcitriol 0.5 mcg;
∙ 2014-10-10;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02431645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91613
∙ TARO-CALCITRIOL
∙ calcitriol 0.5 mcg;
∙ 2019-06-03;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02485729
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97595
∙ CALCITRIOL CAPSULES
∙ calcitriol 0.5 mcg;
∙ 2020-03-09;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ STRIDES PHARMA CANADA INC;
∙ DIN: 02495902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98580
∙ CALCITRIOL INJECTION USP
∙ calcitriol 1 mcg / ml;
∙ 2015-03-27;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 88:16.00 – VITAMIN D;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02399334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88422
∙ SILKIS
∙ calcitriol 3 mcg / g;
∙ 2010-04-09;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02338572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82422
∙ CALCIUM CHLORIDE INJECTION USP
∙ calcium chloride 100 mg / ml;
∙ 1981-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00294748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4230
∙ CALCIJECT INJ 100MG/ML
∙ calcium chloride 100 mg / ml;
∙ 1990-12-31;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 00821780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10770
∙ CALCIUM CHLORIDE INJECTION BP
∙ calcium chloride 100 mg / ml;
∙ 2021-06-25;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ STERIMAX INC;
∙ DIN: 02495945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98584
∙ CALCIUM-45 0.5-4.5
∙ calcium chloride 14.9 g / bottle;
∙ 1995-12-31;
∙ Dialysis | Dialyse;
∙ Powder | Poudre;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02160986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18321
∙ CALCIUM-45 0.25-4.5
∙ calcium chloride 7.45 g / bottle;
∙ 1995-12-31;
∙ Dialysis | Dialyse;
∙ Powder | Poudre;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02161060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18310
∙ CALCIUM CHLORIDE FOR HAEMODIALYSIS
∙ calcium chloride 7.45 g / vial;
∙ 2013-03-26;
∙ Dialysis | Dialyse;
∙ Powder | Poudre;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02387549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87315
∙ CALCIUM GLUCONATE INJECTION, USP 10%
∙ calcium gluconate 100 mg / ml;
∙ 1984-07-19;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02141019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18936
∙ RESONIUM CALCIUM
∙ calcium polystyrene sulfonate 999 mg / g;
∙ 1979-12-31;
∙ Oral , Rectal | Orale , Rectale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 40:18.18 – POTASSIUM-REMOVING AGENTS;
∙ Ethical | Spécialité Médicale;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02017741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17205
∙ INVOKANA
∙ canagliflozin 100 mg;
∙ 2014-06-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02425483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91013
∙ INVOKANA
∙ canagliflozin 300 mg;
∙ 2014-05-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
∙ Prescription | Prescription;
∙ JANSSEN INC;
∙ DIN: 02425491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91014
∙ ILARIS
∙ canakinumab 150 mg / ml;
∙ 2017-08-22;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02460351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94767
∙ ATACAND TAB 16 MG
∙ candesartan cilexetil 16 mg;
∙ 1998-12-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02239092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62548
∙ SANDOZ CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02326973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81230
∙ APO-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02365367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85027
∙ TEVA-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-06-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02366320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85118
∙ CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02377942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86373
∙ ACH-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02379287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86516
∙ TARO-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2013-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02380706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86648
∙ JAMP-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02386526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87209
∙ CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-07-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87424
∙ CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-07-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02388936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87446
∙ PMS-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2012-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02391201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87656
∙ AURO-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93108
∙ MINT-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2018-10-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02476924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96771
∙ AG-CANDESARTAN
∙ candesartan cilexetil 16 mg;
∙ 2020-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02484781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97508
∙ ATACAND
∙ candesartan cilexetil 32 mg;
∙ 2008-07-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02311658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79720
∙ TEVA-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2012-06-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02366339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85119
∙ ACH-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2012-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02379295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86517
∙ TARO-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2013-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02380714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86649
∙ JAMP-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02386534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87210
∙ PMS-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2012-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02391228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87657
∙ APO-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2013-07-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02399105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88401
∙ SANDOZ CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2014-03-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02417340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90197
∙ CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2014-06-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02422069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90678
∙ CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2015-01-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02435845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92019
∙ AURO-CANDESARTAN
∙ candesartan cilexetil 32 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93109
∙ ATACAND
∙ candesartan cilexetil 4 mg;
∙ 2005-06-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02239090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62546
∙ SANDOZ CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02326957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81228
∙ APO-CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02365340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85025
∙ ACH-CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2012-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02379260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86514
∙ TARO-CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2013-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02380684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86646
∙ CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2012-07-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02388901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87444
∙ PMS-CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2012-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02391171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87654
∙ AURO-CANDESARTAN
∙ candesartan cilexetil 4 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93106
∙ ATACAND TAB 8MG
∙ candesartan cilexetil 8 mg;
∙ 1998-12-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02239091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62547
∙ SANDOZ CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02326965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81229
∙ APO-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2011-04-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02365359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85026
∙ TEVA-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-06-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02366312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85116
∙ CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-02-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02377934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86372
∙ ACH-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-02-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02379279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86515
∙ TARO-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2013-01-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02380692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86647
∙ JAMP-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02386518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87208
∙ CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-07-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02388707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87423
∙ CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-07-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02388928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87445
∙ PMS-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2012-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02391198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87655
∙ AURO-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93107
∙ MINT-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2018-10-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02476916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96770
∙ AG-CANDESARTAN
∙ candesartan cilexetil 8 mg;
∙ 2020-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02484773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97506
∙ XELODA
∙ capecitabine 150 mg;
∙ 1998-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02238453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61873
∙ TEVA-CAPECITABINE
∙ capecitabine 150 mg;
∙ 2013-08-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02400022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88486
∙ SANDOZ CAPECITABINE
∙ capecitabine 150 mg;
∙ 2014-07-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02421917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90661
∙ ACH-CAPECITABINE
∙ capecitabine 150 mg;
∙ 2014-09-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02426757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91132
∙ TARO-CAPECITABINE
∙ capecitabine 150 mg;
∙ 2017-08-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02457490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94454
∙ XELODA
∙ capecitabine 500 mg;
∙ 1998-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 02238454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61874
∙ TEVA-CAPECITABINE
∙ capecitabine 500 mg;
∙ 2013-08-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02400030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88487
∙ SANDOZ CAPECITABINE
∙ capecitabine 500 mg;
∙ 2014-07-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02421925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90662
∙ ACH-CAPECITABINE
∙ capecitabine 500 mg;
∙ 2014-09-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02426765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91133
∙ TARO-CAPECITABINE
∙ capecitabine 500 mg;
∙ 2017-08-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02457504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94455
∙ CABLIVI
∙ caplacizumab 11 mg / vial;
∙ 2020-09-04;
∙ Intravenous , Subcutaneous | Intraveineuse , Sous-Cutanée;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:12.92 – ANTITHROMBOTIC AGENTS, MISC.;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02496194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98606
∙ APO-CAPTO TAB 100MG
∙ captopril 100 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00893625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10900
∙ TEVA-CAPTOPRIL
∙ captopril 100 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01942999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11765
∙ APO-CAPTO TAB 12.5MG
∙ captopril 12.5 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00893595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10906
∙ TEVA-CAPTOPRIL
∙ captopril 12.5 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01942964
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11760
∙ APO-CAPTO TAB 25MG
∙ captopril 25 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00893609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10907
∙ TEVA-CAPTOPRIL
∙ captopril 25 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01942972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11763
∙ APO-CAPTO TAB 50MG
∙ captopril 50 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00893617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10908
∙ TEVA-CAPTOPRIL
∙ captopril 50 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01942980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11764
∙ MIOSTAT OPHTHALMIC LIQ 0.01%
∙ carbachol .01 %;
∙ 1980-12-31;
∙ Intraocular | Intraoculaire;
∙ Solution | Solution;
∙ 52:40.20 – MIOTICS;
∙ Prescription | Prescription;
∙ ALCON CANADA INC;
∙ DIN: 00042544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3906
∙ TARO-CARBAMAZEPINE CHEWABLE TABLETS
∙ carbamazepine 100 mg;
∙ 2002-04-19;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02244403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68372
∙ TEGRETOL – SUS 100MG/5ML
∙ carbamazepine 100 mg / 5 ml;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02194333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19729
∙ TARO-CARBAMAZEPINE
∙ carbamazepine 100 mg / 5 ml;
∙ 2011-10-07;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02367394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85224
∙ TEGRETOL 200MG
∙ carbamazepine 200 mg;
∙ 1969-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00010405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=777
∙ TEGRETOL CR TAB 200MG
∙ carbamazepine 200 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00773611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8373
∙ TEVA-CARBAMAZEPINE
∙ carbamazepine 200 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00782718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9242
∙ PMS-CARBAMAZEPINE-CR
∙ carbamazepine 200 mg;
∙ 1998-05-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50886
∙ TARO-CARBAMAZEPINE CHEWABLE TABLETS
∙ carbamazepine 200 mg;
∙ 2002-04-19;
∙ Oral | Orale;
∙ Tablet (Chewable) | Comprimé (À Mâcher);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02244404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68373
∙ SANDOZ-CARBAMAZEPINE CR
∙ carbamazepine 200 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74720
∙ TARO-CARBAMAZEPINE
∙ carbamazepine 200 mg;
∙ 2014-05-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02407515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89220
∙ TEGRETOL CR TAB 400MG
∙ carbamazepine 400 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 00755583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8374
∙ PMS-CARBAMAZEPINE-CR
∙ carbamazepine 400 mg;
∙ 1998-05-28;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02231544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50887
∙ SANDOZ-CARBAMAZEPINE CR
∙ carbamazepine 400 mg;
∙ 2006-02-02;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02261847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74721
∙ CARBETOCIN INJECTION
∙ carbetocin 100 mcg / ml;
∙ 2020-01-21;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02489244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97932
∙ DURATOCIN
∙ carbetocin 100 mcg / ml;
∙ 2020-08-05;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ FERRING INC;
∙ DIN: 02496526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98638
∙ CARBON DIOXIDE 100%
∙ carbon dioxide 100 %;
∙ 1911-12-31;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ AIR LIQUIDE CANADA INC.;
∙ DIN: 00572861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5687
∙ CARBON DIOXIDE USP
∙ carbon dioxide 99 %;
∙ 1993-12-31;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ PRAXAIR CANADA INC;
∙ DIN: 02014459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13884
∙ CARBON DIOXIDE U.S.P
∙ carbon dioxide 99 %;
∙ 1995-12-31;
∙ Inhalation | Inhalation;
∙ Gas | Gaz;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ MESSER CANADA INC.;
∙ DIN: 02154730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19263
∙ CARBOPLATIN INJECTION
∙ carboplatin 10 mg / ml;
∙ 1994-12-31;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02125439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17830
∙ CARBOPLATIN INJECTION BP
∙ carboplatin 10 mg / ml;
∙ 1997-07-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02126680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43846
∙ CARBOPLATIN INJECTION BP
∙ carboplatin 10 mg / ml;
∙ 2015-03-11;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02320371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80581
∙ HEMABATE
∙ carboprost (carboprost tromethamine) 250 mcg / ml;
∙ 1997-11-28;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ 76:00.00 – OXYTOCICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02230417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49287
∙ PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS
∙ carboxymethylcellulose sodium 0.25 % / w/v;
∙ 2002-06-01;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ AKORN CONSUMER HEALTH, A DIVISION OF AKORN INC.;
∙ DIN: 02242082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65756
∙ THERATEARS LUBRICANT EYE DROPS
∙ carboxymethylcellulose sodium 0.25 % / w/w;
∙ 2004-06-24;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ AKORN CONSUMER HEALTH, A DIVISION OF AKORN INC.;
∙ DIN: 02248854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73225
∙ REFRESH PLUS DPS 5MG/ML
∙ carboxymethylcellulose sodium 0.5 %;
∙ 2000-01-31;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02049260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27183
∙ REFRESH TEARS
∙ carboxymethylcellulose sodium 0.5 %;
∙ 1997-07-25;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02231008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50289
∙ REFRESH CONTACTS
∙ carboxymethylcellulose sodium 0.5 %;
∙ 2008-03-13;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02304015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78932
∙ REFRESH CELLUVISC
∙ carboxymethylcellulose sodium 1 %;
∙ 1991-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Drops | Gouttes;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 00870153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11138
∙ REFRESH LIQUIGEL
∙ carboxymethylcellulose sodium 1 %;
∙ 2001-11-19;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Otc | En Vente Libre;
∙ ALLERGAN INC;
∙ DIN: 02244650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68637
∙ KYPROLIS
∙ carfilzomib 10 mg / vial;
∙ 2017-02-13;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02459930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94724
∙ KYPROLIS
∙ carfilzomib 30 mg / vial;
∙ 2017-02-06;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02459949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94725
∙ KYPROLIS
∙ carfilzomib 60 mg / vial;
∙ 2016-02-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02451034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93728
∙ CARBAGLU
∙ carglumic acid 200 mg;
∙ 2015-09-08;
∙ Oral | Orale;
∙ Tablet For Suspension | Comprimé Pour Suspension;
∙ 40:10.00 – AMMONIA DETOXICANTS;
∙ Prescription | Prescription;
∙ RECORDATI RARE DISEASES;
∙ DIN: 02439360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92371
∙ BICNU
∙ carmustine 100 mg / vial;
∙ 1975-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 00297763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2153
∙ PMS-CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2003-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70036
∙ APO-CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2003-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02247935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72245
∙ CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2004-04-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02248754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73122
∙ TEVA-CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2004-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02252325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73720
∙ CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2009-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80997
∙ CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02364948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84981
∙ JAMP-CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2011-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02368919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85388
∙ AURO-CARVEDILOL
∙ carvedilol 12.5 mg;
∙ 2014-02-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02418517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90308
∙ PMS-CARVEDILOL
∙ carvedilol 25 mg;
∙ 2003-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70037
∙ APO-CARVEDILOL
∙ carvedilol 25 mg;
∙ 2003-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02247936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72246
∙ CARVEDILOL
∙ carvedilol 25 mg;
∙ 2004-04-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02248755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73123
∙ TEVA-CARVEDILOL
∙ carvedilol 25 mg;
∙ 2004-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02252333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73721
∙ CARVEDILOL
∙ carvedilol 25 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02364956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84982
∙ JAMP-CARVEDILOL
∙ carvedilol 25 mg;
∙ 2011-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02368927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85389
∙ AURO-CARVEDILOL
∙ carvedilol 25 mg;
∙ 2014-02-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02418525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90309
∙ CARVEDILOL
∙ carvedilol 25.0 mg;
∙ 2009-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80998
∙ PMS-CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2003-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70034
∙ APO-CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2003-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02247933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72243
∙ CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2004-04-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02248752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73120
∙ TEVA-CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2004-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02252309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73718
∙ CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2009-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80995
∙ CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02364913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84979
∙ JAMP-CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2011-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02368897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85386
∙ AURO-CARVEDILOL
∙ carvedilol 3.125 mg;
∙ 2014-02-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02418495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90306
∙ PMS-CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2003-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02245915
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70035
∙ APO-CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2003-08-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02247934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72244
∙ CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2004-04-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02248753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73121
∙ TEVA-CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2004-05-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02252317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73719
∙ CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2009-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324512
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80996
∙ CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2011-06-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02364921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84980
∙ JAMP-CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2011-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02368900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85387
∙ AURO-CARVEDILOL
∙ carvedilol 6.25 mg;
∙ 2014-02-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02418509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90307
∙ CANCIDAS
∙ caspofungin (caspofungin acetate) 50 mg / vial;
∙ 2001-08-23;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02244265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68232
∙ CASPOFUNGIN FOR INJECTION
∙ caspofungin (caspofungin acetate) 50 mg / vial;
∙ 2017-04-19;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02460947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94846
∙ CASPOFUNGIN FOR INJECTION
∙ caspofungin (caspofungin acetate) 50 mg / vial;
∙ 2020-01-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02486989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97713
∙ CANCIDAS
∙ caspofungin (caspofungin acetate) 70 mg / vial;
∙ 2001-10-23;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ MERCK CANADA INC;
∙ DIN: 02244266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68233
∙ CASPOFUNGIN FOR INJECTION
∙ caspofungin (caspofungin acetate) 70 mg / vial;
∙ 2017-04-19;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ JUNO PHARMACEUTICALS CORP.;
∙ DIN: 02460955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94847
∙ CASPOFUNGIN FOR INJECTION
∙ caspofungin (caspofungin acetate) 70 mg / vial;
∙ 2020-01-27;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:14.16 – ECHINOCANDINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02486997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97714
∙ ALLERGENIC EXTRACT-STANDARDIZED CAT HAIR
∙ cat (felis domesticus) pelt and cat dander 10000 unit / ml;
∙ 1999-04-19;
∙ Intracutaneous , Subcutaneous | Intracutanée , Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02239410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62882
∙ TRETTEN
∙ catridecacog 2500 unit / vial;
∙ 2013-01-30;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ NOVO NORDISK CANADA INC;
∙ DIN: 02389975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87544
∙ TEVA-CEFADROXIL
∙ cefadroxil (cefadroxil monohydrate) 500 mg;
∙ 1999-06-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02235134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=56852
∙ APO-CEFADROXIL
∙ cefadroxil 500 mg;
∙ 1999-08-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02240774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64363
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 1 g / vial;
∙ 1995-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02108127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19532
∙ CEFAZOLIN FOR INJECTION USP
∙ cefazolin (cefazolin sodium) 1 g / vial;
∙ 2008-04-18;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02308959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79456
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 1 g / vial;
∙ 2015-09-29;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92142
∙ CEFAZOLIN FOR INJECTION, USP
∙ cefazolin (cefazolin sodium) 1.0 g / vial;
∙ 1998-10-30;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02237138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60453
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 10 g / vial;
∙ 1995-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02108135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19534
∙ CEFAZOLIN FOR INJECTION, USP
∙ cefazolin (cefazolin sodium) 10 g / vial;
∙ 1998-10-30;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02237140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60455
∙ CEFAZOLIN FOR INJECTION USP
∙ cefazolin (cefazolin sodium) 10 g / vial;
∙ 2008-04-18;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02308967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79457
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 10 g / vial;
∙ 2015-06-11;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92143
∙ CEFAZOLIN FOR INJECTION, USP
∙ cefazolin (cefazolin sodium) 100 g / bag;
∙ 2013-06-03;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02401029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88577
∙ CEFAZOLIN INJECTION, USP
∙ cefazolin (cefazolin sodium) 20 mg / ml;
∙ 2021-01-11;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ -;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02496313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98620
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 500 mg / vial;
∙ 1995-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02108119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19521
∙ CEFAZOLIN FOR INJECTION USP
∙ cefazolin (cefazolin sodium) 500 mg / vial;
∙ 2008-04-18;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02308932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79454
∙ CEFAZOLIN FOR INJECTION
∙ cefazolin (cefazolin sodium) 500 mg / vial;
∙ 2015-09-30;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92141
∙ APO-CEFEPIME
∙ cefepime (cefepime hydrochloride) 1 g / vial;
∙ 2018-05-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.16 – FOURTH GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02467496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95586
∙ APO-CEFEPIME
∙ cefepime (cefepime hydrochloride) 2 g / vial;
∙ 2018-05-14;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.16 – FOURTH GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02467518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95587
∙ CEFEPIME FOR INJECTION USP
∙ cefepime (cefepime hydrochloride) 2 g / vial;
∙ 2021-07-09;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.16 – FOURTH GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02499096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98885
∙ SUPRAX
∙ cefixime 100 mg / 5 ml;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 00868965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10523
∙ AURO-CEFIXIME
∙ cefixime 100 mg / 5 ml;
∙ 2018-01-08;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02468689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95716
∙ SUPRAX
∙ cefixime 400 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 00868981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10525
∙ AURO-CEFIXIME
∙ cefixime 400 mg;
∙ 2014-10-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02432773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91720
∙ CEFOTAXIME SODIUM FOR INJECTION, BP
∙ cefotaxime sodium 1 g / vial;
∙ 2015-03-12;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02434091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91844
∙ CEFOTAXIME SODIUM FOR INJECTION, BP
∙ cefotaxime sodium 2 g / vial;
∙ 2015-03-12;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02434105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91845
∙ CEFOXITIN FOR INJECTION
∙ cefoxitin (cefoxitin sodium) 1 g / vial;
∙ 1995-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.12 – CEPHAMYCINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02128187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19200
∙ CEFOXITIN FOR INJECTION
∙ cefoxitin (cefoxitin sodium) 10 g / vial;
∙ 2000-01-01;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.12 – CEPHAMYCINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02240773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64362
∙ CEFOXITIN FOR INJECTION
∙ cefoxitin (cefoxitin sodium) 2 g / vial;
∙ 1995-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.07.12 – CEPHAMYCINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02128195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19201
∙ TARO-CEFPROZIL
∙ cefprozil (cefprozil monohydrate) 125 mg / 5 ml;
∙ 2010-01-12;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02329204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81489
∙ TARO-CEFPROZIL
∙ cefprozil (cefprozil monohydrate) 250 mg;
∙ 2007-04-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02293528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77887
∙ TARO-CEFPROZIL
∙ cefprozil (cefprozil monohydrate) 250 mg / 5 ml;
∙ 2007-04-17;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02293579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77893
∙ TARO-CEFPROZIL
∙ cefprozil (cefprozil monohydrate) 500 mg;
∙ 2007-04-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02293536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77888
∙ AURO-CEFPROZIL
∙ cefprozil 500 mg;
∙ 2012-01-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02347253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83266
∙ CEFTAZIDIME FOR INJECTION BP
∙ ceftazidime (ceftazidime pentahydrate) 1 g / vial;
∙ 2015-05-28;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92221
∙ CEFTAZIDIME FOR INJECTION BP
∙ ceftazidime (ceftazidime pentahydrate) 2 g / vial;
∙ 2015-05-29;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92222
∙ CEFTAZIDIME FOR INJECTION BP
∙ ceftazidime (ceftazidime pentahydrate) 6 g / vial;
∙ 2015-06-08;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02437864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92223
∙ CEFTAZIDIME FOR INJECTION, USP
∙ ceftazidime 1 g / vial;
∙ 1991-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 00886971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11370
∙ CEFTAZIDIME FOR INJECTION, USP
∙ ceftazidime 2 g / vial;
∙ 1991-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 00886955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11372
∙ CEFTAZIDIME FOR INJECTION, USP
∙ ceftazidime 6 g / vial;
∙ 1991-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 00886963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11371
∙ ZEVTERA
∙ ceftobiprole (ceftobiprole medocaril sodium) 500 mg / vial;
∙ 2018-03-20;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06 – CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AVIR PHARMA INC.;
∙ DIN: 02446685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93212
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 1 g / vial;
∙ 2007-04-04;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02250292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73509
∙ CEFTRIAXONE SODIUM FOR INJECTION
∙ ceftriaxone (ceftriaxone sodium) 1 g / vial;
∙ 2007-09-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02287633
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77304
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 1 g / vial;
∙ 2007-02-23;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02292270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77763
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 1 g / vial;
∙ 2011-03-21;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02325616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81098
∙ CEFTRIAXONE SODIUM FOR INJECTION
∙ ceftriaxone (ceftriaxone sodium) 10 g / vial;
∙ 2007-09-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02287668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77306
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 10 g / vial;
∙ 2007-02-23;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02292297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77765
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 10 g / vial;
∙ 2011-03-21;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02325632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81100
∙ CEFTRIAXONE FOR INJECTION
∙ ceftriaxone (ceftriaxone sodium) 100 g / bag;
∙ 2014-06-05;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02409968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89462
∙ CEFTRIAXONE INJECTION, USP
∙ ceftriaxone (ceftriaxone sodium) 1000 mg / 50 ml;
∙ 2021-03-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02499711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98943
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 2 g / vial;
∙ 2007-02-23;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02292289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77764
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 2 g / vial;
∙ 2011-01-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02325624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81099
∙ CEFTRIAXONE INJECTION, USP
∙ ceftriaxone (ceftriaxone sodium) 2000 mg / 50 ml;
∙ 2021-03-18;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02499738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98944
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 250 mg / vial;
∙ 2007-04-30;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02250276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73507
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 250 mg / vial;
∙ 2007-02-23;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02292262
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77762
∙ CEFTRIAXONE SODIUM FOR INJECTION BP
∙ ceftriaxone (ceftriaxone sodium) 250 mg / vial;
∙ 2011-04-23;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.12 – THIRD GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02325594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81096
∙ CEFTIN
∙ cefuroxime (cefuroxime axetil) 125 mg / 5 ml;
∙ 1999-09-13;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02212307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43089
∙ APO-CEFUROXIME
∙ cefuroxime (cefuroxime axetil) 250 mg;
∙ 2001-08-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02244393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68362
∙ AURO-CEFUROXIME
∙ cefuroxime (cefuroxime axetil) 250 mg;
∙ 2012-01-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02344823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83030
∙ APO-CEFUROXIME
∙ cefuroxime (cefuroxime axetil) 500 mg;
∙ 2001-08-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02244394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68363
∙ AURO-CEFUROXIME
∙ cefuroxime (cefuroxime axetil) 500 mg;
∙ 2012-01-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02344831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83031
∙ CEFUROXIME FOR INJECTION, USP
∙ cefuroxime (cefuroxime sodium) 1.5 g / vial;
∙ 2002-12-10;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02241639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65299
∙ CEFUROXIME FOR INJECTION, USP
∙ cefuroxime (cefuroxime sodium) 7.5 g / vial;
∙ 2015-05-04;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02422328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90701
∙ CEFUROXIME FOR INJECTION, USP
∙ cefuroxime (cefuroxime sodium) 750 mg / vial;
∙ 2002-12-05;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02241638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65298
∙ CEFUROXIME FOR INJECTION, USP
∙ cefuroxime (cefuroxime sodium) 750 mg / vial;
∙ 2015-03-24;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.06.08 – SECOND GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02422298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90699
∙ CELEBREX
∙ celecoxib 100 mg;
∙ 1999-04-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02239941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63442
∙ PMS-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02355442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84067
∙ TARO-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02412373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89700
∙ MINT-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02412497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89713
∙ APO-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02418932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90347
∙ MAR-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02420058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90466
∙ ACT CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02420155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90476
∙ CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02424371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90908
∙ JAMP-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02424533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90922
∙ RIVA-CELECOX
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02425386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91003
∙ PRIVA-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02426366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91095
∙ BIO-CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-12-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02426382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91097
∙ CELECOXIB
∙ celecoxib 100 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91412
∙ CELECOXIB
∙ celecoxib 100 mg;
∙ 2015-02-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02436299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92062
∙ AG-CELECOXIB
∙ celecoxib 100 mg;
∙ 2018-06-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02437570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92190
∙ AURO-CELECOXIB
∙ celecoxib 100 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93095
∙ NRA-CELECOXIB
∙ celecoxib 100 mg;
∙ 2019-07-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02479737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97003
∙ M-CELECOXIB
∙ celecoxib 100 mg;
∙ 2020-03-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02495465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98538
∙ CELEBREX
∙ celecoxib 200 mg;
∙ 1999-04-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ UPJOHN CANADA ULC;
∙ DIN: 02239942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63443
∙ PMS-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02355450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84068
∙ TARO-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02412381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89701
∙ MINT-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02412500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89714
∙ APO-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02418940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90348
∙ MAR-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02420066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90467
∙ ACT CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02420163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90477
∙ CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-21;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02424398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90909
∙ JAMP-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02424541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90923
∙ RIVA-CELECOX
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02425394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91004
∙ PRIVA-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02426374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91096
∙ BIO-CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-12-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02426390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91098
∙ CELECOXIB
∙ celecoxib 200 mg;
∙ 2014-11-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02429683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91413
∙ CELECOXIB
∙ celecoxib 200 mg;
∙ 2015-02-05;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02436302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92063
∙ AG-CELECOXIB
∙ celecoxib 200 mg;
∙ 2018-06-22;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02437589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92191
∙ AURO-CELECOXIB
∙ celecoxib 200 mg;
∙ 2015-12-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02445689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93096
∙ NRA-CELECOXIB
∙ celecoxib 200 mg;
∙ 2019-07-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02479745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97004
∙ M-CELECOXIB
∙ celecoxib 200 mg;
∙ 2020-03-24;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02495473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98539
∙ LIBTAYO
∙ cemiplimab 250 mg / 5 ml;
∙ 2019-05-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02487152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97727
∙ LIBTAYO
∙ cemiplimab 350 mg / 7 ml;
∙ 2019-05-24;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02487144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97728
∙ TEVA-CEPHALEXIN 125
∙ cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00342106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5073
∙ LUPIN-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
∙ 2018-12-04;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ LUPIN PHARMA CANADA LIMITED;
∙ DIN: 02469170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95784
∙ AURO-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 125 mg / 5 ml;
∙ 2020-07-23;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02497743
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98755
∙ TEVA-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 250 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00342084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3945
∙ TEVA-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 250 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00583413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5181
∙ APO-CEPHALEX
∙ cephalexin (cephalexin monohydrate) 250 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00768723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9171
∙ AURO-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 250 mg;
∙ 2018-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02470578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95956
∙ TEVA-CEPHALEXIN 250
∙ cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00342092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5072
∙ LUPIN-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
∙ 2018-12-04;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ LUPIN PHARMA CANADA LIMITED;
∙ DIN: 02469189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95785
∙ AURO-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 250 mg / 5 ml;
∙ 2020-07-23;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02497751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98756
∙ TEVA-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 1979-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00342114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3946
∙ TEVA-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 1983-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00583421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5182
∙ APO-CEPHALEX
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 1988-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00768715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9170
∙ CEPHALEXIN-500
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 1989-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 00828866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9908
∙ AURO-CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 2018-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02470586
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95957
∙ CEPHALEXIN
∙ cephalexin (cephalexin monohydrate) 500 mg;
∙ 2020-10-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.06.04 – FIRST GENERATION CEPHALOSPORINS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02495651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98555
∙ ZYKADIA
∙ ceritinib 150 mg;
∙ 2015-04-29;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02436779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92108
∙ BRINEURA
∙ cerliponase alfa 150 mg / 5 ml;
∙ 2019-03-18;
∙ Intracerebroventricular | Intracérébroventriculaire;
∙ Solution | Solution;
∙ 44:00.00 – ENZYMES;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ BIOMARIN INTERNATIONAL LIMITED;
∙ DIN: 02484013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97435
∙ CIMZIA
∙ certolizumab pegol 200 mg / ml;
∙ 2009-08-31;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS , 56:92.00 – MISCELLANEOUS GI DRUGS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ UCB CANADA INC;
∙ DIN: 02331675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81737
∙ CIMZIA
∙ certolizumab pegol 200 mg / ml;
∙ 2017-08-04;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 56:92.00 – MISCELLANEOUS GI DRUGS , 92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ UCB CANADA INC;
∙ DIN: 02465574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95373
∙ REACTINE
∙ cetirizine hydrochloride 10 mg;
∙ 1997-03-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02223554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43370
∙ APO-CETIRIZINE
∙ cetirizine hydrochloride 10 mg;
∙ 1998-10-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02231603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50975
∙ ALLERGY RELIEF
∙ cetirizine hydrochloride 10 mg;
∙ 1999-08-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02240266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63803
∙ EXTRA STRENGTH ALLERGY RELIEF
∙ cetirizine hydrochloride 10 mg;
∙ 2009-08-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ PHARMASCIENCE INC;
∙ DIN: 02315955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80148
∙ REACTINE FAST MELT JUNIOR
∙ cetirizine hydrochloride 10 mg;
∙ 2014-03-21;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02358352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84341
∙ REACTINE ALLERGY LIQUID GELS
∙ cetirizine hydrochloride 10 mg;
∙ 2012-04-01;
∙ Oral | Orale;
∙ Capsule (Immediate Release) | Capsule (À Libération Immédiate);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02368064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85288
∙ MAR-CETIRIZINE
∙ cetirizine hydrochloride 10 mg;
∙ 2015-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02427133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91166
∙ ALLERGY RELIEF LIQUID GELS
∙ cetirizine hydrochloride 10 mg;
∙ 2015-03-17;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ APOTEX INC;
∙ DIN: 02432722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91716
∙ JAMP-CETIRIZINE
∙ cetirizine hydrochloride 10 mg;
∙ 2016-04-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02451778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93812
∙ REACTINE RAPID DISSOLVE
∙ cetirizine hydrochloride 10 mg;
∙ 2018-03-05;
∙ Oral | Orale;
∙ Tablet (Orally Disintegrating) | Comprimé (À Désintégration Orale);
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02467577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95593
∙ NAT-CETIRIZINE
∙ cetirizine hydrochloride 10 mg;
∙ 2020-08-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02496461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98634
∙ REACTINE 20MG TABLET
∙ cetirizine hydrochloride 20 mg;
∙ 2002-01-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 01900978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46803
∙ PMS-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2008-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02315963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80149
∙ MAR-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2015-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02427141
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91167
∙ PRIVA-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2015-10-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02427192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91172
∙ CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2016-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02450526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93668
∙ APO-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2016-04-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02453363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93991
∙ JAMP-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2017-10-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02466171
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95446
∙ MINT-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2019-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02491125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98114
∙ NAT-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2020-08-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02496488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98635
∙ M-CETIRIZINE
∙ cetirizine hydrochloride 20 mg;
∙ 2021-04-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02512025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100119
∙ REACTINE
∙ cetirizine hydrochloride 5 mg;
∙ 1997-03-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02223546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43369
∙ REACTINE
∙ cetirizine hydrochloride 5 mg / 5 ml;
∙ 1999-12-21;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02238337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61744
∙ REACTINE ALLERGY
∙ cetirizine hydrochloride 5 mg / 5 ml;
∙ 2020-02-06;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 04:08.00 – SECOND GENERATION ANTIHISTAMINES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02486954
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97710
∙ CETRIMIDE TINCTURE 0.5%
∙ cetrimonium bromide .5 %;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Tincture | Teinture;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 00873195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10565
∙ CETRIMIDE CREAM 0.5%
∙ cetrimonium bromide .5 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 00874426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12864
∙ CETROTIDE
∙ cetrorelix (cetrorelix acetate) 0.25 mg / vial;
∙ 2004-03-03;
∙ Subcutaneous | Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
∙ Prescription | Prescription;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02247766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72060
∙ ERBITUX
∙ cetuximab 2 mg / ml;
∙ 2008-10-28;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ IMCLONE, LLC;
∙ DIN: 02271249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75672
∙ RINCE BOUCHE ANTISEPTIQUE
∙ cetylpyridinium chloride 0.05 %;
∙ 1984-12-31;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00609900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5812
∙ ANTISEPTIC ORAL RINSE
∙ cetylpyridinium chloride 0.05 %;
∙ 2006-03-22;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ SAGE PRODUCTS LLC;
∙ DIN: 02243571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67489
∙ THERABREATH HEALTHY GUMS ORAL RINSE
∙ cetylpyridinium chloride 0.05 % / w/w;
∙ 2020-03-26;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ DR. HAROLD KATZ, LLC;
∙ DIN: 02486938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97708
∙ CREST PRO-HEALTH MULTI PROTECTION
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2007-11-09;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02268884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75427
∙ CREST PRO-HEALTH INVIGORATING CLEAN MULTI-PROTECTION
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2012-07-23;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02375028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86042
∙ CETYLPYRIDINIUM CHLORIDE ANTISEPTIC ORAL RINSE 0.07 % W/W
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2015-03-05;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ CANADIAN CUSTOM PACKAGING COMPANY;
∙ DIN: 02420945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90554
∙ CREST GUM CARE
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2020-07-06;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02495198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98513
∙ CREST PRO-HEALTH BACTERIA GUARD
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2021-01-04;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02504340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99377
∙ ORAL-B GUM THERAPY
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2021-07-05;
∙ Dental | Dentaire;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02510871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100015
∙ CREST PRO-HEALTH GUM & BREATH PURIFY
∙ cetylpyridinium chloride 0.07 % / w/w;
∙ 2021-07-05;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02511851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100089
∙ COLGATE TOTAL
∙ cetylpyridinium chloride 0.075 % / w/w;
∙ 2016-02-01;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02443783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92853
∙ ZERO FRESH BREATH
∙ cetylpyridinium chloride 0.075 % / w/w;
∙ 2020-06-26;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02495112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98507
∙ ZERO HEALTHY GUMS
∙ cetylpyridinium chloride 0.075 % / w/w;
∙ 2020-06-26;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:28.00 – MOUTHWASHES AND GARGLES;
∙ Otc | En Vente Libre;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02495120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98508
∙ ASTRAZENECA COVID-19 VACCINE
∙ chadox1-s [recombinant] 50000000000 vp / 0.5 ml;
∙ 2021-04-01;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ -;
∙ Covid-19 – Io – Authorization , Schedule D | Covid-19 – Au – Autorisation , Annexe D;
∙ ASTRAZENECA CANADA INC;
∙ DIN: 02510847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100004
∙ COVISHIELD
∙ chadox1-s [recombinant] 50000000000 vp / 0.5 ml;
∙ 2021-03-03;
∙ Intramuscular | Intramusculaire;
∙ Solution | Solution;
∙ -;
∙ Covid-19 – Io – Authorization , Schedule D | Covid-19 – Au – Autorisation , Annexe D;
∙ VERITY PHARMACEUTICALS INC.;
∙ DIN: 02512947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100219
∙ CHARAC-25
∙ charcoal activated 222 mg / ml;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02056429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16533
∙ ACTIVATED CHARCOAL
∙ charcoal activated 225 mg;
∙ 1998-10-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRE LEO DESILETS M.H. INC;
∙ DIN: 02236563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59931
∙ WAMPOLE ACTIVATED CHARCOAL
∙ charcoal activated 225 mg;
∙ 2013-03-19;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02395517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88060
∙ ACTIVATED CHARCOAL 260MG
∙ charcoal activated 260 mg;
∙ 1998-12-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ EXZELL PHARMA INC;
∙ DIN: 00789674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22917
∙ CHARCO CAPS
∙ charcoal activated 260 mg;
∙ 2016-01-15;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ DSE HEALTHCARE SOLUTIONS LLC;
∙ DIN: 02423715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90843
∙ CHARAC-50
∙ charcoal activated 50 g / 225 ml;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 00637955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6317
∙ CHARACTOL-50
∙ charcoal activated 50 g / 250 ml;
∙ 1985-12-31;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 56:04.00 – ANTACIDS AND ADSORBENTS;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 00649236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7267
∙ CHLORAL HYDRATE SYRUP ODAN
∙ chloral hydrate 500 mg / 5 ml;
∙ 2003-08-06;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02247621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71882
∙ LEUKERAN
∙ chlorambucil 2 mg;
∙ 1957-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 00004626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1193
∙ CHLOROMYCETIN SUCCINATE INJECTION 1GM
∙ chloramphenicol (chloramphenicol sodium succinate) 1 g / vial;
∙ 1959-12-31;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.08 – CHLORAMPHENICOL;
∙ Prescription | Prescription;
∙ ERFA CANADA 2012 INC;
∙ DIN: 00312363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2789
∙ CHLORDIAZEPOXIDE
∙ chlordiazepoxide hydrochloride 10 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00522988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4278
∙ CHLORDIAZEPOXIDE
∙ chlordiazepoxide hydrochloride 25 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00522996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4279
∙ CHLORDIAZEPOXIDE
∙ chlordiazepoxide hydrochloride 5 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00522724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4277
∙ PREVORA STAGE 1
∙ chlorhexidine acetate 10 %;
∙ 1993-12-31;
∙ Dental | Dentaire;
∙ Solution , Kit | Solution , Trousse;
∙ 34:00.00 – DENTAL AGENTS;
∙ Prescription | Prescription;
∙ CHX TECHNOLOGIES INC;
∙ DIN: 02046245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15801
∙ CHLORHEXIDINE GLUCONATE SOLUTION 0.05%
∙ chlorhexidine gluconate 0.05 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00832146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17006
∙ SOLUPREP LD SPONGE
∙ chlorhexidine gluconate 0.05 % / w/v;
∙ 1997-09-03;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Sponge | Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02072955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27903
∙ ORO-CLENSE
∙ chlorhexidine gluconate 0.12 %;
∙ 1996-12-31;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02209055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20216
∙ PERIDEX ORAL RINSE
∙ chlorhexidine gluconate 0.12 %;
∙ 1998-08-31;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ 3M CANADA COMPANY;
∙ DIN: 02237452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60786
∙ PERICHLOR
∙ chlorhexidine gluconate 0.12 %;
∙ 2000-02-09;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02240433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63982
∙ DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12%
∙ chlorhexidine gluconate 0.12 %;
∙ 1999-11-26;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ AMD MEDICOM INC;
∙ DIN: 02240526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64096
∙ ORO CLEAR
∙ chlorhexidine gluconate 0.12 %;
∙ 2016-01-25;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02291096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77648
∙ GUM PAROEX
∙ chlorhexidine gluconate 0.12 %;
∙ 2012-10-01;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ SUNSTAR AMERICAS INC;
∙ DIN: 02384272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87001
∙ CHLORHEXIDINE
∙ chlorhexidine gluconate 0.12 % / w/v;
∙ 2017-10-19;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ EURO-PHARM INTERNATIONAL CANADA INC;
∙ DIN: 02462842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95071
∙ PERIOGARD
∙ chlorhexidine gluconate 0.12 % / w/w;
∙ 2018-10-11;
∙ Buccal | Buccale;
∙ Mouthwash | Rince-Bouche;
∙ 52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
∙ Prescription | Prescription;
∙ COLGATE-PALMOLIVE CANADA INC;
∙ DIN: 02467534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95589
∙ BAXEDIN PRE-OP
∙ chlorhexidine gluconate 0.5 %;
∙ 1999-03-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 01936441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=22030
∙ GERMI STAT GEL 2%
∙ chlorhexidine gluconate 2 %;
∙ 1991-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 01930079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11826
∙ DEXIDIN 2 SOLUTION
∙ chlorhexidine gluconate 2 %;
∙ 2000-03-28;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 02238982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62430
∙ ENDURE 420 CIDA-STAT
∙ chlorhexidine gluconate 2 %;
∙ 1999-12-15;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02240416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63965
∙ SOLUPREP AQ
∙ chlorhexidine gluconate 2 %;
∙ 2001-01-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02242513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66260
∙ ANTISEPTIC BODY CLEANSER
∙ chlorhexidine gluconate 2 %;
∙ 2006-02-14;
∙ Topical | Topique;
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SAGE PRODUCTS LLC;
∙ DIN: 02245741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69848
∙ HYGENIPAK 2% CHG FOAMING SKIN CLEANSER
∙ chlorhexidine gluconate 2 %;
∙ 2005-07-29;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ DEB CANADA;
∙ DIN: 02267144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75254
∙ CHLORHEXIDINE SOLUTION
∙ chlorhexidine gluconate 2 %;
∙ 2008-03-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PARTNAR ANIMAL HEALTH INC.;
∙ DIN: 02295253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78057
∙ DEXIDIN 2 DETERGENT
∙ chlorhexidine gluconate 2 % / w/v;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00832138
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10669
∙ LORIS 2% CHG WIPE/SERVIETTE
∙ chlorhexidine gluconate 2 % / w/v;
∙ 2016-10-07;
∙ Topical (Household) | Topique (Maison);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LERNAPHARM (LORIS) INC.;
∙ DIN: 02355965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84115
∙ LORIS 2% CHG SOLUTION
∙ chlorhexidine gluconate 2 % / w/v;
∙ 2014-07-10;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LERNAPHARM (LORIS) INC.;
∙ DIN: 02358018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84308
∙ SOLUPREP AQ SPONGE
∙ chlorhexidine gluconate 2 % / w/v;
∙ 2014-02-20;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Sponge | Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02408430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89318
∙ SOLUPREP AQ SWAB
∙ chlorhexidine gluconate 2 % / w/v;
∙ 2015-09-10;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Swab | Coton-Tige;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02431483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91589
∙ SOLUPREP AQ WIPE
∙ chlorhexidine gluconate 2 % / w/v;
∙ 2015-09-17;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Wipe | Serviette;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 02431491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91590
∙ STERI-CLEAN
∙ chlorhexidine gluconate 2 % / w/w;
∙ 2016-07-25;
∙ Topical (Household) | Topique (Maison);
∙ Spray | Pulvérisation;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LANDCO IMPORT INTERNATIONAL INC;
∙ DIN: 02412438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89704
∙ DEXIDIN 20
∙ chlorhexidine gluconate 20 %;
∙ 1989-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00832030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9824
∙ BAXEDIN LIQ 20%
∙ chlorhexidine gluconate 20 %;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 00658413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10767
∙ CHLORHEXIDINE GLUCONATE SOLUTION USP 20%
∙ chlorhexidine gluconate 20 % / w/v;
∙ 1994-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02053632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16498
∙ GERMI STAT GEL 4%
∙ chlorhexidine gluconate 4 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 01930087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12713
∙ ENDURE 400 SCRUB-STAT 4
∙ chlorhexidine gluconate 4 %;
∙ 1999-02-28;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02239252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62715
∙ CHLORHEXIDINE 4% ANTISEPTIC HAND WASH
∙ chlorhexidine gluconate 4 %;
∙ 2008-03-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PARTNAR ANIMAL HEALTH INC.;
∙ DIN: 02295679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78102
∙ DEXIDIN LIQ 4%
∙ chlorhexidine gluconate 4 % / w/v;
∙ 1990-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LABORATOIRE ATLAS INC;
∙ DIN: 00832111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10668
∙ E-Z SCRUB 747 4%
∙ chlorhexidine gluconate 4 % / w/v;
∙ 1991-12-31;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Sponge | Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ BECTON DICKINSON;
∙ DIN: 01939947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13003
∙ HENRY SCHEIN ANTIMICROBIAL SKIN CLEANSER
∙ chlorhexidine gluconate 4 % / w/v;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ABJ CUSTOM PACKAGING;
∙ DIN: 01994042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14496
∙ SOLUPREP ANTISEPTIC SKIN CLEANSER SPONGE
∙ chlorhexidine gluconate 4 % / w/v;
∙ 1996-12-31;
∙ Topical (Hospital/Hc Facilities) | Topique (Hôpitaux, Établissements De Soins De Santé);
∙ Sponge | Éponge;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ 3M CANADA COMPANY;
∙ DIN: 01925202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19810
∙ DERMSAFE CHLORHEXIDINE GLUCONATE HAND SANITIZER LOTION
∙ chlorhexidine gluconate 4 % / w/v;
∙ 2020-03-11;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SKINVISIBLE PHARMACEUTICALS INC;
∙ DIN: 02310589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79621
∙ DERMSAFE PC
∙ chlorhexidine gluconate 4 % / w/v;
∙ 2012-02-23;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SKINVISIBLE PHARMACEUTICALS INC;
∙ DIN: 02355558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84077
∙ ANTIBACTERIAL HAND SOAP
∙ chloroxylenol 0.5 % / v/v;
∙ 2020-09-08;
∙ Topical (Household) | Topique (Maison);
∙ Emulsion | Émulsion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ CONTRACT PACKAGING DISTRIBUTION INC.;
∙ DIN: 02500191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98990
∙ VISION ANTIBACTERIAL HAND SOAP
∙ chloroxylenol 0.5 % / v/v;
∙ 2021-05-05;
∙ Topical (Household) | Topique (Maison);
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ LAWRASON’S INC;
∙ DIN: 02512319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100161
∙ APPLAUD AB ANTISEPTIC LOTIONIZED HAND SOAP
∙ chloroxylenol 0.5 % / w/w;
∙ 2019-08-02;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Lotion | Lotion;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ZEP MANUFACTURING COMPANY OF CANADA;
∙ DIN: 02480506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97106
∙ VIONEX ANTIMICROBIAL LIQUID SOAP
∙ chloroxylenol 0.52 %;
∙ 1998-08-14;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ MICRO-ASEPTIC PRODUCTS, INC.;
∙ DIN: 02238251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61646
∙ GERMICIDAL HAND SOAP LIQ 0.6%
∙ chloroxylenol 0.6 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ OSTREM CHEMICAL CO LTD.;
∙ DIN: 01977873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12639
∙ VIROBEX-P
∙ chloroxylenol 0.6 %;
∙ 1989-12-31;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ GERMIPHENE CORPORATION;
∙ DIN: 02131471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18208
∙ PHENREX MVD
∙ chloroxylenol 0.6 % / w/w;
∙ 2009-11-10;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ IMREX INC.;
∙ DIN: 02314126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79962
∙ DIGICLEAN E FOAM HAND SOAP
∙ chloroxylenol 1 %;
∙ 2001-03-01;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ ECOLAB CO;
∙ DIN: 02242847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66677
∙ QUICK CLEAN
∙ chloroxylenol 1 %;
∙ 2010-10-01;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ SPRAKITA PRODUCTS;
∙ DIN: 02276917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76258
∙ SOFT CARE DEFEND FOAM
∙ chloroxylenol 1 %;
∙ 2017-02-28;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ DIVERSEY INC;
∙ DIN: 02448866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93459
∙ SOFT CARE DEFEND
∙ chloroxylenol 1 % / w/w;
∙ 2017-02-28;
∙ Topical (Commercial) | Topique (Milieu Commercial);
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ DIVERSEY INC;
∙ DIN: 02449420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93526
∙ PURKLENZ
∙ chloroxylenol 3 % / w/v;
∙ 2015-08-18;
∙ Topical | Topique;
∙ Liquid | Liquide;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ PURKLENZ FORMULATIONS INC;
∙ DIN: 02440458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92481
∙ DETTOL
∙ chloroxylenol 4.8 %;
∙ 1938-12-31;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
∙ Otc | En Vente Libre;
∙ RB HEALTH (CANADA) INC.;
∙ DIN: 00373435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41477
∙ TEVA-PHENIRAM
∙ chlorpheniramine maleate 4 mg;
∙ 1967-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ TEVA CANADA LIMITED;
∙ DIN: 00021288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=579
∙ TEVA-CHLORPROMAZINE
∙ chlorpromazine (chlorpromazine hydrochloride) 100 mg;
∙ 1967-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00232831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1295
∙ TEVA-CHLORPROMAZINE
∙ chlorpromazine (chlorpromazine hydrochloride) 25.0 mg;
∙ 1967-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00232823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1294
∙ TEVA-CHLORPROMAZINE
∙ chlorpromazine (chlorpromazine hydrochloride) 50.0 mg;
∙ 1967-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.24 – PHENOTHIAZINES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00232807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1293
∙ CHLORTHALIDONE
∙ chlorthalidone 50 mg;
∙ 1976-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 40:28.24 – THIAZIDE-LIKE DIURETICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00360279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2467
∙ OLESTYR
∙ cholestyramine resin 4 g / sachet;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 24:06.04 – BILE ACID SEQUESTRANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 00890960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14332
∙ OLESTYR
∙ cholestyramine resin 4 g / sachet;
∙ 1996-03-15;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 24:06.04 – BILE ACID SEQUESTRANTS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02210320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19757
∙ CHOLESTYRAMINE-ODAN
∙ cholestyramine resin 4 g / sachet;
∙ 2016-12-23;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 24:06.04 – BILE ACID SEQUESTRANTS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02455609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94242
∙ JAMP-CHOLESTYRAMINE
∙ cholestyramine resin 4 g / sachet;
∙ 2020-02-10;
∙ Oral | Orale;
∙ Powder For Suspension | Poudre Pour Suspension;
∙ 24:06.04 – BILE ACID SEQUESTRANTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02478595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96937
∙ OVIDREL
∙ choriogonadotropin alfa 250 mcg / 0.5 ml;
∙ 2004-12-20;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02262088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74742
∙ OVIDREL
∙ choriogonadotropin alfa 250 mcg / 0.5 ml;
∙ 2013-05-28;
∙ Subcutaneous | Sous-Cutanée;
∙ Solution | Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02371588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85673
∙ PREGNYL
∙ chorionic gonadotropin 10000 unit / vial;
∙ 1997-08-13;
∙ Intramuscular | Intramusculaire;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ ORGANON CANADA INC.;
∙ DIN: 02182904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44257
∙ CHORIONIC GONADOTROPIN FOR INJECTION, USP
∙ chorionic gonadotropin 10000 unit / vial;
∙ 2004-09-13;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Powder For Solution | Poudre Pour Solution;
∙ 68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
∙ Prescription , Schedule D | Prescription , Annexe D;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02247459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71705
∙ MICRO CR
∙ chromium (chromic chloride) 4 mcg / ml;
∙ 1993-12-31;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00786985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13523
∙ ALVESCO
∙ ciclesonide 100 mcg / act;
∙ 2006-09-27;
∙ Inhalation | Inhalation;
∙ Aerosol, Metered Dose | Aérosol, Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ COVIS PHARMA GMBH;
∙ DIN: 02285606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77111
∙ ALVESCO
∙ ciclesonide 200 mcg / act;
∙ 2006-09-27;
∙ Inhalation | Inhalation;
∙ Aerosol, Metered Dose | Aérosol, Dose Mesurée;
∙ 68:04.00 – ADRENALS;
∙ Prescription | Prescription;
∙ COVIS PHARMA GMBH;
∙ DIN: 02285614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77112
∙ OMNARIS
∙ ciclesonide 50 mcg / act;
∙ 2008-04-10;
∙ Nasal | Nasale;
∙ Spray, Metered Dose | Pulvérisation, À Dose Mesurée;
∙ 52:08.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ COVIS PHARMA GMBH;
∙ DIN: 02303671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78899
∙ PENLAC
∙ ciclopirox 8 % / w/w;
∙ 2004-07-28;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02250535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73535
∙ APO-CICLOPIROX
∙ ciclopirox 8 % / w/w;
∙ 2008-04-18;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02298953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78435
∙ TARO-CICLOPIROX
∙ ciclopirox 8 % / w/w;
∙ 2011-10-25;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02353288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83849
∙ LOPROX
∙ ciclopirox olamine 1 % / w/w;
∙ 1996-12-03;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43306
∙ LOPROX
∙ ciclopirox olamine 1 % / w/w;
∙ 1997-03-24;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 02221810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43307
∙ STIEPROX SHAMPOO
∙ ciclopirox olamine 1.5 %;
∙ 2003-11-17;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:04.08.20 – HYDROXYPYRIDONES;
∙ Prescription | Prescription;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02247228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71470
∙ MAR-CIDOFOVIR
∙ cidofovir (cidofovir dihydrate) 375 mg / 5 ml;
∙ 2018-07-11;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02473925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96392
∙ MYLAN-CILAZAPRIL
∙ cilazapril (cilazapril monohydrate) 1 mg;
∙ 2006-07-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02283778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76935
∙ MYLAN-CILAZAPRIL
∙ cilazapril (cilazapril monohydrate) 2.5 mg;
∙ 2006-07-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02283786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76936
∙ APO-CILAZAPRIL
∙ cilazapril (cilazapril monohydrate) 2.5 mg;
∙ 2007-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02291142
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77652
∙ INHIBACE
∙ cilazapril (cilazapril monohydrate) 5 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ CHEPLAPHARM ARZNEIMITTEL GMBH;
∙ DIN: 01911481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13834
∙ APO-CILAZAPRIL
∙ cilazapril (cilazapril monohydrate) 5 mg;
∙ 2007-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02291150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77653
∙ MYLAN-CILAZAPRIL
∙ cilazapril (cilazapril monohydrate) 5.0 mg;
∙ 2006-07-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02283794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76937
∙ CIMETIDINE
∙ cimetidine 200 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00584215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5195
∙ CIMETIDINE
∙ cimetidine 300 mg;
∙ 1982-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 56:28.12 – HISTAMINE H2-ANTAGONISTS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 00487872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5196
∙ SENSIPAR
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2004-09-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02257130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74235
∙ MYLAN-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2016-06-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02434539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91886
∙ TEVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2016-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02441624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92601
∙ APO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2016-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93910
∙ AURO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02478900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96960
∙ MAR-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2018-11-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02480298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97082
∙ M-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2018-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02481987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97245
∙ PRIVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2020-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02499355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98909
∙ JAMP CINACALCET TABLETS
∙ cinacalcet (cinacalcet hydrochloride) 30 mg;
∙ 2021-02-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02500094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98980
∙ SENSIPAR
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2004-09-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02257149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74236
∙ MYLAN-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2016-12-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02434547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91887
∙ TEVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2016-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02441632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92602
∙ APO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2016-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93911
∙ AURO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02478919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96962
∙ MAR-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2018-11-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02480301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97083
∙ M-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2018-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02481995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97246
∙ PRIVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2020-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02499363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98910
∙ JAMP CINACALCET TABLETS
∙ cinacalcet (cinacalcet hydrochloride) 60 mg;
∙ 2021-02-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02500108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98981
∙ SENSIPAR
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2004-09-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AMGEN CANADA INC;
∙ DIN: 02257157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74237
∙ MYLAN-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2016-12-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02434555
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91888
∙ TEVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2016-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02441640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92603
∙ APO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2016-05-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02452715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93912
∙ AURO-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2019-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02478943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96965
∙ MAR-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2018-11-29;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02480328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97084
∙ M-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2018-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02482002
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97247
∙ PRIVA-CINACALCET
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2020-08-04;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02499371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98911
∙ JAMP CINACALCET TABLETS
∙ cinacalcet (cinacalcet hydrochloride) 90 mg;
∙ 2021-02-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02500116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98982
∙ CIPRO XL
∙ ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 1000 mg;
∙ 2004-04-08;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02251787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73669
∙ CIPRO XL
∙ ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 500 mg;
∙ 2003-08-07;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02247916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72225
∙ PMS-CIPROFLOXACIN XL
∙ ciprofloxacin (ciprofloxacin – ciprofloxacin hydrochloride) 500 mg;
∙ 2014-01-14;
∙ Oral | Orale;
∙ Tablet (Immediate And Extended Release) | Comprimé(À Libération Immédiate Et Prolongée);
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02416433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90104
∙ SANDOZ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 %;
∙ 2012-07-03;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02387131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87272
∙ CILOXAN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/v;
∙ 1992-12-31;
∙ Ophthalmic | Ophtalmique;
∙ Solution | Solution;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 01945270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12953
∙ CILOXAN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % / w/w;
∙ 1998-10-07;
∙ Ophthalmic | Ophtalmique;
∙ Ointment | Pommade;
∙ 52:04.04 – ANTIBACTERIALS;
∙ Prescription | Prescription;
∙ NOVARTIS PHARMACEUTICALS CANADA INC;
∙ DIN: 02200864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42964
∙ ACT CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71582
∙ PMS-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02248437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72788
∙ SANDOZ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02248756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73124
∙ TARO-CIPROFLOX
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2008-01-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02303728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78902
∙ PRO-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02317796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80332
∙ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2010-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83851
∙ MAR-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2012-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02379686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86555
∙ JAMP-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2012-03-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02380358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86616
∙ AURO-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02381907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86775
∙ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 250 mg;
∙ 2012-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02386119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87170
∙ ACT CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71583
∙ PMS-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02248438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72789
∙ SANDOZ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02248757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73125
∙ RIVA-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2004-03-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02251248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73619
∙ TARO-CIPROFLOX
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2008-01-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02303736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78903
∙ PRO-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2008-10-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02317818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80333
∙ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2010-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83852
∙ MAR-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2012-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02379694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86556
∙ JAMP-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2012-03-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02380366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86617
∙ AURO-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2012-06-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02381923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86776
∙ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2012-06-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02386127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87171
∙ MINT-CIPROFLOX
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2014-06-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02423561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90828
∙ BIO-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2016-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02444887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93011
∙ PRIVA-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2016-06-17;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02445344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93057
∙ AG-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2020-01-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02476592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96666
∙ NRA-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 500 mg;
∙ 2020-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02492008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98201
∙ ACT CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02247341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71584
∙ PMS-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02248439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72790
∙ SANDOZ CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2004-02-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02248758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73126
∙ TARO-CIPROFLOX
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2008-01-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02303744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78904
∙ JAMP-CIPROFLOXACIN
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2012-03-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02380374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86618
∙ MINT-CIPROFLOX
∙ ciprofloxacin (ciprofloxacin hydrochloride) 750 mg;
∙ 2014-06-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02423588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90829
∙ CIPROFLOXACIN INJECTION USP
∙ ciprofloxacin 2 mg / ml;
∙ 2008-04-08;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02301903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78723
∙ CIPROFLOXACIN INTRAVENOUS INFUSION BP
∙ ciprofloxacin 2 mg / ml;
∙ 2008-03-27;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02304759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79003
∙ CIPRO ORAL SUSPENSION
∙ ciprofloxacin 500 mg / 5 ml;
∙ 1998-09-15;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 08:12.18 – QUINOLONES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 02237514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60849
∙ CISATRACURIUM OMEGA MULTIDOSE
∙ cisatracurium (cisatracurium besylate) 2 mg / ml;
∙ 2014-01-20;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
∙ Prescription | Prescription;
∙ OMEGA LABORATORIES LIMITED;
∙ DIN: 02408813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89357
∙ CISPLATIN INJECTION BP
∙ cisplatin 1 mg / ml;
∙ 1997-05-09;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02126613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43840
∙ CISPLATIN INJECTION, BP
∙ cisplatin 1 mg / ml;
∙ 2012-04-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ ACCORD HEALTHCARE INC;
∙ DIN: 02355183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84044
∙ CISPLATIN INJECTION BP
∙ cisplatin 1 mg / ml;
∙ 2011-09-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02366711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85155
∙ CISPLATIN INJECTION
∙ cisplatin 1.0 mg / ml;
∙ 2013-08-29;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02403188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88800
∙ PMS-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2005-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02270609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75597
∙ RIVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2008-01-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02303256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78858
∙ TEVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2008-12-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02312336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79783
∙ CITALOPRAM-10
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2009-06-25;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02325047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81046
∙ MAR-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2012-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85700
∙ AG-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2014-08-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02374617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85994
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2012-06-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02387948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87351
∙ NAT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2014-02-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02409003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89374
∙ MINT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02429691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91414
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02430517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91495
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02445719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93099
∙ NRA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 10 mg;
∙ 2018-08-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02477637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96828
∙ CELEXA 20 MG
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 1999-03-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02239607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63077
∙ APO-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2004-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02246056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70187
∙ PMS-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2004-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02248010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72326
∙ CITALOPRAM-20
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2004-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02257513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74277
∙ AURO-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2011-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02275562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76120
∙ RAN-CITALO
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2006-12-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02285622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77113
∙ TEVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2007-09-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02293218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77858
∙ RIVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2008-01-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02303264
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78859
∙ AG-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2014-09-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02339390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82501
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83886
∙ MAR-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2012-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85701
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2012-06-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02387956
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87352
∙ NAT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2014-02-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02409011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89375
∙ MINT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02429705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91415
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02430541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91496
∙ CCP-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2017-07-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02459914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94722
∙ NRA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 20 mg;
∙ 2018-08-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02477645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96829
∙ CTP 30
∙ citalopram (citalopram hydrobromide) 30 mg;
∙ 2007-10-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02296152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78149
∙ CELEXA 40 MG
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 1999-03-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LUNDBECK CANADA INC;
∙ DIN: 02239608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63078
∙ APO-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2004-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02246057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70188
∙ PMS-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2004-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02248011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72327
∙ CITALOPRAM-40
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2004-12-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02257521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74278
∙ AURO-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2011-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02275570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76121
∙ TEVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2007-12-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02293226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77859
∙ RIVA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2008-01-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02303272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78860
∙ AG-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2014-09-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02339404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82502
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2010-07-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02353679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83887
∙ MAR-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2012-09-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02371901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85702
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2012-06-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02387964
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87353
∙ NAT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2014-02-12;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NATCO PHARMA (CANADA) INC;
∙ DIN: 02409038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89376
∙ MINT-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2015-10-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02429713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91416
∙ CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2014-09-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02430568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91497
∙ CCP-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2017-07-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ CELLCHEM PHARMACEUTICALS INC.;
∙ DIN: 02459922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94723
∙ NRA-CITALOPRAM
∙ citalopram (citalopram hydrobromide) 40 mg;
∙ 2018-08-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02477653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96830
∙ CLADRIBINE INJECTION
∙ cladribine 1 mg / ml;
∙ 2009-06-30;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02319918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80536
∙ CLADRIBINE INJECTION
∙ cladribine 1 mg / ml;
∙ 2020-08-19;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ GENERIC MEDICAL PARTNERS INC;
∙ DIN: 02494574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98457
∙ MAVENCLAD
∙ cladribine 10 mg;
∙ 2017-11-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
∙ Prescription | Prescription;
∙ EMD SERONO, A DIVISION OF EMD INC., CANADA;
∙ DIN: 02470179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95915
∙ BIAXIN
∙ clarithromycin 125 mg / 5 ml;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02146908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18066
∙ TARO-CLARITHROMYCIN
∙ clarithromycin 125 mg / 5 ml;
∙ 2012-09-04;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02390442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87588
∙ CLARITHROMYCIN
∙ clarithromycin 125 mg / 5 ml;
∙ 2013-09-05;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02408988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89372
∙ BIAXIN BID
∙ clarithromycin 250 mg;
∙ 1992-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 01984853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12779
∙ PMS-CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2007-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02247573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71828
∙ SANDOZ CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2008-06-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02266539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75196
∙ APO-CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2007-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02274744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76021
∙ CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2009-10-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80993
∙ RAN-CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2011-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02361426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84648
∙ CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92681
∙ CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95443
∙ M-CLARITHROMYCIN
∙ clarithromycin 250 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96049
∙ BIAXIN
∙ clarithromycin 250 mg / 5 ml;
∙ 2002-05-28;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02244641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68628
∙ TARO-CLARITHROMYCIN
∙ clarithromycin 250 mg / 5 ml;
∙ 2012-09-04;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02390450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87587
∙ CLARITHROMYCIN
∙ clarithromycin 250 mg / 5 ml;
∙ 2013-09-05;
∙ Oral | Orale;
∙ Granules For Suspension | Granules Pour Suspension;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02408996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89373
∙ BIAXIN BID
∙ clarithromycin 500 mg;
∙ 1994-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ BGP PHARMA ULC;
∙ DIN: 02126710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17240
∙ PMS-CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2007-08-10;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02247574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71829
∙ SANDOZ CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2008-06-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02266547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75197
∙ APO-CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2007-07-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02274752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76022
∙ CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2009-10-08;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02324490
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80994
∙ RIVA-CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2010-06-16;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02346532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83196
∙ RAN-CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2011-02-01;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ RANBAXY PHARMACEUTICALS CANADA INC.;
∙ DIN: 02361434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84649
∙ ACT CLARITHROMYCIN XL
∙ clarithromycin 500 mg;
∙ 2014-12-01;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02403196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88801
∙ APO-CLARITHROMYCIN XL
∙ clarithromycin 500 mg;
∙ 2014-09-03;
∙ Oral | Orale;
∙ Tablet (Extended-Release) | Comprimé (À Libération Prolongée);
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02413345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89802
∙ CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2015-07-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02442485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92683
∙ CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2017-10-20;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02466139
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95444
∙ M-CLARITHROMYCIN
∙ clarithromycin 500 mg;
∙ 2018-03-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 08:12.12.92 – OTHER MACROLIDES;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02471396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96050
∙ DALACIN C FLAVOURED GRANULES
∙ clindamycin (clindamycin 2-palmitate hydrochloride) 75 mg / 5 ml;
∙ 1972-12-31;
∙ Oral | Orale;
∙ Granules For Solution | Granules Pour Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00225851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1225
∙ DALACIN C 150 MG
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 1970-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00030570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=874
∙ TEVA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2000-02-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02241709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65371
∙ AURO-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2015-03-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02436906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92122
∙ RIVA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2017-10-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02468476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95690
∙ M-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2019-05-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02479923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97049
∙ JAMP CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2019-09-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02483734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97408
∙ AG-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2020-02-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02485109
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97536
∙ NRA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 150 mg;
∙ 2020-07-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02493748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98373
∙ DALACIN C 300 MG
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02182866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19455
∙ TEVA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2000-02-18;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02241710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65372
∙ AURO-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2015-03-02;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02436914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92123
∙ RIVA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2017-10-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02468484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95691
∙ M-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2019-05-28;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02479931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97050
∙ JAMP CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2019-09-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02483742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97409
∙ AG-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2020-01-27;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ ANGITA PHARMA INC.;
∙ DIN: 02485117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97537
∙ NRA-CLINDAMYCIN
∙ clindamycin (clindamycin hydrochloride) 300 mg;
∙ 2020-07-06;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02493756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98374
∙ TARO-CLINDAMYCIN
∙ clindamycin (clindamycin phosphate) 1 % / w/v;
∙ 2005-10-03;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02266938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75233
∙ CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP
∙ clindamycin (clindamycin phosphate) 1 % / w/v;
∙ 2019-12-11;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.;
∙ DIN: 02483769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97411
∙ CLINDAMYCIN IV INFUSION
∙ clindamycin (clindamycin phosphate) 12 mg / ml;
∙ 2013-12-05;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02408511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89326
∙ DALACIN C PHOSPHATE
∙ clindamycin (clindamycin phosphate) 150 mg / ml;
∙ 1973-12-31;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 00260436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1620
∙ CLINDAMYCIN INJECTION USP
∙ clindamycin (clindamycin phosphate) 150 mg / ml;
∙ 1999-01-15;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02230535
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49605
∙ CLINDAMYCIN INJECTION USP
∙ clindamycin (clindamycin phosphate) 150 mg / ml;
∙ 1999-01-19;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Liquid | Liquide;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02230540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49612
∙ CLINDAMYCIN IV INFUSION
∙ clindamycin (clindamycin phosphate) 18 mg / ml;
∙ 2013-12-05;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02408538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89327
∙ DALACIN VAGINAL CREAM
∙ clindamycin (clindamycin phosphate) 20 mg / g;
∙ 1994-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.04 – ANTIBIOTICS;
∙ Prescription | Prescription;
∙ PFIZER CANADA ULC;
∙ DIN: 02060604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15942
∙ CLINDAMYCIN INJECTION IN 5% DEXTROSE
∙ clindamycin (clindamycin phosphate) 300 mg / 50 ml;
∙ 2019-11-20;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02485451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97570
∙ CLINDAMYCIN INJECTION IN 5% DEXTROSE
∙ clindamycin (clindamycin phosphate) 600 mg / 50 ml;
∙ 2019-11-26;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02485478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97571
∙ CLINDAMYCIN INJECTION IN 5% DEXTROSE
∙ clindamycin (clindamycin phosphate) 900 mg / 50 ml;
∙ 2019-12-03;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 08:12.28.20 – LINCOMYCINS;
∙ Prescription | Prescription;
∙ BAXTER CORPORATION;
∙ DIN: 02485486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97572
∙ TEVA-CLOBAZAM
∙ clobazam 10 mg;
∙ 1998-07-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ TEVA CANADA LIMITED;
∙ DIN: 02238334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61740
∙ APO-CLOBAZAM
∙ clobazam 10 mg;
∙ 2001-11-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02244638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68625
∙ DERMOVATE OINTMENT
∙ clobetasol propionate .05 %;
∙ 1999-12-20;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 02213273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36953
∙ DERMOVATE SCALP APPLICATION
∙ clobetasol propionate .05 %;
∙ 2001-06-25;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 02213281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36954
∙ TEVA-CLOBETASOL
∙ clobetasol propionate 0.05 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01910272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13437
∙ TEVA-CLOBETASOL
∙ clobetasol propionate 0.05 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01910299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13438
∙ TEVA-CLOBETASOL
∙ clobetasol propionate 0.05 %;
∙ 1992-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 01910280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13439
∙ MYLAN-CLOBETASOL CREAM
∙ clobetasol propionate 0.05 %;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02024187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14381
∙ MYLAN-CLOBETASOL OINTMENT
∙ clobetasol propionate 0.05 %;
∙ 1993-12-31;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02026767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14382
∙ DERMOVATE CREAM
∙ clobetasol propionate 0.05 %;
∙ 1999-09-07;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.;
∙ DIN: 02213265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36952
∙ MYLAN-CLOBETASOL SCALP APPLICATION
∙ clobetasol propionate 0.05 %;
∙ 1996-09-10;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02216213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43175
∙ TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%
∙ clobetasol propionate 0.05 %;
∙ 2002-04-22;
∙ Topical | Topique;
∙ Solution | Solution;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02245522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69609
∙ TARO-CLOBETASOL CREAM USP, 0.05%
∙ clobetasol propionate 0.05 %;
∙ 2002-04-22;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02245523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69610
∙ TARO-CLOBETASOL OINTMENT USP, 0.05%
∙ clobetasol propionate 0.05 %;
∙ 2002-04-22;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02245524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69611
∙ CLOBEX SHAMPOO
∙ clobetasol propionate 0.05 %;
∙ 2004-12-15;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02256371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74161
∙ CLOBEX SPRAY
∙ clobetasol propionate 0.05 % / w/w;
∙ 2007-12-19;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:06.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ GALDERMA CANADA INC;
∙ DIN: 02299739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78510
∙ TARO-CLOBETASOL SPRAY
∙ clobetasol propionate 0.05 % / w/w;
∙ 2019-08-26;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02489619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97970
∙ ODAN CLOBETASOL SPRAY
∙ clobetasol propionate 0.05 % / w/w;
∙ 2019-09-26;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:06.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ ODAN LABORATORIES LTD;
∙ DIN: 02490706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98076
∙ SANDOZ CLOBETASOL
∙ clobetasol propionate 0.05 % / w/w;
∙ 2020-04-23;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:06.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02495023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98498
∙ TARO-CLOBETASOL SHAMPOO
∙ clobetasol propionate 0.05 % / w/w;
∙ 2020-12-22;
∙ Topical | Topique;
∙ Shampoo | Shampoing;
∙ 84:06.08 – CORTICOSTEROIDS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02506203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99554
∙ SPECTRO ECZEMACARE MEDICATED CREAM
∙ clobetasone butyrate 0.05 % / w/w;
∙ 1999-09-27;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:06.00 – ANTI-INFLAMMATORY AGENTS;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02214415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37001
∙ CLASTEON
∙ clodronate disodium 400 mg;
∙ 2004-05-13;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 92:24.00 – BONE RESORPTION INHIBITORS;
∙ Prescription | Prescription;
∙ SUNOVION PHARMACEUTICALS CANADA INC;
∙ DIN: 02245828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69944
∙ CLOLAR
∙ clofarabine 1 mg / ml;
∙ 2010-02-10;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 10:00.00 – ANTINEOPLASTIC AGENTS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02330407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81614
∙ ULONE
∙ clofedanol hydrochloride 25 mg / 5 ml;
∙ 1962-12-31;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ BAUSCH HEALTH, CANADA INC.;
∙ DIN: 01966294
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13907
∙ ANAFRANIL
∙ clomipramine hydrochloride 10 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00330566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2164
∙ ANAFRANIL
∙ clomipramine hydrochloride 25 mg;
∙ 1973-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00324019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2039
∙ TARO-CLOMIPRAMINE
∙ clomipramine hydrochloride 25 mg;
∙ 2020-05-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02497506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98731
∙ ANAFRANIL
∙ clomipramine hydrochloride 50 mg;
∙ 1981-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 00402591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4382
∙ TARO-CLOMIPRAMINE
∙ clomipramine hydrochloride 50 mg;
∙ 2020-05-07;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
∙ Prescription | Prescription;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02497514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98733
∙ PMS-CLONAZEPAM- TAB 0.25MG
∙ clonazepam 0.25 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PHARMASCIENCE INC;
∙ DIN: 02179660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19221
∙ RIVOTRIL 0.5TAB
∙ clonazepam 0.5 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00382825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2568
∙ PMS-CLONAZEPAM TAB 0.5MG
∙ clonazepam 0.5 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PHARMASCIENCE INC;
∙ DIN: 02048701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14588
∙ APO-CLONAZEPAM
∙ clonazepam 0.5 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02177889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19063
∙ PMS-CLONAZEPAM-R
∙ clonazepam 0.5 mg;
∙ 1996-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PHARMASCIENCE INC;
∙ DIN: 02207818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19628
∙ RIVA-CLONAZEPAM
∙ clonazepam 0.5 mg;
∙ 2000-05-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65751
∙ PRO-CLONAZEPAM
∙ clonazepam 0.5 mg;
∙ 2008-07-28;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 02311593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79715
∙ PMS-CLONAZEPAM TAB 1.0MG
∙ clonazepam 1 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PHARMASCIENCE INC;
∙ DIN: 02048728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14587
∙ PRO-CLONAZEPAM
∙ clonazepam 1 mg;
∙ 2008-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 02311607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79716
∙ RIVOTRIL 2TAB
∙ clonazepam 2 mg;
∙ 1977-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ HOFFMANN-LA ROCHE LIMITED;
∙ DIN: 00382841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2569
∙ PMS-CLONAZEPAM TAB 2MG
∙ clonazepam 2 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PHARMASCIENCE INC;
∙ DIN: 02048736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14589
∙ APO-CLONAZEPAM
∙ clonazepam 2 mg;
∙ 1995-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ APOTEX INC;
∙ DIN: 02177897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19048
∙ RIVA-CLONAZEPAM
∙ clonazepam 2 mg;
∙ 2000-05-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02242078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65752
∙ PRO-CLONAZEPAM
∙ clonazepam 2 mg;
∙ 2008-07-09;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:12.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ PRO DOC LIMITEE;
∙ DIN: 02311615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79718
∙ TEVA-CLONIDINE
∙ clonidine hydrochloride 0.025 mg;
∙ 2008-06-26;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02304163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78947
∙ TEVA-CLONIDINE
∙ clonidine hydrochloride 0.1 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02046121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14715
∙ MINT-CLONIDINE
∙ clonidine hydrochloride 0.1 mg;
∙ 2017-06-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02462192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94992
∙ TEVA-CLONIDINE
∙ clonidine hydrochloride 0.2 mg;
∙ 1993-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02046148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14713
∙ MINT-CLONIDINE
∙ clonidine hydrochloride 0.2 mg;
∙ 2017-06-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 24:08.16 – CENTRAL ALPHA-AGONISTS;
∙ Prescription | Prescription;
∙ MINT PHARMACEUTICALS INC;
∙ DIN: 02462206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94993
∙ TEVA-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 300 mg;
∙ 2013-01-02;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02388065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87363
∙ APO-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 300 mg;
∙ 2013-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02398591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88354
∙ PLAVIX
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 1998-10-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ SANOFI-AVENTIS CANADA INC;
∙ DIN: 02238682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62114
∙ APO-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2011-12-19;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02252767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73770
∙ TEVA-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2011-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02293161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77854
∙ ACT CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2011-12-07;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 02303027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78834
∙ PMS-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2011-12-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMASCIENCE INC;
∙ DIN: 02348004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83336
∙ TARO-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2012-04-30;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ SUN PHARMA CANADA INC;
∙ DIN: 02379813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86568
∙ CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2012-06-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ SIVEM PHARMACEUTICALS ULC;
∙ DIN: 02385813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87143
∙ RIVA-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2012-07-24;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02388529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87405
∙ CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2012-11-22;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ PRO DOC LIMITEE;
∙ DIN: 02394820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87998
∙ CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2013-02-13;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ SANIS HEALTH INC;
∙ DIN: 02400553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88535
∙ JAMP-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2014-01-15;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ JAMP PHARMA CORPORATION;
∙ DIN: 02415550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90014
∙ AURO-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2014-02-06;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ AURO PHARMA INC;
∙ DIN: 02416387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90094
∙ MAR-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2015-01-21;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ MARCAN PHARMACEUTICALS INC;
∙ DIN: 02422255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90695
∙ BIO-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2019-09-23;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ BIOMED PHARMA;
∙ DIN: 02444895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93012
∙ PRIVA-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2020-12-11;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ PHARMAPAR INC;
∙ DIN: 02445336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93056
∙ NRA-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2020-03-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ NORA PHARMA INC;
∙ DIN: 02482037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97237
∙ M-CLOPIDOGREL
∙ clopidogrel (clopidogrel bisulfate) 75 mg;
∙ 2020-11-03;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 20:12.18 – PLATELET AGGREGATION INHIBITORS;
∙ Prescription | Prescription;
∙ MANTRA PHARMA INC;
∙ DIN: 02502283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99186
∙ CLORAZEPATE
∙ clorazepate dipotassium 15 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00860697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10899
∙ CLORAZEPATE
∙ clorazepate dipotassium 3.75 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00860689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10902
∙ CLORAZEPATE
∙ clorazepate dipotassium 7.5 mg;
∙ 1990-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 28:24.08 – BENZODIAZEPINES;
∙ Targeted (Cdsa Iv) | Ciblés (Lrcdas Iv);
∙ AA PHARMA INC;
∙ DIN: 00860700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10903
∙ CLOTRIMADERM CREAM 1%
∙ clotrimazole 1 %;
∙ 1988-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00812382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11893
∙ CANESTEN 1% TOPICAL CREAM
∙ clotrimazole 1 %;
∙ 1995-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19487
∙ CLOTRIMAZOLE VAGINAL 6
∙ clotrimazole 1 %;
∙ 2005-04-29;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02229378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47168
∙ CLOTRIMAZOLE CREAM USP 1%
∙ clotrimazole 1 %;
∙ 1996-12-31;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02229380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47181
∙ CANESTEN EXTERNAL CREAM
∙ clotrimazole 1 %;
∙ 2010-03-10;
∙ Topical , Vaginal | Topique , Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02311720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79727
∙ CLOTRIMADERM VAGINAL 6
∙ clotrimazole 1 % / w/w;
∙ 1989-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00812366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9926
∙ CANESTEN 6 DAY INTERNAL CREAM
∙ clotrimazole 1 % / w/w;
∙ 1995-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19483
∙ CANESTEN EXTERNAL ANTIFUNGAL CREAM
∙ clotrimazole 1 % / w/w;
∙ 2000-06-02;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02239432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62905
∙ CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM
∙ clotrimazole 1 % / w/w;
∙ 2018-05-29;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02462397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95015
∙ CANESTEN 1 DAY INTERNAL CREAM
∙ clotrimazole 10 % / w/w;
∙ 1997-06-11;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44016
∙ CLOTRIMAZOLE VAGINAL 3
∙ clotrimazole 2 %;
∙ 1996-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 02229379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47180
∙ CLOTRIMADERM VAGINAL 3
∙ clotrimazole 2 % / w/w;
∙ 1989-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ TARO PHARMACEUTICALS INC;
∙ DIN: 00812374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9927
∙ CANESTEN 3 DAY INTERNAL CREAM
∙ clotrimazole 2 % / w/w;
∙ 1995-12-31;
∙ Vaginal | Vaginale;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19484
∙ CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM
∙ clotrimazole 2 % / w/w;
∙ 2020-02-14;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02490927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98096
∙ CANESTEN COMFORTAB 3
∙ clotrimazole 200 mg;
∙ 1995-12-31;
∙ Vaginal | Vaginale;
∙ Vaginal Tablet | Comprimé Vaginal;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19479
∙ CANESTEN COMFORTAB 1
∙ clotrimazole 500 mg;
∙ 1995-12-31;
∙ Vaginal | Vaginale;
∙ Vaginal Tablet | Comprimé Vaginal;
∙ 84:04.08.08 – AZOLES;
∙ Otc | En Vente Libre;
∙ BAYER INC;
∙ DIN: 02150859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19480
∙ CLOXACILLIN FOR INJECTION
∙ cloxacillin (cloxacillin sodium) 1 g / vial;
∙ 2011-07-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02367416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85226
∙ CLOXACILLIN FOR INJECTION
∙ cloxacillin (cloxacillin sodium) 10 g / vial;
∙ 2013-04-03;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16 – PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02400081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88492
∙ TEVA-CLOXACILLIN
∙ cloxacillin (cloxacillin sodium) 125 mg / 5 ml;
∙ 1980-12-31;
∙ Oral | Orale;
∙ Granules For Solution | Granules Pour Solution;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00337757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3794
∙ CLOXACILLIN FOR INJECTION
∙ cloxacillin (cloxacillin sodium) 2 g / vial;
∙ 2011-07-28;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02367424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85227
∙ TEVA-CLOXACILLIN
∙ cloxacillin (cloxacillin sodium) 250 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00337765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2233
∙ TEVA-CLOXACILLIN
∙ cloxacillin (cloxacillin sodium) 500 mg;
∙ 1975-12-31;
∙ Oral | Orale;
∙ Capsule | Capsule;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ TEVA CANADA LIMITED;
∙ DIN: 00337773
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2234
∙ CLOXACILLIN FOR INJECTION
∙ cloxacillin (cloxacillin sodium) 500 mg / vial;
∙ 2011-09-14;
∙ Intramuscular , Intravenous | Intramusculaire , Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 08:12.16.12 – PENICILLINASE-RESISTANT PENICILLINS;
∙ Prescription | Prescription;
∙ STERIMAX INC;
∙ DIN: 02367408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85225
∙ CLOZARIL
∙ clozapine 100 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ HLS THERAPEUTICS INC;
∙ DIN: 00894745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11421
∙ GEN-CLOZAPINE
∙ clozapine 100 mg;
∙ 2003-03-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02247244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71486
∙ AA-CLOZAPINE
∙ clozapine 100 mg;
∙ 2004-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02248035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72355
∙ GEN-CLOZAPINE
∙ clozapine 200 mg;
∙ 2008-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02305011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79039
∙ AA-CLOZAPINE
∙ clozapine 200 mg;
∙ 2017-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02458756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94590
∙ CLOZARIL
∙ clozapine 200 mg;
∙ 2019-12-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ HLS THERAPEUTICS INC;
∙ DIN: 02490676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98073
∙ CLOZARIL
∙ clozapine 25 mg;
∙ 1991-12-31;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ HLS THERAPEUTICS INC;
∙ DIN: 00894737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11422
∙ GEN-CLOZAPINE
∙ clozapine 25 mg;
∙ 2003-03-14;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02247243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71485
∙ AA-CLOZAPINE
∙ clozapine 25 mg;
∙ 2004-01-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02248034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72354
∙ GEN-CLOZAPINE
∙ clozapine 50 mg;
∙ 2008-02-05;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ MYLAN PHARMACEUTICALS ULC;
∙ DIN: 02305003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79038
∙ AA-CLOZAPINE
∙ clozapine 50 mg;
∙ 2017-02-27;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ AA PHARMA INC;
∙ DIN: 02458748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94589
∙ CLOZARIL
∙ clozapine 50 mg;
∙ 2019-12-18;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
∙ Prescription | Prescription;
∙ HLS THERAPEUTICS INC;
∙ DIN: 02490668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98072
∙ IMMUNINE VH
∙ coagulation factor ix (human) 720 unit / 5 ml;
∙ 1996-10-18;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ TAKEDA CANADA INC;
∙ DIN: 02206021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43011
∙ IDELVION
∙ coagulation factor ix (recombinant) – albumin fusion protein (rix-fp) 1000 unit / vial;
∙ 2019-07-04;